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Streptococcus sanguinis is the second most common causative agent of bacterial 
infective endocarditis (IE). Risk of S. sanguinis IE is dependent on pre-disposing damage 
to the heart valve endothelium, which results in deposition of clotting factors for formation 
of a sterile thrombus (referred to as vegetation). Despite medical advances, high mortality 
and morbidity rates persist. Molecular characterization of S. sanguinis virulence 
determinants may enable development of prevention methods. In a previous screen for S. 
sanguinis virulence determinants by signature-tagged mutagenesis (STM) an attenuated 
mutant was identified with a transposon insertion in the nrdD gene, encoding an anaerobic 
 xvi 
xvii 
ribonucleotide reductase. Evaluation of this mutant, as well as an nrdD in-frame deletion 
mutant, JFP27, by a soft-agar growth assay confirmed the anaerobic growth sensitivity of 
these strains. These studies suggest that an oxygen gradient occurs at the site of infection 
which selects for expression of anaerobic-specific genes at the nexus of the vegetation. The 
random STM screen failed to identify any favorable streptococcal surface-exposed 
prophylactic candidates. It was also apparent that additional genetic tools were required to 
facilitate the in vivo analyses of mutant strains. As it was desirable to insert antibiotic 
resistance markers into the chromosome, we identified a chromosomal site for ectopic 
expression of foreign genes. In vitro and in vivo analyses verified that insertion into this 
site did not affect important cellular phenotypes. The genetic tools developed facilitated 
further in vivo screening of S. sanguinis cell wall-associated (Cwa) protein mutants. A 
directed application of STM was employed for a comprehensive analysis of this surface 
protein class in the rabbit model of IE. Putative sortases, upon which Cwa proteins are 
dependent for cell surface localization, were also evaluated. No single S. sanguinis Cwa 
protein was determined essential for IE by STM screening; however competitiveness for 
colonization of the infection site was reduced for the mutant lacking expression of sortase 
A. The studies described here present a progressive picture of S. sanguinis IE, beginning 
with surface protein-dependent colonization of the vegetation in early IE, that later shifts to 
a bacterial persistence in situ dependent on condition-specific housekeeping genes, 
including nrdD. 
 
  
 
 
 
INTRODUCTION 
 
The human oral flora 
 More than 700 different bacterial species and phylotypes have been detected in 
the human oral cavity; roughly 50 % of detected species (spp.) are uncultivable ex vivo 
by current laboratory methods. Bacterial spp. native to the oral cavity typically exhibit a 
predilection for specific anatomical sites within the mouth, so that certain sites have a 
subset of commonly associated isolates. The largest biomasses of oral bacteria in the 
mouth exist on the teeth and at the back of the tongue (referred to as the dorsum of the 
tongue). Bacteria on the teeth, which comprise dental plaque, can accumulate to ~1011 
organisms per gram wet weight. The actual content and density of dental plaque is 
dependent on host factors including oral hygiene, and food intake. Epithelial cells 
sloughed from the surface of the tongue often contain greater than 100 organisms per 
cell (81). Resident oral bacteria preferentially colonize different oral surfaces through 
the specific recognition of oral surface receptors by bacterial cell surface adhesins.  
Species identification by 16S rRNA gene sequencing has facilitated the 
detection of previously unrecognized oral species, which do not thrive once isolated 
from the complex oral environment. Aas and colleagues recently described a technique 
for direct extraction of DNA from plaque samples from multiple oral sites, including the 
dorsum and lateral sides of the tongue, buccal fold, hard and soft palates of the mouth,
1 
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labial gingiva and soft tissue surfaces, and supra- and sub-gingival plaques from the 
tooth surfaces. In their comprehensive analysis the researchers identified 141 taxa from 
six different bacterial phyla, including the Firmicutes (low G+C gram-positive species), 
the Actinobacteria (high G+C gram-positive species), the Proteobacteria, the 
Bacteroidetes (including pathogenic Porphyromonas and Prevotella spp.), the 
Fusobacteria, and a phylum of uncultivatable species, TM7 (1). DNA probe detection 
has also identified species that may be clustered as “bacterial complexes”, as general 
indicators of oral health (237, 238). For example, species associated with clinical 
aspects of periodontal disease, including Porphyromonas gingivalis, Treponema 
denticola, and Prevotella intermedia typically cluster, and are exclusive from bacterial 
species commonly associated with healthy oral sites, including Streptococcus gordonii, 
Streptococcus intermedius, Streptococcus oralis, and Streptococcus sanguinis (237). 
Indeed, a healthy oral cavity contains distinctively different flora from one afflicted 
with oral disease. In healthy oral sites sampled by Aas and colleagues, neither spp. 
associated with periodontal disease, nor dental caries (dental cavities) were detected (1). 
Periodontitis is demarcated by the shift in dental plaque flora from gram-positive 
facultative anaerobes to gram-negative obligate anaerobes (237). Dental caries is 
associated with an increase in focal acidogenicity attributed to breakdown of dietary 
sucrose by Streptococcus mutans and Lactobacillus spp. (150). Fluctuations in the oral 
environment are in part defined by the oral microflora; however host behaviors and 
physiology also influence the composition of the flora. 
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Oral streptococci  
 The genus Streptococcus consists of more than 50 spp., the majority of which 
are divisible into one of six phylogenetic clusters on the basis of 16S rRNA gene 
sequence similarity. Streptococcus spp. are gram-positive and spherical or ovoid in 
shape, with a diameter less than 2 µm. The pattern of cellular division in streptococci 
distinguishes this genus from other gram-positive coccus shaped bacteria. In 
streptococci division occurs along a single axis, resulting in chains or pairs of cocci 
(233). The name Streptococcus derives from sreptos, meaning easily bent or twisted, 
like a chain, and kokkos, meaning berry, as a descriptive of the spherical shape of the 
cell. Streptococci are catalase-negative, facultatively anaerobic, non-motile and do not 
produce spores or gas. Unlike enterococci, streptococci do not grow in 6.5 % sodium 
chloride. Streptococci are also distinct from lactococci, which are Lancefield (cell 
surface carbohydrate) group N organisms. 
 Streptococci constitute ~20 % of the normal human oral flora, and are abundant 
at most oral sites, although species within the Streptococcus genera demonstrate 
preferential association with different oral locales. For example, S. salivarius, S. 
parasanguinis and S. australis are typically found on the dorsum of the tongue, whereas 
S. sanguinis and S. gordonii exhibit a predilection for the tooth surface (1). S. mutans 
associates with teeth along the gingival margin of the tooth and gum tissue, and at pits 
and fissures at the surface of molars (81). In contrast, S. mitis is nearly ubiquitous in the 
oral cavity (1). Among the oral microbes streptococci have been heavily investigated as 
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these bacteria are readily cultivatable, are a major component of the microflora on most 
oral surfaces, and in the case of S. mutans, may be relevant for oral disease. 
S. sanguinis is of particular interest to the research described here. S. sanguinis 
is a member of the mitis group of streptococci, which also includes S. gordonii, S. 
parasanguinis, S. oralis, S. mitis, S. pneumoniae, S. pseudopneumoniae, S. infantis, S. 
cristatus, S. peroris, S. australis and S. sinensis (106, 120). With the exception of S. 
pneumoniae and S. pseudopneumoniae the mitis group streptococci are oral 
commensals, and pioneer colonizers of the tooth surface. S. sanguinis has also been 
classified as a member of its own group, the sanguinis group, in recent literature, which 
was expanded to include S. gordonii and S. parasanguinis as well. In this case, the 
separation between sanguinis and mitis groups is based on the predominance of 
sanguinis group strains that are positive for two catalytic tests, the deamination of 
arginine and the hydrolysis of esculin (71). The majority of mitis group strains are 
negative for these assays.  
 Despite these differences in grouping, both mitis and sanguinis group 
streptococci, and additional oral streptococcal groups are subgroups of a more general 
classification, the viridans group of streptococci. (This term does not encompass S. 
pneumoniae, however; 71.) The term viridans derives from the Latin word viridis, or 
green, which refers to the coloration on blood agar resulting from partial hemolysis of 
erythrocytes by α-hemolytic streptococci, due to the release of streptococcal H2O2 (10). 
While S. sanguinis is positive for α-hemolysis, the designation of viridans for this group 
is confusing given that members of the group have also been documented as γ-
 
5 
hemolytic (no lytic zones observed surrounding colonies on blood agar), and β-
hemolytic (zones of clearing surrounding colonies on blood agar due to complete 
hemolysis of erythrocytes) (233). The viridans group has been described as 
characteristically lacking in features which distinguish other major streptococcal 
pathogens, including β-hemolysis, Lancefield typing (cell wall carbohydrate) of β-
hemolytic streptococci, CAMP test (for Lancefield group B streptococci), and optochin 
sensitivity (S. pneumoniae) (233). 
 The complete genome sequences of many streptococcal species, including a few 
oral streptococcal species, S. mutans UA159, S. gordonii CH1 Challis, and S. sanguinis 
SK36 are currently available (3, 270, 285). The SK36 strain of S. sanguinis was chosen 
for genome sequencing because this strain exhibits definitive characteristics of this 
species, including robust glucan production, superior platelet adhesion and aggregation 
phenotypes (relative to other sequencing candidates), genetic competence, and 
infectivity in the rat model of IE comparable to virulent strains 
(www.sanguinis.mic.vcu.edu/strain_selection.htm). The streptococcal chromosome is 
uniformly a single circular DNA molecule. Among published streptococcal genomes, S. 
sanguinis SK36 has the largest; at 2,388,435 bp, it is roughly 7 to 24 % larger than other 
published genomes (285). The difference in genome size between these species is also 
reflected in the number of predicted encoded proteins. S. sanguinis SK36 is predicted to 
code for 2,274 proteins, whereas S. mutans UA159, and S. gordonii CH1 Challis are 
predicted to encode 1,960 and 2,051 proteins, respectively (3, 270, 285). S. sanguinis 
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SK36 also has the highest G+C genome content of the low G+C streptococci, at 43.4 % 
(285).  
S. sanguinis has a general lack of sequence elements suggestive of genetic 
transfer by transposons or prophage. This may be attributed to the presence of a putative 
DpnII-like system that reduces the efficiency of horizontal gene transfer (HGT) by 
phage infection, conjugative plasmid transfer and plasmid transformation in S. 
pneumoniae (134). However, at least 270 genes of S. sanguinis were predicted as 
candidates for HGT based on phyletic patterns of gene distribution (285). It is likely 
that transformation is the major method accounting for HGT in S. sanguinis SK36. 
(Transformation by chromosomal DNA would be unaffected by the putative DnpII 
restriction system.) S. sanguinis SK36, like several other oral streptococci encodes a 
genetic system for the uptake and integration of foreign DNA in response to a strain-
specific competence inducer, referred to as competence stimulating peptide (CSP) (79). 
In S. pneumoniae 22 proteins are required for chromosomal transformation by this 
quorum sensing system. Orthologs of 20 of these proteins were identified for S. 
sanguinis (285). These reports suggest that the genetic complexity of S. sanguinis may 
be attributed to the acquisition of novel genes by HGT through transformation in situ.  
 
Streptococcal colonization of the oral cavity  
 Shortly after birth, bacteria appear in the mouths of infants as their oral 
microflora begins to take shape. Early on, S. salivarius is detectible (primarily on the 
dorsum of the tongue), and by one month of age all infants are colonized with at least 
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one viridans streptococcal species (201). It is thought that most endogenous flora 
microorganisms are acquired from parents or attendants of the infant. The emergence of 
teeth results in more drastic changes in an infant’s oral flora. The hydroxyapatite 
surface of the tooth, once covered in salivary proteins (the salivary pellicle) presents an 
abundance of binding sites utilized by streptococcal colonizers for retention in the oral 
cavity. S. sanguinis has been shown to bind specific salivary proteins including salivary 
IgA and α-amylase, among the heterogeneous mix of salivary components and 
glycoproteins on the tooth surface (40, 85). The window of colonization of the tooth 
surface by S. sanguinis has been narrowed to ~9 months of age, with the first 
appearance of teeth. In a study of tooth colonization by S. sanguinis, Caufield and 
colleagues discovered that infants with higher salivary proportions of S. sanguinis 
experienced delayed colonization by S. mutans, suggesting competition between these 
streptococci for potential binding sites, nutrient resources, or by release of inter-species 
inhibitors. The latter was supported by the observation that eventual emergence of S. 
mutans resulted in decreased levels of S. sanguinis (40). S. sanguinis, as a major 
component of dental plaque and primary colonizer of the tooth surface, is thought to act 
as a scaffold to bring other bacterial species closer to the surface of the tooth for 
formation of complex multi-species dental plaque. While S. mutans is also a dental 
plaque species, mounting evidence supports the theory that these two species do not 
complacently coexist. Comparisons of sequential colonization of S. sanguinis and S. 
mutans in an in vitro mixed biofilm assay suggest that once one species gains a 
foothold, the other is at a loss and can not overcome the initial disadvantage. However, 
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when co-administered the two strains are capable of forming a mixed species biofilm, 
and thus interact in a way that is much more complex than general antagonism. It has 
been demonstrated that the effectors aiding in competitive colonization in vitro of these 
two species include, for S. sanguinis, H2O2 production, and for S. mutans, production of 
the bacteriocin, mutacin (132). However whether a similar interplay occurs in vivo, in 
which bacteriocins may be inactivated by proteolytic enzymes of dental plaque has not 
been determined. Despite the apparent benefit of S. sanguinis in the oral cavity—as an 
indicator of oral health and putative competitor of pathogenic oral bacteria—S. 
sanguinis is a medically relevant opportunistic agent of infective endocarditis. 
 
Infective endocarditis 
 Infective endocarditis (IE) is a life threatening, non-contagious chronic infection 
of the cardiac valves, or lining of the heart mainly caused by bacterial species, although 
fungi can also be associated with this infection (20). Viral infections are also related to 
development of IE. Cardiac complications, including IE are of great concern for HIV 
patients. A risk factor for bacterial IE in this population is intravenous drug use (45, 
263). Cardiac complications leading to bacterial IE have also been described following 
varicella zoster virus infection (2).  
 A comprehensive review of 26 publications, encompassing more than 3,500 
cases of IE revealed important epidemiological trends for this disease. The mean 
incidence for disease was 3.6 cases per 100,000, per year. The incidence of disease 
increased with age, with fewer than 5 cases per 100,000 in individuals less than 50 yrs 
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to more than 15 cases per 100,000 in individuals over 65 yrs (176). The mean age of 
patients ranged from 36 to 69 yrs. In the preantibiotic era this disease commonly 
affected persons between 30 and 40 yrs. The emergence of antibiotic therapy and 
increased longevity in developed countries has resulted in a shift to more aged IE 
patients (181). The male to female ratio was determined to be roughly two-to-one. 
IE may be classified as sub-acute or acute related to the severity of the clinical 
presentation and progression of the disease. Additional classifications include the nature 
of the valve involved (native vs. prosthetic), and the source of the causative agent, such 
as community acquired infection, nosocomial IE, or IE attributed to intravenous (IV) 
drug use. Risk factors for IE may be classified as cardiac risk factors or risk factors for 
bacteremia. A prosthetic valve is an example of a cardiac risk factor, whereas IV drug 
use and some medical procedures are considered risk factors for bacteremia.  
Native-valve IE (NVE) is classically associated with congenital heat disease and 
chronic rheumatic heart disease. In addition valvular lesions due to valve dysfunction—
attributed to mitral and aortic valve regurgitation, as well as aortic valve stenosis and 
mitral valve prolapse—are major predisposing factors in elderly populations (186). 
NVE most commonly presents as “left sided” IE, with infection of the mitral and aortic 
valves of the heart most common. Prosthetic valve IE (PVE) is divided into late or early 
infection depending on whether infection presents within 60 days of surgery (early) or 
later. This condition is most common within the first 2 months of valve implantation, 
and is often caused by S. aureus and S. epidermidis. Late PVE is more commonly 
attributed to non-staphylococcal organisms, including streptococci, and gram-negative 
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bacteria of the HACEK group (Haemophilus spp., Actinobacillus 
actinomycetemcomitans, Cardiobacterium hominus, Eikenella corrodens, and Kingella 
kingae) (181). IE resulting from IV drug use is more common among younger cohorts 
(30 to 40 yrs.). IV drug users more often present with the tricuspid valve of the heart 
affected. Organisms resulting in IE in this group are typically skin isolates, with S. 
aureus as the most common causative agent. In nosocomial IE, many patients lack 
predisposing cardiac damage associated with NVE. Predominant causative agents of 
nosocomial IE include enterococci and staphylococci, which may be introduced into the 
bloodstream on contaminated catheters or other indwelling devices (176). 
Staphylococci are the most common causative agents of IE, accounting for 44 % 
of NVE, 69 % of intravenous drug user IE, 67 % of early PVE, and 46 % of late PVE. 
The second most common causative agents of NVE and late PVE are streptococci, 
which account for ~31 % and 35 % of infections, respectively (176). The oral 
streptococci are the most common agents of streptococcal IE, and among viridans group 
streptococci, S. sanguinis is most often implicated as the cause of NVE (57, 67, 216, 
272).  
 
Progression of oral streptococcal NVE  
 The development of NVE proceeds in a series of general steps. As described 
above, the first step is predisposing damage to heart valve endothelium. During 
transient bacteremia, streptococci adhere to, and colonize the site of endothelial 
damage. The characteristic lesion of IE, referred to as a vegetation, includes a platelet 
 
11 
and fibrin thrombus, embedded with infective microorganisms and inflammatory 
immune cells. Once attached, the bacteria become engulfed in vegetation components 
as the vegetation enlarges in size, and persist at the site of infection. Dissemination of 
septic emboli may then result in peripheral manifestations of this disease (reviewed in 
176, 177). 
 Following damage to endothelia, sub-endothelial components including 
endothelial matrix proteins triggering blood coagulation are exposed or secreted. During 
thrombosis, induction of pro-inflammatory cytokines results in the up-regulation of 
proteins mediating coagulation, such as tissue factor, a glycoprotein that in surface-
bound or soluble form interacts with soluble factors to form proteolytically active 
thrombin. Thrombin converts plasma fibrinogen to fibrin, which envelops and stabilizes 
the developing blood clot (232). 
The bacteremic event preceding IE by oral streptococci is asymptomatic and 
may result from dental manipulation or less invasive daily tasks. Dental procedures 
resulting in the greatest levels of subsequent bacteremic events include dental 
extraction, periodontal probing in patients with periodontitis, tartar removal from the 
tooth surface, endodontic procedures, and tooth scaling to remove plaque from below 
the gum-line (207). Bacteremic events may also result from mundane daily activities 
like eating, chewing gum, tooth brushing, flossing, or use of toothpicks (75, 86). 
Development of S. sanguinis IE putatively requires adhesin-dependent bacterial 
colonization of the vegetation within minutes of transient bacteremia onset. Surface 
adhesins of streptococci are considered indispensable in the primary interaction with 
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host proteins. Several S. sanguinis surface-exposed cell wall-anchored proteins have 
been determined to be mediators of platelet interaction and activation in vitro (98, 122, 
204). This phenotype has been correlated with virulence in the rabbit model of IE (97). 
The capacity for adherence and aggregation of platelets could be an important factor in 
colonization of the platelet and fibrin matrix during transient bacteremia, and may also 
encourage further deposition of platelets and fibrin for engulfment of streptococci at the 
site of infection. In spite of the course of disease progression described here, and the 
observation that duplication of these conditions incites IE in the rabbit model of the 
disease, there is evidence to suggest that streptococcal colonization of damaged 
endothelium can occur in the absence of the pre-formed aseptic thrombus. In the study 
resulting in this observation, rabbits with induced valve damage, treated with warfarin 
(an inhibitor of fibrin-platelet matrix formation) still had bacterial colonization on the 
surface of the valve. As expected, vegetation formation was altered in these rabbits; 
however they presented with characteristic morbidities of IE, including high fever and 
constant bacteremia. However, the antibiotic therapies administered to these rabbits 
were more effective than in control rabbits that did not receive warfarin, therefore 
suggesting that vegetation formation has an additional benefit for the infective bacteria 
(104). Oral streptococci encode many surface proteins vital for maintenance in the oral 
cavity; yet several proteins which bind to human salivary proteins have also been shown 
to bind extracellular matrix proteins (ECM) in vitro (14, 52). Therefore these proteins 
could potentially facilitate the association of oral streptococci with sub-endothelial 
ECM proteins exposed at the site of tissue damage.  
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Following streptococcal colonization of the vegetation, the progression of the 
disease is, at least in part, due to the pro-inflammatory response initiated by monocytes 
attracted to the site of infection. At the site of infection peripheral blood monocytes are 
proposed to undergo activation resulting in production of pro-inflammatory cytokines 
and tissue factor activity, leading to further coagulation of blood components for 
engulfment of adherent streptococci (176). In the rabbit model of IE, bacteria are 
completely engulfed within three hours of administration (63). In vitro assays of S. 
sanguinis infected endothelial cell monolayers have indicated that pro-coagulant 
activity from tissue factor production is enhanced by soluble IL-1 and TNF-α during 
monocyte co-culture (268, 269). Additionally, ELISA of patient sera has revealed 
increased presence of the pro-inflammatory cytokine Interleukin-6 (IL-6), and the 
cytokine receptor IL-2R, which diminish during treatment with antibiotic alone, or 
antibiotic and cell wall-active antibacterial agents (4, 211). In this scenario, the 
progressive vegetation enlargement in response to cytokine production and tissue factor 
activity would cause multiple pathologies associated with IE (181).  
 Transmission electron microscopy of vegetations isolated from infected rabbits 
shows streptococci embedded in layers of fibrin meshwork (Fig. 1). Oftentimes 
streptococci are found in multiple zones of the vegetation. Multiple rounds of 
streptococcal deposition on the vegetation may occur by re-seeding of vegetation 
components dislodged in the bloodstream. As streptococci are known to not only 
persist, but also grow within the vegetation, it is also possible that the layers observed 
are due to outgrowth from the initial colonization site (63). Within 24 hours of 
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Figure 1. S. sanguinis SK36 vegetation 
 
A transmission electron micrograph of an SK36 vegetation cross-section, resulting from 
an experimental case of IE, is shown. Bacterial cells are electron dense and are spherical 
or ovoid in shape. The bacterial zone is surrounded by fibrin layers.
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Figure 1. S. sanguinis SK36 vegetation  
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administration, streptococci begin to exhibit biofilm-like sessile community 
characteristics, including the development of antibiotic resistant microcolonies (51, 63, 
64). 
If left untreated, IE is uniformly fatal, with death resulting from embolization of 
vegetation components to major organs, or congestive heart failure. Infection-induced 
valvular damage is typically the cause of congestive heart failure in patients with IE. In 
rare cases myocardial infarction results from embolization of vegetation fragments. Up 
to 60 % of embolic IE events involve the central nervous system, and neurological 
complications, including stroke and mycotic aneurism, occur in ~20 to 40 % of patients. 
The spleen, kidney and liver are also commonly affected by systemic embolization and 
seeding of septic vegetation fragments (181).  
 
Symptoms, treatment and prevention of bacterial IE 
 Symptoms of IE are general and include fever, anorexia, weight loss, malaise 
and night sweats. Heart arrhythmias like heart murmur are also common indicators of 
IE, in conjunction with other described symptoms. However, in most cases the heart 
murmur is preexisting and due to valve dysfunction (181, 186). Peripheral 
manifestations include petechiae on the skin, conjunctiva, or oral mucosa owing to 
small hemorrhages following embolization of vegetation pieces. In addition, Osler’s and 
Janeway’s lesions, attributed to the deposition of immune complexes subcutaneously 
and in small blood vessels, respectively, are pathognomonic of IE (181). 
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 In 1994 the “Duke Criteria” for diagnosis of IE was proposed by a group at 
Duke University. The criteria were validated worldwide and then revised in 2000 for 
creation of diagnostic criteria that would identify culture-negative IE with greater 
accuracy (66, 147). The criteria incorporate clinical, laboratory and echocardiographic 
information for informed diagnosis of IE. The proposed criteria were subdivided into 
“major criteria”, including blood culture and echocardiography findings, and “minor 
criteria”. 
 The major blood culture criteria include two positive blood cultures of a typical 
IE organism drawn more than 30 minutes apart, as well as blood cultures described as 
“persistently positive”, meaning two culture sets drawn at least 12 hours apart, or three 
to four sets drawn over more than a 1-hour window. The culture criteria are not 
applicable to culture-negative agents, which has prompted the expansion of detection 
methods to include assays for DNA detection, and immunodetection.  
 Echocardiography may provide strong indication of the presence of a vegetation. 
Transthoracic echocardiography (TTE) is a quick and non-invasive detection tool. 
However some patients are not good candidates for TTE due to issues with visualization 
within the chest cavity. (Obesity, chronic obstructive pulmonary disease, or chest-wall 
deformities complicate the interpretation of TTE results.) Transesophageal 
echocardiography, in which an ultrasound transducer probe is inserted into a patient’s 
esophagus, is an alternative to TTE for enhanced visualization of the vegetation mass 
(181).  
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 Minor criteria for IE diagnosis include predisposing cardiac conditions and 
intravenous drug use, as well as the more general symptoms and peripheral indicators of 
IE described above. The combination of positive factors between the major and minor 
criteria sub-groups results (theoretically) in diagnoses that range from definite IE, to 
possible IE, to rejection of IE being the affliction. 
 The treatment regimen for resolution of IE requires prolonged administration of 
antibiotics. In the case of viridans streptococci the antibiotics suggested differ according 
to the penicillin-susceptibility of the infective agent. The aggressive treatment strategy 
implemented typically requires IV or intramuscular administration of antibiotics daily, 
for a minimum of two weeks. For penicillin-sensitive streptococci ceftriaxone alone, or 
in combination with netilmicin may be recommended. Alternatives include procaine 
benzylpenicillin alone or with gentamycin, or vancomycin for patients allergic to β-
lactam antibiotics. For elimination of intermediate penicillin-resistant viridans 
streptococci procaine benzylpenicillin with gentamycin, or vancomycin may be used 
(176). In extreme cases surgery is required for treatment of IE. Surgical intervention 
encompasses radical valve replacement and removal of the infective vegetation, or 
repair of the damaged heart valve (176, 181). 
 As no vaccine for prevention of IE exists, the most effective prophylactic 
measures include identification of at-risk patients and their education of behaviors that 
might cause bacteremia. American Heart Association (AHA) recommendations for 
patients at high risk for IE emphasize the maintenance of proper oral health and 
antibiotic prophylaxis during dental procedures. Antibiotic prophylaxis is generally 
 
19 
recommended for procedures associated with significant bleeding from hard or soft 
tissues, including periodontal surgery, scaling and tooth cleaning. For efficacy 
antibiotics should be administered, at the latest, 2 hours post-procedure (282). Despite 
improvements in endocarditis outcome through advances in anti-microbial therapy and 
better diagnostic and treatment tools, substantial morbidity and mortality still result 
from IE. Therefore development of alternative preventative methods is called for. 
 
Streptococcal virulence factors for IE 
The investigation of streptococcal virulence factors for IE has included surface-
exposed proteins that would mediate the initial stages of disease. These include the 
major surface-exposed protein class of gram-positive bacteria, the cell wall anchored 
(Cwa) proteins. Cwa proteins are considered particularly important in pathogenesis as 
many have been grouped as MSCRAMMs, or microbial surface components 
recognizing adhesive matrix molecules of host tissue and host cells. The staphylococcal 
MSCRAMMs, clumping factor A (ClfA) and fibronectin binding proteins A and B 
(FnbA, FnbB) have been demonstrated by experimental IE to be important 
pathogenicity factors (177). As their name implies, FnbA and FnbB are capable of 
binding to fibronectin in vitro, and ClfA has fibrinogen binding capacity in vitro; both 
of these proteins are soluble in blood, and fibronectin exists in the extracellular matrix 
of most host tissues (114, 167, 206). 
Streptococcal MSCRAMMs identified as mediators of IE include Hsa of S. 
gordonii, and CbpA of S. sanguinis. Hsa is a serine rich protein with fibronectin binding 
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capacity in vitro, and was shown to contribute to infectivity under competitive 
conditions in the rabbit model of IE (248). CbpA of S. sanguinis was an identified 
mediator of platelet aggregation in vitro (98). A mutant defective for expression of 
CbpA also exhibited reduced infectivity in the rabbit model of IE, suggesting that the 
platelet interaction phenotype contributes to development of IE (97).  
Extracellular production of glucan polymers has also been linked to viridans 
streptococcal adherence phenotypes in vitro and infectivity in vivo. The extracellular 
glucans are synthesized by bacterially encoded glucosyltransferase (Gtf) and 
fructosyltransferase (Ftf) enzymes from a sucrose substrate. In a previous study the 
production of water-soluble glucan by S. sanguinis grown in 5 % sucrose enhanced 
adherence to aortic, mitral and tricuspid valves in vitro, thus suggesting that 
exopolysaccharide production may enhance colonization in the development of IE 
(210). In vivo analysis of an S. mutans mutant deficient for glucan and fructan synthesis 
confirmed that exopolysaccharide production was positively correlated with the 
development of IE in the rat model of infection. In vitro phenotypic analysis suggests 
that glucan and fructan production both enhance streptococcal survival post-
phagocytosis, and putatively mediate adherence to vegetation-like matrices (180). 
However, an S. gordonii gtf mutant maintained infectivity in the rat model of IE; 
therefore the role of sugar-polymer production in development of IE may differ between 
Streptococcus species (277). 
 A family of related lipoproteins, including FimA of S. parasanguinis, has also 
been implicated in streptococcal adherence and virulence phenotypes. A fimA mutant 
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displayed decreased binding to fibrin monolayers in vitro, and was decreased for 
infectivity in the rat model of IE (34). The fimA ortholog in S. mutans, SloC is also 
important for development of IE (126, 197). FimA and SloC are members of ABC 
transport systems for acquisition of extracellular manganese and iron; this specific 
function has also been evidenced as important for S. mutans IE (197). 
 The random signature-tagged mutagenesis (STM) technique (technical details of 
which are further described in Chapter V) was recently applied to S. sanguinis SK36 for 
identification of virulence determinants in the rabbit model of IE. Of 800 transposon 
insertion mutants screened in vivo, five were identified in which insertion mutagenesis 
resulted in a drastic decrease in recovery. In the five strains, genes encoding 
housekeeping functions, including amino acid and nucleic acid synthesis, and the ability 
to survive in anaerobic conditions (further detail is provided in Chapter III) were 
mutated (198). Genes considered virulence factors for development of IE, including 
MSCRAMMs and lipoproteins were not identified in this screen.
 
  
MATERIALS AND METHODS 
 
Bacterial strains, growth media and chemicals 
 Strains and plasmids used in the described studies are listed in Table 1. S. sanguinis 
SK36, a human oral isolate was obtained from Mogens Killian (University of Aarhus, 
Denmark) (124). S. sanguinis strains were routinely cultured under a reduced O2 condition 
created by gas exchange with the final gas mixture unknown, a 6 % O2 condition (10 % H2, 
10 % CO2, and 80 % N2), or in an anaerobe chamber (Forma Scientific, Marietta, Ohio) 
with a palladium catalyst to maintain O2 levels less than 1 ppm. All culture media were 
purchased from Difco. S. sanguinis strains were routinely cultured in brain heart infusion 
(BHI) (Difco) media for liquid culture, or on Tryptic soy broth (TSB) (Difco) containing 
1.5 % agar (TSA). Soft-agar studies required growth of S. sanguinis strains in TSB 
supplemented with 1 % low melting point (LMP) agarose. For transformation experiments 
S. sanguinis strains were cultured in Todd-Hewitt broth containing 2.5 % heat-inactivated 
horse serum (TH-HS). For this purpose TH broth was adjusted to a pH of 7.6, filter 
sterilized, and stored at -20 ºC. TH broth was thawed and supplemented with 2.5 % HS 
immediately before use. For chromosomal DNA preparation S. sanguinis was grown in 
BHI supplemented with 20 mM DL-threonine (BHIT). When required for selective growth 
of S. sanguinis, erythromycin (Em), chloramphenicol (Cm), spectinomycin (Sc),  
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Table 1. Bacterial strains and plasmids used  
 
S. sanguinis  Genotype or description Source 
SK36 Human plaque isolate (124)  
6-26 Cmr; nrdD::magellan2, derived from SK36 (198)  
3-24 Cm
r; SSA_0707-SSA_0708 intergenic region::magellan2, 
derived from SK36 (198) 
VT1614  Knr; ΔsrpA::aphA-3, derived from SK36 (204)  
JFP27 ΔnrdD, derived from SK36 This study 
JFP36 Emr; Δ0169::pSerm, derived from SK36 This study 
JFP56 Spr; Δ0169::aad9, derived from SK36 This study 
JFP76 Tetr; Δ0169::tetM, derived from SK36 This study 
CWA STM Cmr; SSA_#::Himar1 derived magellan2 This study 
SRT18 Cmr; srtC::magellan2 This study 
SRT21 Cmr; srtA::magellan2 This study 
SRT24 Cmr; srtB::magellan2 This study 
JFP42  Scr; ΔsrtA::aad9  This study 
JFP44 Knr; ΔsrtB::kan This study 
JFP47 Scr, Knr; ΔsrtA::aad9, 0169::srtAkan This study 
JFP42 (pJFP50) Scr, Emr; ΔsrtA::aad9 (pJFP50)  This study 
JFP52 Scr, Emr; ΔsrtA::aad9 (pJFP52)  This study 
JFP62  Spr, Emr; ΔsrtA::aad9 (pJFP62)  This study  
Plasmid Genotype or description Source 
pVA2606 Kn
r; suicide vector derived from pUC19 by replacement 
of bla with aphA-3 (198) 
pJFP27 Knr; pVA2606 containing ΔnrdD This study  
pVA838 Emr, Cmr; E. coli-Streptococcus shuttle plasmid (154)  
pJFP29 Emr; pVA838 containing the 2.7-kb nrdD locus This study  
pJFP30 Emr; pVA838 containing the 2.4-kb nrdD locus This study  
pJFP34  Knr; derivative of pVA2606 with 0169  This study  
pJFP36 Knr, Emr; derivative of pJFP34 with pSerm This study  
pJFP46 Knr; derivative of pJFP34 with AscI, NotI in 0169 This study  
pJFP56 Scr; derivative of pJFP46 with aad9 This study  
pJFP76 Tetr; derivative of pJFP46 with tetM This study  
pJFP16 Knr; derivative of pVA2606 containing 3.3 kb nrdD::cat (196) 
pCM18 Emr; pTRKL2-PCP25-RBSII-gfpmut3-T0-T1 (90)  
pJFP50 Emr, Cmr; pVA838 containing the 1.112 kb srtA locus This study  
pJFP52 Emr; pCM18 containing the 0.8 kb srtA locus This study  
pJFP62 Emr, Cmr; pVA838-PCP25-srtA This study  
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kanamycin (Kn) and tetracycline (Tet) were used at 10, 5, 200, 500, and 5 μg ml-1, 
respectively.  
Electromax E. coli DH10B (Invitrogen) was used as a bacterial host for plasmid 
construction. All E. coli strains were cultured in Luria-Bertani (LB) medium, or on LB 
containing 1.5 % agarose (LA). When required for E. coli X-gal was added at 40 or 60 µg 
ml-1. For selective culture of E. coli, Kn, Em, Cm, Tet, and Sc were used at 50, 300, 5, 2.5, 
and 100 µg ml-1, respectively.  
 
DNA Manipulations  
 Chromosomal DNA was isolated from S. sanguinis SK36 as described previously 
(126). Labeling and detection in Southern dot-blotting was performed by the Genius 
digoxigenin system (Roche Molecular Biochemicals). PCR was routinely performed in a 
GeneAmp 960 thermal cycler (PE Biosystems), MyCycler (Bio-Rad), or an MJ Research 
PCT-200 thermal cycler (Bio-Rad). Real-time quantitative PCR was preformed with a 
7500 Fast Real Time PCR System (Applied Biosystems). PCR amplification was 
performed using Platinum® PCR Supermix (Supermix) or High Fidelity Platinum® PCR 
Supermix (HIFI Supermix) (Invitrogen). PCR reaction mixtures typically included 0.2 
pmol µl-1 primers, and S. sanguinis SK36 chromosomal DNA or PCR amplicon as template 
at 0.2 ng µl-1. Plasmid DNA as PCR template was used at 0.01 ng µl-1. Oligonucleotide 
primers were synthesized by the Nucleic Acids Research Facility of Virginia 
Commonwealth University or Integrated DNA Technologies. Restriction enzymes were 
purchased from New England Biolabs Inc. and used according to the manufacturer’s 
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instructions. DNA purification from agarose was routinely performed using Quantum Prep 
Freeze ’N Squeeze columns (Bio-Rad). For plasmid DNA extraction form E. coli the 
Quantum Prep Plasmid Mini-Prep Kit (Bio-Rad) or the QiaPrep Spin Miniprep Kit 
(Qiagen) was used. Purification of PCR products was performed using the MinElute PCR 
Purification kit (Qiagen). T4 DNA ligase (Invitrogen) was routinely used for cloning 
purposes, as directed by the manufacturer. 
 
Development and screening of S. sanguinis SK36 mutant strains 
The sequences of most primers described in this section are given in Appendix A.  
Construction of JFP27 (ΔnrdD): Gene Splicing by Overlap Extension (Gene SOEing 
(105) was used to construct an internal, in-frame deletion of the nrdD gene with the fusion 
of the first 12 codons and last 14 codons. Oligonucleotide pairs ARTR-SalI-24495-up and 
ARTR-23327-dn, and ARTR-21212-up and ARTR-SalI-20031-dn were used in the first 
PCR with S. sanguinis SK36 chromosomal DNA (gDNA) template and Supermix. The 
cycling conditions were as follows: One cycle at 94 ºC for five min; followed by 30 cycles 
at 94 ºC for five min, 55 ºC for 30 sec, and 72 ºC for one min; and a final extension step at 
72 ºC for 7 min. The resulting PCR products were gel extracted, purified (Bio-Rad), and 
concentrated by precipitation with 3 M NaOAc and 95 % EtOH. The purified products 
were adjusted to 4 ng µl-1 and combined at a 1:1 ratio for amplification in a second PCR 
reaction with primers ARTR-SalI-24495-up and ARTR-SalI-20031-dn. The cycling 
conditions used were as follows: one cycle at 94 ºC for 40 sec; followed by 30 cycles of  
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94 ºC for 40 sec, 58 ºC for 30 sec, and 72 ºC for 6 min; and a final extension step at 72 ºC 
for 7 min.  
The band of the anticipated size was gel extracted, purified and concentrated as 
described above. The ARTR-24495/20031 product was then cloned into suicide plasmid 
pVA2606 (Fig. 2A) via a SalI restriction site for creation of the pJFP27 (Fig. 2B). E. coli 
DH10B was electrotransformed with pJFP27 and plated on LA containing Kn and X-gal. 
Blue-white screening of resulting colonies identified pJFP27 transformants. Plasmid DNA 
was prepared (Bio-Rad) and screened by PCR with ARTR-SalI-24495-up and ARTR-SalI-
20031-dn primers. DNA sequence analysis confirmed proper insertion and in-frame 
deletion of nrdD.  
S. sanguinis SK36 was transformed with 500 ng SspI-linearized pJFP27 and plated 
on TSA. Colonies were inoculated into overnight broth cultures for rapid PCR analysis by 
the boiled cell extraction technique. Briefly, 1 ml of each overnight culture was centrifuged 
(18,000 x g for 2 min) and the cell pellet was washed in 1 ml 10 mM Tris-HCl (pH 8.0), 
and suspended in 100 µl 10 mM Tris-HCl. Tubes were then boiled for 5 min, cooled and 
centrifuged again, and 100 µl of supernatant was transferred to a new tube. Two µl of the 
supernatant served as template for PCR screening reactions with primers ARTR-SalI-
24495-up and ARTR-SalI-20031-dn. A clone that produced a PCR amplicon consistent 
with nrdD deletion was selected for further study and named JFP27.  
Construction of plasmids for nrdD complementation: Two nrdD gene region constructs 
were designed for complementation studies. Primers specific for the two constructs, 
ARTR-EcoI-up1, ARTR-EcoRI-up2 and ARTR-EcoRI-dn were used in PCR reactions 
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Figure 2. Plasmid maps of pVA2606 and pJFP27 
 
A) The pVA2606 vector was derived from the E. coli plasmid pUC19 by replacement of 
the bla ampicillin resistance determinant with the aphA-3 kanamycin resistance (KnR) 
cassette (198). The plasmid contains the pMB1 origin of replication (ori) from pBR322, 
but includes additional modifications for temperature-determined copy number, roughly 75 
plasmid copies per cell at 37 ºC (and >200 copies per cell at 42ºC). The multiple cloning 
site (MCS), in red, is in frame with the lacZα gene (lacZ-alpha) for screening of MCS 
insertion by α-complementation (289).  
 
B) The Gene splicing by overlap extension (Gene SOEing) PCR technique was used to 
create an in-frame deletion of the nrdD gene. Flanking primers were designed for 
amplification and cloning of the mutation site, and neighboring ORFs, including a putative 
membrane protein gene (mem) upstream of nrdD, a hypothetical protein gene overlapping 
the 3’ end of nrdD (hypo), as well as two putative downstream acetyltransferase genes (ac1 
and ac2). The SalI restriction sites incorporated into flanking primers permitted cloning of 
the construct into pVA2606 to create pJFP27. The plasmid was made linear by SspI 
digestion prior to transformation of SK36. 
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with S. sanguinis SK36 gDNA template, and Supermix (Invitrogen). Cycling conditions 
for amplification with the up1/dn primer pair were: one cycle at 94 ºC for five min; five 
cycles of 94 ºC for 40 sec, 41 ºC for 30 sec, and 68 ºC for 3 min; then 25 cycles of 94 ºC 
for 40 sec, 52 ºC for 30 sec, and 68 ºC for 3 min; followed by a final extension at 68 ºC for 
7 min. Cycling conditions for amplification with the up2/dn primer pair were: one cycle at 
94 ºC for five min; five cycles of 94 ºC for 40 sec, 41 ºC for 30 sec, and 68 ºC for 3 min; 
then 25 cycles of 90 ºC for 40 sec, 54 ºC for 30 sec, and 68 ºC for 3 min; followed by a 
final extension at 68 ºC for 7 min. 
PCR products were gel extracted and purified (BioRad) as described above and 
cloned into the pVA838 shuttle vector (Fig. 3A) via EcoRI restriction sites, creating 
plasmids pJFP29 and pJFP30 (shown in Fig. 3B and 3C, respectively). E. coli DH10B was 
electrotransformed with pJFP29 and pJFP30, and transformants were selected on LA 
containing Em. Plasmid DNA was extracted (BioRad), and then screened for the insert by 
EcoRI digestion. Sequencing with pVA838 specific primers, pVA838-2939 and pVA838-
5331, confirmed correct construct insertion at splicing junctions. The plasmids were 
introduced into S. sanguinis strains by transformation with 250 ng of DNA. Transformants 
were selected by plating on TSA containing Em. PCR with pVA838-specific primers was 
used to confirm the presence of appropriate plasmids.  
PCR analysis of 6-26 (pJFP29) and 6-26 (pJFP30): Lenticular colonies of 6-26 were 
isolated from TSB-LMP agarose tubes by a sterile pipette tip and cultured in 5 ml BHI 
with Em overnight, under a reduced O2 condition. An aliquot of the overnight culture was 
used to prepare a -70 ºC, 30 % glycerol freezer stock, for later analysis by the soft-agar 
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Figure 3. Plasmid maps of pVA838, pJFP29 and pJFP30 
 
A) The pVA838 cloning vector is capable of replication in S. sanguinis and E. coli. It 
confers Emr to both E. coli and streptococci. The Cmr cat marker is expressed only in E. 
coli, and may be inactivated by insertion at the internal EcoRI site. This is a low copy 
number plasmid in E. coli with ~8 plasmid copies/chromosomal equivalent in E. coli V854 
(154). In the described studies this vector was employed for cloning S. sanguinis SK36 
genes for complementation studies. 
 
B) The nrdD gene of S. sanguinis SK36 was PCR amplified and cloned into the pVA838 
EcoRI restriction site to interrupt expression of cat, the chloramphenicol resistance 
determinant gene to create pJFP29. In the insert nrdD was preceded by its predicted native 
upstream terminator, promoter, and ribosome binding site.  
 
C) The nrdD gene of S. sanguinis SK36 was PCR amplified and cloned into the pVA838 
EcoRI restriction site to interrupt expression of cat, the chloramphenicol resistance 
determinant gene, to create pJFP30. In the insert nrdD was preceded by its predicted 
ribosome binding site only. 
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assay as described above. The same overnight culture was prepared for PCR amplification 
by boiled cell extraction (as described above), or washed for use as template: 1 ml of cells 
were centrifuged at 18,000 x g for 1 min; then washed twice in 1 ml of 10 mM Tris-HCl 
(pH 8.0), and subsequently suspended in 100 µl of 10 mM Tris-HCl. Boiled cell and whole 
cell preparations were PCR amplified in reactions containing ARTR-SalI-24495-up and 
ARTR-SalI-20031-dn primers, 3 µl of template, and 45 µl Supermix in a 50 µl reaction. 
Cycling conditions were as follows: one cycle of 94 ºC for 5 min; 30 cycles of 94 ºC for 40 
sec, 58 ºC for 30 sec, and 72 ºC for 6 min; and a final extension cycle at 72 ºC for 7 min.  
Development of JFP36: The S. sanguinis suicide plasmid pVA2606 (Fig. 2A) was used as 
a vector for cloning of the SSA_0169 (0169) locus to generate pJFP34 (Fig. 4A). Primers 
specific for 0169 flanking DNA, 0169-SalI-up and 0169-SalI-dn were used for PCR 
amplification with S. sanguinis SK36 gDNA as template. Cycling conditions were as 
follows: 1 cycle at 95 ºC for 5 min; 5 cycles of 94 ºC for 45 sec, 45 ºC for 45 sec, and 72 
ºC for 1 min and 40 sec; followed by 25 cycles of 94 ºC for 1 min, 59 ºC for 1 min, and 72 
ºC for 1 min and 40 sec; and a final extension step at 72 ºC for 7 min.  
 The resulting PCR products were combined and purified (Qiagen) and digested by 
SalI (NEB) for cloning into the SalI digested, shrimp alkaline phosphatase (SAP) (Roche) 
treated pVA2606 vector. Fifty ng of the digested insert and vector were then combined for 
ligation (Invitrogen). E. coli DH10B was electroporated with the resulting plasmid, 
pJFP34, and transformants were selected on LA containing Kn and X-gal. Plasmid DNA 
was extracted as described above (Bio-Rad) and integration of the insert determined by 
SalI digest. 
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Figure 4. Plasmid maps of pJFP34 and pJFP36 
 
A) SalI restriction sites were incorporated into an amplicon of S. sanguinis SK36 by PCR 
amplification. The PCR product included the 0169 ORF flanked by ~700 bp of upstream 
and downstream genomic DNA sequence. The amplicon was cloned into the SalI 
restriction site of pVA2606 to create pJFP34. Blue/white screening identified E. coli 
transformants with the 0169 insert (as a result of insertional inactivation of lacZα). 
 
B) A unique NcoI site central to 0169 in pJFP34 was adopted for cloning of the 
erythromycin resistance cassette pSerm. The resulting plasmid, pJFP36 was transformed 
into S. sanguinis SK36 for creation of the erythromycin resistant strain, JFP36. 
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To develop pJFP36 (Fig. 4B), we adopted the erythromycin resistance cassette, 
pSerm, as a selective marked based on the knowledge that this gene could be expressed in 
both streptococci and E. coli. The pSerm construct was kindly provided by Dr. Don 
Morrison, University of Illinois at Chicago. Primers specific for pSerm, pSerm-NcoI-up 
and pSerm-NcoI-dn were used in PCR with Supermix (Invitrogen) for integration of NcoI 
RE sites at the 5’ and 3’ ends of the pSerm construct, with a pSerm PCR amplicon as 
template. PCR cycling conditions were as follows: 1 cycle at 94 ºC for 5 min; 5 cycles at 
94 ºC for 30 sec, 40 ºC for 30 sec, and 72 ºC for 1 min; 25 cycles of 94 ºC for 30 sec, 52 ºC 
for 30 sec, and 72 ºC for 1 min; followed by a final extension step at 72 ºC for 1 min. 
The PCR product was purified and digested by NcoI for cloning into the pJFP34-
encoded 0169 via an NcoI restriction site (the NcoI site is 39 bp within 0169). The digested 
insert and vector were combined at a 1.5 to 1 molar ratio for ligation (Invitrogen). The 
resulting ligated product was transformed into E. coli DH10B, and Emr, Knr clones were 
selected for further evaluation. Orientation of 0169 and pSerm in pJFP36 was determined 
by BssHII and XcmI digest, respectively. S. sanguinis SK36 was transformed with 45 ng 
pJFP36 and transformants were selected on TSA containing Em. Sequencing with primers 
0169-SalI-up, 0169-SalI-dn, Jxn-up, and Jxn-dn confirmed correct construct integration 
into S. sanguinis genomic DNA for creation of JFP36. 
Development of JFP56: A linker with AscI and NotI sites was integrated into the NcoI site 
of pJFP34 for development of pJFP46 (Fig. 5A). The 0169RE-up and 0169RE-dn 
oligonucleotides include complementary sequences with, at the 5’ end of 0169RE-up an 
NcoI sticky end, followed by a NotI site and AscI site. The 0169RE-dn sequence also 
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includes NotI and AscI sites. Complementary base pairing between the two 
oligonucleotides results in a 5’ NcoI sticky end overhang for ligation into the NcoI site of 
pJFP34. A base pair change at one end of the oligonucleotide (in bold in Appendix A) 
abolishes the second NcoI site for a series of unique cloning sites including AscI, NotI and 
NcoI.  
The 0169RE-up and 0169RE-dn oligonucleotides, at 0.5 pmol µl-1 were 5’ 
phosphorylated with 0.25 U µl-1 T4 DNA Kinase (Invitrogen) in the presence of 0.1 M 
ATP for 30 min at 37 ºC. The reaction mixtures were then combined and heated at 94 ºC 
for two min, then put at room temperature for gradual cooling to facilitate annealing 
between the complementary base pairs of 0169RE-up and 0169RE-dn. The linker was 
combined in a 6:1 ratio (linker:vector) with NcoI digested, SAP treated pJFP34 in the 
presence of T4 DNA ligase (Invitrogen) for ligation. E. coli DH10B was transformed with 
the ligation product with cells containing the plasmid selected by Knr. Clones containing 
the RE-linker were identified by NotI digestion of plasmid DNA. To eliminate the 
possibility of linker multimerization at the cloning site, plasmids identified as containing 
the linker were digested with NotI, gel electrophoresed, and the correct size linear band 
extracted from the gel. The band was purified and concentrated as described above (Bio-
Rad). Fifteen fmol of the plasmid was then re-ligated in a 20 µl reaction volume. The 
ligation product was transformed into E. coli DH10B cells, and plasmid transformants 
selected on LA with Kn. Plasmid DNA was extracted from E. coli (Bio-Rad), and plasmids 
containing the linker identified by AscI digestion. Sequence fidelity was confirmed by 
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sequencing with Jxn-up and Jxn-dn primers. The resulting plasmid, pJFP46 was used for 
cloning of tetM and aad9 in development of S. sanguinis JFP76 and JFP56.  
For construction of pJFP56, the aad9 cassette from pR412 (161) was cloned into 
the NotI and NcoI RE sites of pJFP46 (Fig. 5B). The spectinomycin resistance cassette was 
PCR amplified with Sc-NotI-up and Sc-NcoI-dn primers, with as pR412 template in a 
reaction containing HIFI Supermix. The PCR cycling conditions used were as follows: one 
cycle at 95 ºC for 4 min; followed by 30 cycles at 94 ºC for 30 sec, 56 ºC for 30 sec, and 68 
ºC for 1.5 min; and a final extension step at 68 ºC for 7 min. The resulting PCR product 
was purified (Qiagen), and subsequently digested by NotI and NcoI. The digested PCR 
product was combined in a 3:1 ratio with the NotI and NcoI double digested and SAP 
treated pJFP46 vector for ligation (Invitrogen). E. coli DH10B was transformed with the 
ligation product, and resulting transformants were selected on LA containing Sc. Plasmid 
DNA was extracted from E. coli clones (Qiagen) and digested by NotI and NcoI for 
confirmation of the presence of the aad9 insert in pJFP56. S. sanguinis SK36 was 
transformed with 200 ng pJFP56, and transformants were selected on TSA containing Sc. 
Sequencing with primers 0169-SalI-F, 0169-SalI-up, Spc638, Spc246, Jxn-up and Jxn-dn 
validated integration of the correct construct into S. sanguinis gDNA.  
Development of JFP76: For construction of pJFP76, the tetM cassette from pJM133 (88) 
was cloned into the NotI and NcoI RE sites of PJFP46 (Fig. 5C). The tetracycline 
resistance cassette was PCR amplified from pJM133 template by Tet-NotI-up and Tet-
NcoI-dn primers, in a reaction containing HIFI Supermix (Invitrogen).  
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Figure 5. Plasmid maps of pJFP46, pJFP56 and pJFP76 
 
A) The pJFP46 vector was derived from the E. coli plasmid pJFP34 by insertion of an 
AscI, NotI, linker in the 0169 insert to create a small, multiple cloning site region for 
insertion of antibiotic resistance markers. 
 
B) The cloning site linker of pJFP46 was adopted for development of JFP56. The aad9 
gene of pR412 (161) was cloned into the NotI and NcoI restriction sites, and the resulting 
plasmid was propagated in E. coli prior to transformation into SK36. The aad9 resistance 
determinant confers spectinomycin resistance; the resulting SK36 derivative was named 
JFP56.  
 
C) The cloning site linker of pJFP46 was also used for development of pJFP76. The tetM 
gene of pJM133 (88) was cloned into the NotI and NcoI restriction sites, and the resulting 
plasmid was propagated in E. coli DH10B before transformation of SK36 to create a 
tetracycline resistant derivative of SK36, designated JFP76.  
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 The PCR cycling conditions used were as follows: 1 cycle of 94 ºC for 5 min; 
followed by 30 cycles of 94 ºC for 40 sec, 45, 49.3 and 50 ºC for 30 sec, and 68 ºC for 2 
min and 10 sec; and a final extension step at 68 ºC for 7 min. The resulting PCR product 
was purified (Qiagen), and subsequently digested by NcoI and NotI. The digested PCR 
product was combined in a 3:1 ratio with the NcoI and NotI double digested and SAP 
treated pJFP46 vector for ligation (Invitrogen). E. coli DH10B was transformed with the 
ligation product, and resulting transformants were selected on LA containing Tet. Plasmid 
DNA was extracted from E. coli clones (Qiagen) and digested for confirmation of the 
presence and orientation of the tetM insert by AscI and HindIII digest, respectively. S. 
sanguinis SK36 was transformed with 200 ng pJFP76 and transformants were selected on 
TSA containing Tet. Sequencing with primers Jxn-up, Jxn-dn, Tet-NcoI-dn, TetMF1 and 
TetMF2 validated the correct construct integration into S. sanguinis genomic DNA for 
creation of JFP76.  
Development of pJFP16: Plasmid pJFP16 was used for genetic competence comparison of 
JFP36 and SK36. To construct pJFP16, the mini-transposon containing cat and 
approximately 1.4 kb of flanking DNA was amplified from the STM strain 6-26 using 6-
26-BamHI-up and 6-26-BamHI-dn primers, and Supermix (Invitrogen) (198). The PCR 
product was gel-purified (Bio-Rad) and ligated (Invitrogen) into pVA2606 via BamHI 
restriction sites. Ligation products were electroporated into E. coli DH10B and 
transformants selected on LA with Kn, Cm and X-gal. Plasmid DNA was extracted as 
above and orientation of the insert determined by EcoRI and NdeI digest.  
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PCR amplification of ORFs for in vitro transposition: PCR was performed in 50 μl 
reaction volumes with 45 µl of HIFI Supermix (Invitrogen), or 100 µl reaction volumes 
with 90 µl of HIFI Supermix (Invitrogen), with S. sanguinis SK36 gDNA template, and the 
ORF-specific primer set (Appendix B). The cycling conditions used were as follows: 1 
cycle at 94 ºC for five min, followed by 30 cycles of 94 ºC for 40 sec, 53 to 56.5 ºC for 30 
sec, and extension at 68 ºC for 3 min. This was followed by a final extension at 68º for 7 
min.  
In vitro transposition of PCR amplicons: The signature-tagged plasmid library used for in 
vitro transposition was previously described (198). The plasmids were pre-screened by Dr. 
Todd Kitten to select 40 with signature-tags producing high-signal intensity, and minimal 
cross-reactivity in dot-blot DNA hybridization. The in vitro transposition reaction included 
1.2 µg of PCR product template (above), 0.5 µg µl-1 of pJFP1-encoded magellan2 
containing a unique sequence tag (referred to numerically, 1-40), 2 µl of 10 x NEB4 
buffer, 100 µg ml-1 BSA (New England Biolabs Inc.), and 1µl of 2 mg ml-1 MarC9 Tnp in 
a total volume of 20 µl. Transposition was performed at 30 ºC for 1 h. Immediately 
following transposition 380 µl 1 x Tris-EDTA (TE) was added, and an the sample 
extracted with an equal volume of phenol/CHCl3, followed by a second extraction with 
CHCl3. Organic phase separation was performed in 2 ml Phase-Lock Gel Heavy tubes (5 
Prime).  
DNA was precipitated from the aqueous phase with the addition of 2 µl oyster 
glycogen or 1 μl Ethachinmate (Wako), 0.1 volumes of 3 M NaOAc, and 1 ml of EtOH, 
and suspended in 14 µl of 0.1 x TE. Gaps in the DNA sequence following transposition 
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were filled by T4 DNA polymerase (Invitrogen). The reaction mixture contained 2 µl of 10 
x T4 DNA polymerase buffer, 2 µl of 1 mM dNTPs, 50 µg µl-1 of BSA (New England 
Biolabs), 1 µl of T4 DNA polymerase (1-3 units µl-1), and 14 µl of transposition product. 
The entire reaction was incubated at 12 ºC for 15 min, and was terminated with the 
addition of EDTA to 10 mM. The enzyme was then heat inactivated by incubation of the 
mixture at 75 ºC for 20 min. To remove residual dNTPs and enzyme the transposition 
products were purified on a column from the MinElute PCR Purification Kit (Qiagen), 
with DNA eluted from the column in 16 µl 0.1 x TE. Nicks in the DNA phosphate 
backbone were the sealed by a ligation reaction. For this, 15 µL of eluate was combined 
with 10 x T4 DNA ligase buffer and 1 µl of T4 DNA ligase (Invitrogen) in a total reaction 
volume of 20 µl. Ligation was performed at room temperature for 1 h. T4 DNA ligase was 
subsequently inactivated by incubation of the mixture at 75 ºC for 10 min. Ten µl of the 
transposition product was then used for transformation of S. sanguinis SK36. 
Diagnostic PCR for estimation of transposon location: Chloramphenicol resistant clones 
were selected and inoculated into 2 ml BHI containing Cm, in a 48 well block. The block 
was covered with an air-pore tape strip and incubated overnight at 6 % O2, 37 ºC. Once 
cultures reached turbidity indicative of stationary phase 1 ml was removed and centrifuged 
in a bench top microcentrifuge at 14k rpm for 1 min. The cells were washed with Tris-HCl 
(pH 8.0) for use as template in PCR, as described above. For diagnostic PCR primers 
flanking the ORF were used in conjunction with the magellan2 inverted repeat primer 
Mout. For each clone two PCR reactions were performed, one primed by the ORF-up 
primer and Mout, and a second PCR primed by the ORF-dn primer and Mout. PCR 
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reactions included 18 µl Platinum Supermix (Invitrogen), 1.2 µl of the washed cells as 
template, and primer pairs at 0.2 pmol µl-1. The cycling conditions used were: 1 cycle at 94 
ºC for 1 min, followed by 30 cycles of 94 ºC for 30 sec, 56 ºC for 30 sec, and 72 ºC for 2 
min 30 sec; amplification terminated with a final single extension step at 72 ºC for 7 min.  
Gene SOEing for creation of JFP42 and JFP44: Mutagenesis of srtA or srtB was 
conducted in a three-step approach. The gene SOEing (105) strategy used is shown in 
Figure 6. The templates for PCR included S. sanguinis SK36 gDNA; pR412 (161); or the 
kanamycin resistance cassette, kan, expressed from a synthetic promoter designed for S. 
pneumoniae (243).  
 In the first step, antibiotic resistance markers and 5’ and 3’ regions of the S. 
sanguinis gene were amplified in three separate PCR reactions. pR412 (primer set spcUP 
(+) and spcDO (-)), or kan (primer set DAM303 (+) and DAM347 (-)) was used as 
template. Cycling conditions for amplification of aad9 were: 1 cycle of 94 ºC for 5 min, 30 
cycles of 94 ºC for 45 sec, 50 ºC for 45 sec, and 68 ºC for 1.5 min, and a final extension 
cycle at 68 ºC for 7 min. Cycling conditions for amplification of kan were 1 cycle of 94 ºC 
for 5 min, 30 cycles of 94 ºC for 45 sec, 55 ºC for 45 sec, and 68 ºC for 1.3, and a final 
extension at 68 ºC for 7 min.  
 For srtA and srtB constructs the 5’ portion of the gene and upstream sequence was 
amplified with consensus primer 1 (+), and primer 2 (-) designed to include a 5’ tail 
complementary to the antibiotic resistance primer (+). For both constructs the 3’ portion of 
the gene and downstream sequence was amplified with primer 3 (+) which includes a 5’ 
tail complementary to the antibiotic resistance primer (-), and consensus primer 4 (-). The 
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cycling conditions for srtA1 and srtA2, srtA3 and srtA4 reactions were: 1 cycle at 94 ºC 
for 5 min, followed by 30 cycles of 94 ºC for 45 sec, 60 ºC for 45 sec, and 68 ºC for 1.75 
min, followed by a final extension cycle at 68 ºC for 7 min. The cycling conditions for 
srtB1 and srtB2, srtB3 and srtB4 reactions were: 1 cycle at 94 ºC for 5 min, followed by 30 
cycles of 94 ºC for 45 sec, a gradient between 55 - 65 ºC for 45 sec, and 68 ºC for 1.3 min, 
followed by a final extension cycle at 68 ºC for 7 min. PCR products from the three 
reactions were purified from remaining primers and reaction buffer (Qiagen).  
In the second step, 5’ or 3’ portions of each gene were fused to antibiotic resistance 
markers in two separate PCR reactions. The cassette aad9 was fused to the 5’ (primer pair 
srtA1 (+) and spcDO (-)) or 3’ (primer pair spcUP (+) and srtA4 (-)) portion of srtA. The 
cassette kan was fused to the 5’ (primer pair srtB1 (+) and DAM347 (-)) or 3’ portion of 
srtB (primer pair DAM303 (+) and srtB4 (-)). The 5’ or 3’ PCR product and antibiotic 
cassette PCR product were combined as the PCR template. Amplification conditions for 
aad9 fusion were: 1cycle 94 ºC for 45 sec, 30 cycles of 94 ºC for 45 sec, 58 ºC for 45 sec 
(5’:aad9) or 54 ºC for 45 sec (aad9:3’), and 68 ºC for 2.75 min; followed by a final 
extension cycle at 68 ºC for 7 min. Amplification conditions for kan fusion were: 1 cycle 
94 ºC for 45 sec, 30 cycles of 94 ºC for 45 sec, a gradient of 55 to 60 ºC for 45 sec, and 68 
ºC for 2.25 min; followed by a final extension at 68 ºC for 7 min. The resulting fusion 
products were purified as described above. 
 The third step created a fusion of the entire construct: the 5’ portion of each gene, 
antibiotic resistance cassette, and the 3’ portion of each gene. For this the 5’:ab cassette 
and 3’:abr cassette products for each gene were combined as template for PCR. Flanking 
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Figure 6. Gene SOEing strategy for sortase mutation  
 
The three-step approach used for mutagenesis of S. sanguinis (Ss) srtA and srtB is 
depicted. Through gene SOEing (105), deletion of the majority of the ORF was coupled 
with insertion of an antibiotic resistance cassette. SOEing was enabled by 5’ tails 
incorporated into primer 2 and primer 3 that were complementary to the (+) and (-) 
antibiotic resistance (Abr) cassette primers, respectively. In the first step the 5’ portion and 
3’ portion of the ORF were amplified, as well as the antibiotic resistance cassette. 
Amplification of the 5’ upstream region of the ORF was primed by pair 1 and 2. 
Amplification of the 3’ downstream region of the ORF was primed by pair 3 and 4. The 
resistance marker was amplified by the (+) and (-) pair. In the second step the antibiotic 
resistance cassette was fused to the 5’ fragment, or 3’ fragment of the gene in a PCR 
reaction primed by 1 and (-), or (+) and 4, respectively. The resulting products were 
combined as template in the third, and final amplification reaction primed by the ORF 
flanking primers 1 and 4. 
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Figure 6. 
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consensus primers were used to amplify the entire construct. For srtA amplification the 
primers srtA1 and srtA4 were used, whereas srtB1 and srtB4 were paired for srtB. Cycling 
conditions for srtA:aad9 fusion were: 1 cycle of 94 ºC for 5 min, followed by 30 cycles of 
94 ºC for 40 sec, a gradient of 54, 58, and 63 ºC for 30 sec, and 68 ºC for 3.75 min, 
followed by a final extension cycle at 68 ºC for 7 min. Cycling conditions for srtB:kan 
fusion were: 1 cycle of 94 ºC for 5 min, followed by 30 cycles of 94 ºC for 40 sec, a 
gradient of 60, and 65 ºC for 30 sec, and 68 ºC for 3.5 min, followed by a final extension 
cycle at 68 ºC for 7 min. The complete mutagenic constructs were purified as described 
above and transformed into S. sanguinis SK36. Transformants were selected by antibiotic 
resistance conferred by the cassette used. DNA sequencing of the srtA mutant with primers 
srtA1, srtA2, srtA3, srtA4, spcDO, spcUP, spc246 and spc638 confirmed sequence fidelity 
of regions flanking srtA in strain JFP42. DNA sequencing of the srtB mutant was 
performed with primers srtB1, srtB2, srtB3, srtB4, DAM303, DAM347, kan306R and 
kan637F confirmed sequence fidelity in regions flanking srtB in strain JFP44.  
Development of JFP47: In this complementation strategy, srtA downstream of its putative 
native promoter and RBS, was recombined into the genomic locus used for creation of 
JFP36, JFP56 and JFP76, SSA_0169 (Fig. 7B). An extensive gene SOEing (105) strategy 
was developed for fusion of srtA with its predicted native promoter upstream of gyrA (Fig. 
7A) to the kanamycin resistance cassette kan. The fusion construct was flanked by 
consensus sequences upstream and downstream of SSA_0169 that would permit 
homologous recombination with the intended insertion locus. A schematic depicting 
progressive amplifications is shown in Figure 7C. 
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 Templates for PCR amplification were SK36 gDNA and a kan PCR product (243). 
Successive rounds of amplification resulted in SOEing of the entire construct. Each 
template was purified (Qiagen) before inclusion in the next PCR reaction. A 
complementary 5’ end to the 0169-2 primer was incorporated in the 0169srtAP fusion 
primer for SOEing of the upstream SSA_0169 region to the srtA promoter and coding 
region. A complementary 5’ end to the DAM303 primer was incorporated in the kansrtA 
fusion primer for SOEing of the kan resistance marker 3’ to srtA. A complementary 5’ end 
to the DAM347 primer was incorporated in the kan0169 primer for SOEing of kan to the 
SSA_0169 downstream region. 
 Amplification of the SSA_0169 upstream and downstream regions was performed 
with the SK36 gDNA template, the 0169-SalI-up [0169-1 in Fig. 7B and 7C, and below] 
and 0169-2 primer pair, or the kan0169 and 0169-SalI-dn [0169-4 in Fig. 7B and 7C, and 
below] primer pair, and HIFI Supermix (Invitrogen). The cycling conditions were as 
follows: 1 cycle of 95 ºC for 5 min; five cycles of 94 ºC for 45 sec, 45 ºC for 45 sec, and 
68 ºC for 45 sec; 25 cycles of 94 ºC for 1 min, 56 and 59 ºC for 1 min, and 68 ºC for 45 
sec; followed by a final extension cycle of 68 ºC for 7 min. The kan cassette was fused to 
the downstream SSA_0169 region by combining a previously amplified kan PCR product 
(see construction of JFP44 above) and the kan0169/0169-SalI-dn PCR product as template 
for amplification with the DAM303 and 0169-SalI-dn primer pair. Cycling conditions 
were: 1 cycle of 94 ºC for 40 sec; 30 cycles of 94 ºC for 40 sec, 50, 55 and 60 ºC for 30 
sec, and 68 ºC for 1.5 min; followed by a final extension cycle at 68 ºC for 7 min.  
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Figure 7. Construction of JFP47 
 
A) The predicted srtA RBS, and srtA coding region were fused to the predicted promoter 
of srtA transcription, 5’ of gyrA. Spacing between the promoter, RBS and start ATG of 
gyrA were conserved, though nucleotides external to the promoter were changed for 
fidelity to the 24 nucleotides preceding srtA. 
 
B) The final PCR amplified fusion construct is shown, along with primer pairs used for 
sequential PCR amplification in synthesis of the larger amplicon. 5’ primer tails enabling 
gene SOEing are indicated by color coding. 
 
C) The overall PCR strategy for creation of the srtA:kan:SSA_0169 fusion is shown. In the 
first step kan and the SSA_0169 downstream region were PCR amplified in separate 
reactions primed by the primers shown. The products were combined as template in a 
SOEing PCR for fusion of the kan cassette with the 3’ region of SSA_0169. A long primer 
incorporating a 5’ tail complementary to SSA_0169, the native gyrA promoter, and srtA 
sequence was for amplification of srtA from SK36 gDNA. The srtA amplicon was 
combined with the kan:SSA_0169 PCR product as template in a reaction for amplification 
with the primer pairs shown. In a final PCR reaction, the fusion construct was combined 
with a PCR amplicon of the 5’ SSA_0169 region as template amplified by flanking 0169 
primers. The flanking SSA_0169 ends of the amplicon permitted recombination of the PCR 
products into the SSA_0169 locus of JFP42. A Knr clone, JFP47 was used in 
complementation studies. 
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Figure 7. 
 
A.  
 
Predicted transcription elements of gyrA (SSA_1220) 
Predicted promoter region of gyrA   gyrA RBS     gyrA 
AACGTTTTTACAAACGGTTCAAAATACTGAAAAATTAAAGAAAATGTGGTATAATATAGGATAGTTTAATATG 
 
gyrA promoter, srtA fusion construct  
Predicted promoter region of gyrA   srtA RBS     srtA 
AACGTTTTTACAAACGGTTCAAAATACTGAAAAATTAAAGAAAATGTCGAATCGTAAAAGAGGACCTCTATATG 
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 Fusion of srtA to the gyrA promoter was performed using the long fusion primer 
0169srtAP and the kansrtA fusion primer with SK36 gDNA as template. The reaction 
mixture was as described above. Cycling conditions were: 1 cycle at 94 ºC for 5 min; 5 
cycles of 94 ºC for 45 sec, 45 ºC for 45 sec, and 68 ºC for 1 min; 25 cycles of 94 ºC for 45 
sec, 55 or 60 ºC for 45 sec, and 68 ºC for 7 min; a final extension cycle was performed at 
68 ºC for 7 min. The resulting PCR product was fused to the kan:0169 amplicon in a 
subsequent PCR reaction. The two templates were combined in a reaction as described 
above, with amplification primed by the 0169srtAP and 0169-SalI-dn primer pair. Cycling 
conditions were: 1 cycle of 94 ºC for 5 min; 30 cycles of 94 ºC for 45 sec, 55 ºC for 45 sec, 
and 68 ºC for 2.5 min; followed by a final extension cycle of 68 ºC for 7 min. In a final 
PCR reaction the entire fusion construct was created by combining the PsrtA/kan:0169 
amplicon and the upstream 0169 amplicon as template in a reaction primed by the 0169-
SalI-up and 0169-SalI-dn primer pair. The templates were combined in reaction as 
described above. Cycling conditions were: 1 cycle of 94 ºC for 5 min; 30 cycles of 94 ºC 
for 45 sec, 52, 56.8 or 60 ºC for 45 sec, and 68 ºC for 3.25 min; followed by a final 
extension at 68 ºC for 7 min. 
 Ten µl of the PCR product was transformed into competent JFP42 cells (SK36 
served as a control for transformation), and transformants were selected on TSA containing 
Kn. Clones were selected for sequencing of the SSA_0169 insertion site by primers Jxn-up, 
Jxn-dn, kan306. Clone JFP47 was selected for further analyses.  
Development of JFP42 (pJFP50): An alternative native promoter of srtA was predicted in 
the 3’ sequence of gyrA. The 320 bp upstream of srtA and the srtA coding region were 
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cloned into the pVA838 shuttle vector. EcoRI sites were incorporated into the primer set, 
srtA-EcoRI-up and srtA-EcoRI-dn, used for PCR amplification of srtA from SK36 gDNA. 
Cycling conditions were as follows: 1 cycle of 94 ºC for 5 min; 30 cycles of 94 ºC for 46 
sec, 55 ºC for 45 sec, and 68 ºC for 1.25 min; followed by a final extension cycle at 68 ºC 
for 7 min. The resulting PCR product was purified (Qiagen), and digested by EcoRI for 
ligation into the EcoRI digested, SAP treated pVA838 vector. The digested insert and 
vector were then combined at a 3 to 1 molar ratio for ligation (Invitrogen). Two µl of the 
ligation reaction were electroporated into E. coli DH10B (Invitrogen). E. coli 
transformants were selected by Emr on LA plates.  
The pVA838 vector encodes both Cm, and Em resistance (Fig. 3A). The EcoRI 
cloning site is within the Cmr cassette, and therefore clones containing the insert would be 
rendered Cms. Fifty Emr resistant DH10B clones were replicate plated on LA, followed by 
LA with Cm at 20 µg µl-1 to screen for and recover Cms clones. Twelve of the 50 clones 
were Cms. These clones were cultured from the LA plate in LB containing Em, and 
plasmid DNA prepared (BioRad). The resulting plasmid, termed pJFP50 (Fig. 8) was sent 
for DNA sequencing with primers srtA-EcoRI-up, pVA838-2939, and pVA838-5331 to 
confirm srtA sequence fidelity. Competent JFP42 was transformed with 200 ng pJFP50, 
and transformants were selected on TSA containing Em.  
Development of JFP52: In an alternative strategy for complementation of JFP42, srtA was 
cloned into the pCM18 E. coli-streptococcal shuttle vector (Fig. 9A). SphI RE sites were 
engineered in the primers, srtA-SphI-up and srtA-SphI-dn, used for PCR amplification of 
srtA from SK36 gDNA. Cycling conditions were: 1 cycle at 94 ºC for 5 min; 30 cycles at  
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Figure 8. Plasmid map of pJFP50 
 
The 320 bp preceding srtA (3’ gyrA), and the srtA coding sequence were cloned into the 
EcoRI restriction site of pVA838. E. coli electrotransformants were selected by Emr, and 
screened for Cms resulting from insertion inactivation of the Cmr cassette. The plasmid 
with sequence fidelity designated pJFP50 was transformed into competent JFP42 cells. 
Emr transformants were then screened for complementation of srtA mutant phenotypes.  
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Figure 8. 
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Figure 9. Construction of pJFP52 
 
A) The region of pCM18 used for cloning of srtA is shown. The synthetic lactococcal 
promoter, CP25, and the synthetic ribosomal binding site (RBSII) from pQE70 (Qiagen) 
drive expression of the gfpmut3 green fluorescent protein gene in E. coli, as well as S. 
gordonii. Plasmid selection is through an Emr cassette not shown. This low copy number 
plasmid (6-9 copies per chromosomal equivalent) exerts a broad host range, owing to its 
small size (8.2 kb) and the presence of both gram-positive (pAMβ1) and gram-negative 
(P15A) replicons (90). 
 
B) The srtA gene of S. sanguinis was cloned into pCM18 via the SphI restriction site 
occurring in the first codon of gfpmut3, thus placing srtA under the control of the CP25 
promoter. The resulting plasmid, pJFP52 was transformed into S. sanguinis JFP42, with 
Emr confirming maintenance of the plasmid. Transcription through srtA to gfpmut3 was 
evidenced by green fluorescence of JFP42 and SK36 (not shown).  
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Figure 9. 
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94 ºC for 45 sec, 44 ºC for 45 sec, and 68 ºC for 1 min; followed by a final extension cycle 
at 68 ºC for 7 min. The PCR product was purified (Qiagen), and then digested with SphI. 
The digested insert was cloned into SphI linearized, and SAP treated pCM18 (Invitrogen). 
The resulting ligation product was electroporated into E. coli DH10B and transformants 
were selected by Emr conferred by pCM18. Plates were viewed on a Dark Reader 
transilluminator (Clare Chemical Research) for identification of non-fluorescing colonies, 
which would indicate insertion of srtA 5’ of gfpmut3. Plasmid DNA extracted from E. coli 
(Bio-Rad) was digested by SphI and PvuI to confirm the presence of srtA in pCM18; the 
plasmid containing the insert was termed pJFP52 (Fig. 9B). Plasmid DNA was sequenced 
with primers CP25, srtA-SphI-up, and gfpmut. Following confirmation of srtA sequence 
fidelity and proper orientation of srtA, 150 ng of plasmid DNA was used for 
transformation of JFP42. Transformants were selected on TSA containing Em. 
Development of JFP62: pCM18 instability in JFP42 resulted in the development of a final 
complementation construct incorporating features of previous constructs. The srtA gene 
was cloned with the CP25 promoter from pCM18 into the stabile pVA838 shuttle vector 
(Fig. 3A). The primer set pJFP52srtA-up and pJFP52EcoRI-dn was used for amplification 
of pJFP52 encoded srtA. Cycling conditions were: 1 cycle of 94 ºC for 5 min; 30 cycles of 
94 ºC for 40 sec, 50, 56.1 or 60 ºC for 30 sec, and 68 ºC for 1.25 min; followed by a final 
extension at 68 ºC for 7 min. The PCR product was cloned into the EcoRI site of pVA838, 
and ligation products were electroporated into Electromax DH10B cells as described 
above. Resulting Emr clones were screened for Cms, as described above. DNA sequencing 
of the resulting plasmid, pJFP62 (Fig. 10), was completed using primers pVA838-2245,  
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Figure 10. Plasmid map of pJFP62 
 
The L. lactis synthetic promoter CP25, ribosomal binding site (RBSII) and srtA gene were 
cloned from the unstable pCM18 background into the stable pVA838 vector by preexisting 
or engineered EcoRI restriction sites. Integration of the insert at EcoRI inactivated the Cmr 
marker. This was the basis of screening for the insert in E. coli. Plasmid prepared from 
Emr, Cms E. coli was transformed into JFP42. Emr transformants were further evaluated 
for complementation of srtA mutant phenotypes. 
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Figure 10. 
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pVA838-2939, pVA838-5331, and 1219-F. Competent JFP42 cells were transformed with 
200 ng pJFP62, and transformants were selected by Emr. The resulting strain was 
designated JFP62. 
 
Transformation of S. sanguinis.  
In vitro transformations of S. sanguinis strains were performed as previously described 
(198). Briefly, strains were cultured in TH-HS to an OD at 660 nm of 0.06 to 0.08. 
Transforming DNA, 330 µl of cells, and 70 ng synthetic CSP—with the amino acid 
sequence DLRGVPNPWGWIFGR (79)—were transferred to 0.7-ml microcentrifuge tubes 
and incubated at 37 °C for 1 h. Cells were plated on TSA with or without selective 
antibiotics and grown at 37 °C for 48 h under 6 % O2. The frequency of transformation 
was defined as the ratio of transformants to total colony-forming units (CFUs). The 
efficiency of DNA uptake was defined as the number of transformants per µg of 
transforming DNA. 
 
In vitro growth comparisons 
Soft-agar evaluation of anaerobic growth sensitivity: For soft-agar studies (Kurtz 2002) 
LMP agarose was dissolved in TSB by autoclaving, and then aliquoted in 10 ml volumes 
into glass Hungate tubes or polystyrene (PS) Falcon tubes (BD). Em, 5 µg µl-1 of the 
oxygen dye indicator resazurin sodium salt (Acros), or 20 µg µl-1 of the oxygen indicator, 
methylene blue were added to select tubes. All tubes were then placed in a 37 ºC incubator 
inside an anaerobe chamber for 48 h. Tubes were then inoculated with 100 µl of 
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streptococcal overnight cultures, mixed by inversion, and incubated at ambient temperature 
in the anaerobe chamber for 30 minutes to permit solidification of the agar. Tubes were 
then removed from the anaerobe chamber and incubated aerobically with the caps loosened 
at 37 ºC for 24 h. The depth of growth in cm was measured in each tube with a standard 
ruler and documented using a digital camera. Values were compared using ANOVA with 
the Tukey-Kramer multiple-comparisons post-test with α=0.05. 
Overnight growth comparisons in a microplate format: Stationary phase S. sanguinis 
cultures were diluted 100-fold in BHI, and 200 µl aliquots added to the wells of a 96-well 
microplate (Greiner). Growth at 37 ºC, at ambient atmosphere was monitored every 10 min 
over 20 h by measuring the OD at 450 nm. The cells were mixed by orbital shaking (140 
rounds/min) with a shaking width of 4 mm for 10 sec before every recording. The 
experiment was performed in a FLUOstar microplate reader (BMG Technologies).  
 When noted in the results section a modified procedure was used. Colonies of S. 
sanguinis strains taken from TSA plates containing selective antibiotics were cultured 
overnight in BHI to stationary phase. Cells were diluted 10-fold in pre-incubated BHI for 
three additional h of subculture at 37 ºC. Cells were harvested by centrifugation at 3,743 x 
g for 10 min at 4 ºC, and washed once in ice-cold sterile PBS (pH 7.2 – 7.4) before 
suspension in 7 ml of PBS. The optical density at 660 nm of each strain was adjusted to 
~0.8. Cells at this concentration were diluted 200-fold in BHI and 200 µl aliquots 
monitored in a 96-well plate, as described above. 
In vitro competitive index assays: The effect of co-culturing strains in vitro was studied by 
replicating incubation times described above for in vivo competitive index (CI) assays 
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(below). Stationary phase cultures of S. sanguinis strains in BHI (sans antibiotics) were 
diluted 10-fold in fresh BHI and grown for an additional three h at 37 ºC. Cells were 
washed in PBS as described above, and the optical density of each strain was adjusted to 
0.8 at 660 nm. Equal volumes of strains at the same optical density were combined for the 
“mock” inoculum. From this mixed strain culture, 10 µl was diluted into 10 ml of pre-
incubated BHI for growth at 37 ºC, 6 % O2 overnight. The inoculum was also serially 
diluted and plated on TSA containing selective antibiotics for enumeration of CFUs for 
each strain. Following 20.5 – 23 h of co-culture in BHI, cells were serially diluted and 
plated on TSA containing selective antibiotics. Plates were incubated at 37 ºC, 6 % O2 for 
2 days. The competitive index value was determined by dividing the CFU ratio of the 
mutant to control after 20 h of co-culture by the CFU ratio of mutant to control inoculated. 
Significance was determined by a paired t-test of log transformed CI values, with P < 0.05 
indicating a significant difference in co-culture growth in vitro. 
 
Strain evaluation in the rabbit model of IE 
A previously described rabbit model of infective endocarditis was adapted for use 
in this study, with specific-pathogen free New Zealand White rabbits weighing 3 to 3.9 kg 
as subjects (65, 198). The protocol used was approved by the Institutional Animal Care 
and Use Committee, and is in compliance with all federal guidelines and institutional 
policies. To impose pre-disposing valve damage for infective endocarditis, a catheter was 
inserted along the right carotid artery and past the aortic valve of anesthetized rabbits. The 
catheter was sutured and remained in place for the duration of the experiment. Two days 
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post-surgery, streptococci were inoculated into the right lateral ear vein of the rabbits. At 
pre-determined times rabbits were sacrificed by intravenous injection of euthasol (Virbac 
AH, Inc.). During necropsy accurate placement of the catheter was confirmed and the heart 
excised. Apparent vegetations were recovered from the aortic valve and surface of the left 
ventricle and homogenized in sterile PBS. Multiple vegetation homogenate dilutions were 
spread on the surface of TSA plates for recovery of bacterial strains. 
 
STM analyses in the rabbit model of IE 
Inoculum preparation: Signature-tagged mutants were cultured overnight in a 48-well 
block in 1.25 ml BHI containing Cm. Cells were mixed by vortexing and pooled into a 50 
ml conical tube. From the conical tube, an aliquot was diluted 1:10 into 12.6 ml pre-
incubated BHI, and 1.5 ml pooled cells were transferred to 10.5 ml pre-incubated BHIT. 
The tube containing BHIT was sub-cultured for 2.25 h at 37 ºC, with addition of 0.6 g 
glycine at 1.5 h post-dilution. Cells in BHIT were then harvested by centrifugation at 
3.743k x g, 10 min, 4 ºC and the resulting pellet washed in 1 ml cold, sterile dH2O, and 
then stored at -20 ºC until DNA extraction was performed (126). 
 Cells in BHI were subcultured for 3 h at 37 ºC and then harvested by centrifugation 
at 3.743k x g, for 10 min at 4 ºC. The resulting cell pellet was washed in 7 ml cold, sterile 
PBS (pH 7.2-7.4). The cells were then diluted in PBS to achieve an OD at 660 nm 
equivalent to ~ 1 x 108 cells ml-1. Cells at this concentration were used as the inoculum, 
with 0.5 ml loaded into 1 ml Leur-lock syringes, fitted with 26 gauge, ½ in. needles. Pre-
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catheterized rabbits were injected with the inoculum and infection permitted to proceed to 
20 h. 
Amplification of signature tags: For each rabbit tested TSA plates containing recovered 
colonies with 4,500 – 10,000 colonies per plate were suspended in 1 ml BHIT. The 
suspended colonies were then diluted 60 – 100 fold in fresh BHIT containing Cm for 
overnight growth. Cells were then diluted 10 fold and sub-cultured for 3 additional hours 
prior to preparation of chromosomal DNA as previously described (126).  
 DNA extracted from input pooled strains and output pooled strains was then used 
as template in PCR with signature tag invariant end primers, PB1 and PB2. PCR 
components included 1 µg extracted DNA, 90 µl Supermix, and 0.5 pmol µl-1 PB1 and 
PB2 primers in 100 µl total reaction volume. PCR cycling conditions used were: 1 cycle at 
95 ºC for 1 min, followed by 25 cycles of 94 ºC for 30 sec, 45 ºC for 1 min, and 72 ºC for 
10 sec. PCR terminated in a final extension cycle at 72 ºC for 2 min. PCR products were 
electrophoresed on 3 % NuSieve agarose gels, purified on Freeze ’N Squeeze columns 
(BioRad), and ethanol precipitated with a final resuspension of the pellet in 20 µl 0.1x TE. 
The PCR digoxigenin probe synthesis kit (Roche) was used to DIG-label amplified 
signature tags in a second round of PCR. The nested primer pair PB11 and PB12, at 0.25 
pmol µl-1 was combined with 10 x buffer, DIG-labeled dNTPs, unlabeled dNTPs, 
polymerase and 2 µl of PCR template in a 100 µl reaction volume, as specified by the 
manufacturer. The PCR cycling protocol was as follows: 1 cycle at 95 ºC for 1 min, 
followed by 20 cycles of 94 ºC for 30 sec, 37 ºC for 1 min, 72 ºC for 10 sec, and a single 
final extension at 72 ºC for 2 min. DIG-labeled products were purified (Qiagen), and DNA 
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eluted in 15 µl 1 x TE was gel electrophoresed on a 3 % NuSieve agarose gel (Cambrex). 
DNA bands of the input and output amplicons were excised from the gel and prepared for 
hybridization analysis by the addition of 1 ml of hybridization fluid. The tube was boiled 
for 5 min to melt the agarose and denature the probe. Hybridization analysis was 
performed as described below. 
Dot blot hybridization analysis: Dot blots were created by transferring 1.1 µg of each 
STM plasmid (containing tags used) in 22 µM NaOH, and 6X SSC buffer to a 
MagnaGraph nylon membrane (Micron Separations) with a vacuum manifold (Schleicher 
& Schuell Bioscience). DNA was then cross-linked to the membrane using a UV 
Stratalinker (Stratagene). Duplicate membranes were then probed with the input pool and 
output DNA probes as directed by the Genius chemiluminescent kit protocol (Roche). The 
resulting chemiluminescent signal was detected by a FluorChem Imager with FluorChem 
software, V. 3.04A (Alpha Innotech Corporation). 
 
Competitive index analyses in the rabbit model of IE 
Inoculum preparation: The S. sanguinis colonies from TSA were grown in BHI (without 
antibiotic unless otherwise specified) overnight. Stationary phase cells of the strains were 
pooled (unless otherwise indicated) and diluted 1:10 in 14 ml pre-incubated BHI for 3 
additional h of sub-culture at 37 ºC. Cells were harvested by centrifugation at 3,743 x g for 
10 min at 4 ºC, washed once in ice-cold PBS (pH 7.2 – 7.4) and adjusted to an optical 
density of 0.8 at 660 nm, corresponding to ~5 x 107 – 1 x 108 CFUs ml-1 of each strain. 
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Five-hundred μl of cells at this optical density were injected into the right lateral ear vein 
of pre-catheterized rabbits.  
When strains were not pooled for co-culture prior to inoculation, they were 
subcultured separately for 3 h and each strain was subsequently adjusted to an optical 
density at 660 nm of 0.8, as described above. Equal volumes of strains compared were then 
combined, and 0.5 ml of the combined strain inoculum injected into previously 
catheterized rabbits. 
Determination of the CI value: The actual number of CFUs rabbits received was 
determined by plating the inoculum on TSA containing selective antibiotics. Twenty h 
after infection, rabbits were sacrificed as described above. Vegetations collected from the 
aortic valve during necropsy were homogenized, diluted and plated. Plates containing the 
inoculum or vegetation homogenates were grown for 2 days at 37 °C, 6 % O2. Resulting 
colonies were enumerated for determination of the competitive index (CI) value, which is 
defined as the mutant/wild-type ratio of the homogenate divided by the mutant/wild-type 
ratio in the inoculum. Since colony numbers are often highly skewed log transformed 
values were used to compute the CI value. Statistical significance was determined by 
Student’s paired t-test, with P < 0.05 representing significance. 
Previous experiments in our lab revealed that selection via the Cm resistance 
cassette of STM strains caused reduced colony formation under the normal growth 
atmosphere of 6 % O2. A previously described layer-plating technique that is not inhibitory 
for Cmr clones was used when comparing STM mutants to JFP36. Briefly, bacterial cells 
suspended in 12.5 ml TSB with 1 % LMP agarose were poured into a petri dish. The dish 
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was left at room temperature to allow the agar to harden, and then transferred to a 37 ºC 
incubator for 2 h. The top layer of 12.5 ml TSA, containing selective antibiotics was then 
added. As the TSB-LMP agarose layer contains no antibiotic, twice the normal selective 
antibiotic concentration was added to TSA. The agar was kept at room temperature until 
completely hardened, and plates were then incubated at 37 ºC, aerobically for 2 days.  
In several experiments S. sanguinis SK36 derivative strains were compared directly 
to the parental strain. S. sanguinis SK36 lacks a selective marker; therefore, plating in the 
presence and absence of selective antibiotic (specific for the mutant tested) was used to 
enumerate mutant CFUs and total CFUs, respectively. SK36 CFUs were determined by 
subtracting the mutant CFUs from total CFUs.  
 
Individual inoculum analyses in the rabbit model of IE 
Inoculum preparation: Colonies of the mutant strain (from TSA with selective antibiotic) 
or SK36 (from TSA) were inoculated in 5 ml BHI for growth at 37 ºC, 6 % O2 overnight. 
Cells of each strain were sub-cultured in pre-incubated BHI, and then adjusted to an optical 
density at 660 nm of 0.8. Previously catheterized rabbits received 0.5 ml of the single 
strain inoculum. The inoculum was then diluted and plated on TSA for estimation of the 
number of bacteria in the inoculum received by rabbits. 
Determination of bacterial recovery: Rabbits infected with streptococci were sacrificed at 
2 or 20 h post-inoculation. During necropsy surgeons were cautious to only remove 
material with the characteristic vegetation appearance. Vegetations recovered were 
weighed, and then homogenized in 2 ml of ice-cold, sterile PBS (pH 7.2 – 7.4). Serial 
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dilutions of the homogenate were spread on TSA (no antibiotics), and plates were 
incubated for 2 days at 37 ºC, 6 % O2. The number of colonies recovered from each rabbit 
was determined. As colony counts are often skewed the values were log transformed. To 
account for differences in the amount of vegetation matter collected, the CFU recovered 
was divided by the gram weight of the homogenized vegetations. Significance was 
determined by comparing log CFU/g values for each strain in a Welch corrected (equal 
variance not assumed), unpaired t-test, with P < 0.5 indicating a significant difference in 
bacterial recovery. 
 
qRT-PCR analysis  
RNA extraction for analysis of 0169: A stationary phase culture of S. sanguinis SK36 was 
diluted 1:20 into BHI pre-incubated aerobically (225 rpm), under 6 % O2, or anaerobic 
conditions (0 % O2); and grown 5 additional h at 37 °C. RNA was extracted from cells by 
Trizol (Invitrogen).  
RNA extraction for analysis of srtA: Early stationary phase cultures of S. sanguinis strains 
SK36, JFP36, JFP42, and JFP47 in BHI were used for RNA extraction by Trizol 
(Invitrogen). 
Treatment of RNA for transcript detection: RNA samples were purified and double-
DNase I treated on RNeasy columns (Qiagen), and RNA quality assessed by the Experion 
RNA StdSens Chip (Bio-Rad). Reverse transcription was performed with pre-formulated 
beads from the Ready-To-Go You-Prime First-Strand reverse transcriptase kit (Amersham 
Biosciences), and primed by the random hexamer primer pd(N)6. For each RNA sample a 
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control reaction without reverse-transcriptase was performed to monitor for DNA 
contamination. PCR reactions (10 µl) comprised 5 µl RT2 Real-Time SYBR Green/Rox 
PCR master mix (SuperArray), 10 pmol of each forward and reverse primer (detectors are 
described in Appendix A) and 1 µl template. The cDNA quantity was used for 
normalization of samples, with a previously described technique (148). Briefly, an aliquot 
of each RNA sample was combined with RNA hydrolysis solution (1 mM EDTA, 100 mM 
NaOH) and heated for 20 min at 70 °C before and after reverse transcription. The samples 
were then neutralized by addition of 6 µl 0.5 M Tris-HCl, pH 6.4. The neutralized samples 
were mixed with 200-fold diluted RiboGreen (Invitrogen) and fluorescence measured at 
485/520 nm excitation/emission wavelengths in a FLUOstar microplate reader (BMG 
technologies). The correction factor used for normalization was calculated by subtracting 
fluorescence of samples before reverse transcription from fluorescence values of samples 
following the reverse transcription reaction. Following quantitative PCR, the transcript 
abundance value was divided by the correction factor of the corresponding sample. 
Transcript abundance of each gene was quantified based on standard curves created by 
serially diluting a PCR amplification product of each gene of interest and using it as 
template for the real-time reaction. Relative to the standard curve, n-fold differences 
among template quantities for a specific gene could be compared among samples.  
 
Static in vitro biofilm formation assay 
This assay is based on the ability of streptococci to develop biofilms on solid PS 
surfaces, and was modified from previously described protocols (190, 76). Early stationary 
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phase S. sanguinis strains were diluted 1:100 in chemically defined biofilm medium (BM) 
containing 1 % glucose (BM + Glu), or 1 % sucrose (BM + Suc) (151). Aliquots of 0.1 ml 
were transferred to the wells of a 96-well PS plate for incubation at 37 °C for 20 h at 6 % 
O2. Wells with media alone served as negative controls. For biofilm quantification, media 
and planktonic cells were removed from the wells by decanting and washing twice with 
dH2O. Wells were dried and stained with 1 % (wt/vol) crystal violet (CV) for 15 min. 
Excess dye was removed with three dH2O washes, and CV staining assessed via release of 
biofilm-associated dye into 30 % glacial acetic acid. The OD at 600 nm of soluble CV was 
recorded. Significance was determined by one-way ANOVA with a Tukey-Kramer 
multiple comparisons post-test, with significance represented by P < 0.05. 
 
Polystyrene adhesion screening 
The adhesion assay used was modified from previously described PS binding 
analyses for simultaneous screening of multiple clones. Colonies from transformation 
plates were inoculated into 1 ml BHI containing the appropriate antibiotics and grown 
overnight under 6 % O2, at 37 ºC. Cells were diluted 10-fold into pre-incubated BHI and 
sub-cultured at 37 ºC for 3 additional h to achieve early stationary phase growth. Cells 
were then diluted 50-fold into pre-incubated BM + Glu, and 200 µl transferred to the wells 
of a 96-well microplate (Greiner) in duplicate. Plates were incubated for 4 h at 37 ºC to 
permit adhesion of bacteria to the PS surface. Non-adherent cells were removed by 
decanting and a single wash with dH2O. Adherent cells were stained with 25 µl of 1 % CV 
for 15 min. Excess dye was removed by three washes with dH2O, and bound dye released 
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by the addition of 30 % (v/v) glacial acetic acid. One-hundred and twenty-five µl of the 
dye was transferred to a new 96-well Greiner plate, and the OD at 660 nm was recorded. 
 
Production of CwFrac antisera 
Mutanolysin digestion was used to extract cell wall-associated proteins of SK36 for 
generation of antisera reactive to the cell surface peptidoglycan-linked proteins. The cell 
wall fraction of SK36 was prepared from 400 ml of early stationary phase SK36. Cells 
were harvested by centrifugation at 5k x g for 10 min at 4 ºC, and washed twice in 20 ml 
TE + protease inhibitor cocktail (Pi) (Sigma) (1:100). Each pellet was vigorously 
suspended in 2.4 ml protoplasting buffer (2 M Tris, 1 mM MgCl2, 0.44 M raffinose) (SEB) 
+ Pi (1:100) using a vortex, and then inverted with 120 µl of mutanolysin (Sigma) (10,000 
U ml-1). Tubes were incubated at 37 ºC for 30 min and then centrifuged at 5k x g for 20 
min at 4 ºC. The supernatant containing mutanolysin released cell wall fragments was 
collected. This protein fraction was twice dialyzed against 1 L PBS at 4 ºC in Snakeskin 
tubing (22 mm x 35 ft, 7000 Mw) (Pierce). Protein concentration was then determined by 
the BCA Protein Assay Kit (Pierce). The cell wall fraction (CwFrac) immunogen was then 
sent to Covance for production of rabbit polyclonal antisera.  
 
Whole cell ELISA 
 The procedure used for cell fixation was previously described (103, 189). S. 
sanguinis strains grown overnight in BHI with selective antibiotics were sub-cultured for 3 
h in BHI alone. Cells were harvested and adjusted to an optical density at 660 nm of ~0.9 
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in TNMC (1 mM Tris-HCl [pH 8.0] containing 0.15 M NaCl, 1 mM MgCl2, and 1 mM 
CaCl2) buffer. Fifty µl of the adjusted cells were transferred to the wells of a 96-well 
4HBX Immunolon plate (Thermo electron); 1 mg ml-1 BSA (Pierce) was included in 
several wells as a control for non-specific reactivity. Plates were centrifuged at 800 rpm, 
for 5 min at 20 ºC. To fix the cells, 0.1 ml TNMC with 0.25 % glutaraldehyde was added 
to each well, and the plates centrifuged at 800 rpm for 5 min, at 4 ºC. The plates were then 
incubated at 20 ºC for 20 min. Excess liquid was aspirated from the wells and the cells 
were then washed twice with 100 µl of blocking buffer (TBS containing 0.2 % Tween-20 
and 2.5 % BSA), prior incubation with 100 µl blocking buffer overnight at 4 ºC.  
Detection of SrpA: A SrpA mAb provided by Dr. Hui Wu (University of Alabama) was 
used for detection of SrpA on the surface of whole cells. Following incubation in blocking 
buffer overnight, 0.05 ml of 1:50 diluted α-SrpA mAb in a blocking buffer was added to 
each well and plates were incubated at room temperature for 2.5 h. Unassociated mAb was 
removed by three washes with 0.1 ml TBS-T. The secondary antibody, α-mouse IgG 
conjugated to alkaline phosphatase (AP) (1:1,000 in blocking buffer) was added to the 
wells in 0.05 ml volumes. Plates were incubated for 2.5 h, and unassociated secondary 
antibody removed by three washes in 0.1 ml TBS-T. One-hundred µl of the alkaline 
phosphatase substrate, p-NPP (KPL) was added to each well. The reaction proceeded for 
three minutes before addition of 0.1 ml 5 % EDTA. Plates were read at 410 nm on a 
FLUOStar plate reader. Significance was determined by a Kruskal-Wallis test 
(nonparametric ANOVA), with P < 0.05 representing a significant difference.  
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Detection of whole cells by CwFrac: Antisera prepared against the cell wall fraction of S. 
sanguinis SK36 (referred to as CwFrac below) was used to demonstrate equal amounts of 
whole cells following glutaraldehyde fixation. Following incubation with blocking buffer 
overnight, 0.05 ml of diluted CwFrac in blocking buffer was added to each well. Plates 
were incubated at room temperature for 2.5 h, and unassociated antibody removed by three 
washes with 0.1 ml TBS-T. The α-Rabbit IgG AP conjugated secondary antibody, diluted 
1:2,000 in blocking buffer was added to the wells in 0.05 ml volumes, and plates were 
incubated at room temperature for 2.5 h. Following three washes with TBS-T, CwFrac 
association was detected by p-NPP, as described above.  
Two separate protocols were used to demonstrate the specificity and sensitivity of 
CwFrac for detection of SK36. To determine the antibody dilution permitting specific, 
non-saturating reactivity with whole cells, serially diluted antisera (1:5,000, 1:10,000, 
1:50,000, 1:100,000, and 1:200,000) was reacted against fixed whole cells of SK36 (as 
well as other strains tested). The optimal dilution of 1:25,000 was then used to demonstrate 
differential reactivity of the sera reflective of various amounts of cells present in the wells. 
The optical density of each strain tested was adjusted to ~0.9 at 660 nm, as described 
above. After adjustment, cells at this optical density were serially diluted across a 96-well 
plate so that each serial dilution occurred in triplicate. The range of dilutions included 
undiluted, 2-fold, 4-fold, 8-fold, 16-fold and 32-fold. BSA at 1 mg ml-1 served as a 
negative control for nonspecific reactivity of the immune sera. An identical assay was used 
with pre-immune sera collected from rabbits prior to challenge with CwFrac. Reactivity to 
sera was determined in a chromophore assay, as described above.  
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Fractionation of S. sanguinis 
 S. sanguinis strains cultured overnight in 20 ml BHI were centrifuged at 5k x g, for 
10 min at 4 ºC. The cell pellet and supernatant were then treated to obtain a supernatant 
protein fraction, cell wall-associated protein fraction, and a protoplast protein fraction. 
To prepare the supernatant fraction, 18 ml of supernatant was collected following 
centrifugation and then processed for precipitation of secreted proteins. Supernatants were 
filtered across a 0.2 µm membrane, and 10 % (v/v) TCA was added. Tubes were mixed by 
vortexing and incubated on ice for 1 h. The mixture was centrifuged at 9.5k x g for 15 min 
at 4 ºC for extraction of TCA precipitated proteins. The resulting pellet was washed twice 
in 1 ml -20 ºC acetone, and dried in an oven for 5 min to drive off residual acetone. The 
pellet was resuspended in 0.2 ml PBS + Pi (10:1 (v/v)).  
 For preparation of the cell wall fraction the cell pellet was washed twice in 1 ml TE 
Buffer + Pi (10:1 (v/v)) before suspension by vortexing in 0.24 ml SEB + Pi (10:1 (v/v)). 
The cell suspension was then mixed with 12 µL mutanolysin (Sigma) by inversion and 
incubated at 37 ºC for 1 h. The suspension was centrifuged at 5k x g for 15 min at 4 ºC for 
collection of the supernatant containing proteins released by mutanolysin.  
 The remaining protoplast pellet was washed once in 0.5 ml SEB + Pi, and then 
resuspended in 1 ml PBS + Pi. Protoplasts were lysed by sonication at 80 % for 10 min, 
followed by bead beating in Lysing Matrix B tubes (BIO 101). Following centrifugation at 
15k x g for 15 min at 4 ºC, the supernatant containing released proteins was collected to 
represent the protoplast fraction.  
 
75 
 
SrpA Immunoblot analysis 
 Bacterial cell fractions were subjected to SDS-PAGE in 5 % precast Tris-HCl gels 
(Criterion, Bio-Rad). For immunoblot analysis, proteins were transferred from gels onto a 
PVDF membrane (Bio-Rad) by electroblotting. Immunoblots were blocked for 1 h in a 
blocking buffer (TBS containing 0.2 % Tween-20 and 1 % BSA). After blocking, the 
immunoblot was incubated overnight at 4 ºC with 1:50 diluted α-SrpA primary antibody. 
AP-conjugated α-mouse IgG (Pierce), diluted 1:7,500 served as the secondary antibody. 
The immunoblot was incubated with the secondary antibody for 1 h at room temperature. 
The immunoblot was washed with TBS-T after each incubation step for removal of 
unbound antibody. Detection of bound AP antibody was by the Western-blue alkaline 
phosphatase substrate (Pierce). General protein staining of duplicate Tris-HCl gels was 
performed with SYPRO Ruby (Invitrogen), per the manufacturer’s instructions. Protein 
bands were visualized by UV light in a Fluorchem Imager with Fluorchem software, 
v.3.04A (Alpha Innotech Corporation). 
 
Hexadecane phase partitioning 
 Stationary phase overnight cultures were diluted 10-fold into 12.6 ml pre-incubated 
BHI and sub-cultured for 3 h art 37 ºC. Cells were harvested and washed in cold, sterile 
150 mM NaCl once prior to suspension in 8 ml 150 mM NaCl. Cells were then evenly 
divided between 4 snap-top conical tubes. Two tubes served as non-hexadecane controls. 
The remaining tubes were supplemented with 333 µl of n-hexadecane, followed by 
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immediate vortexing for 1 min. Afterward cells were incubated at room temperature, 
undisturbed for 25 min. The optical density at 660 nm was recorded for the aqueous phase 
of each strain. Duplicate reads in the presence and absence of hexadecane were averaged 
and the percent affinity for hexadecane of each strain determined by the following 
equation: % Affinity = 100 x [1- (A/A0)], where A = the absorbance of cells with n-
hexadecane, and A0 = the absorbance of cells without n-hexadecane.  
 
Bioinformatics 
 Oligonucleotide primers used were designed using Oligo (Molecular Biology 
Insights) and FastPCR (www.biocenter.helsinki.fi/bi/bare-1_html/fastpcr.htm) software. 
DNA sequences were viewed and aligned using SeqMan II software (DNASTAR Inc). 
Multiple sequence comparisons were made using ClustalW W (202). Transcriptional 
terminators were predicted using the Genetics Computer Group program Terminator (29, 
30). Plasmid maps were created using Gene Construction Kit® v3.0 (Textco BioSoftware). 
Search algorithms for ORFs encoding putative Cwa proteins: Open reading frames 
(ORFs) predicted by Glimmer (54) from the compiled and contiguous S. sanguinis SK36 
genome sequence (GenBank accession number CP000387) were searched for proteins 
containing the characteristic C-terminal LPXTG tripartite motif of Cwa proteins. This cell 
wall sorting signal included an LPXTG sortase substrate pattern (in which X may be any 
amino acid), followed by a hydrophobic domain, and at least one positively charged amino 
acid within 8 residues of the C-terminus. The EMBOSS (http://www.emboss.org) program 
fuzzpro uses predictive patterns to search protein sequences. The query pattern for 
 
77 
identification of putative S. sanguinis Cwa proteins was modified from that published by 
Janulczyk and Rasmussen: L-P-[SKTAQEHLDN]-[TA]-[GN]-[EDASTV]- X(0,8)-
[VIFAGTSML](17)- [RK]-[RK](2), for prediction by fuzzpro of proteins containing the 
motif terminating within 5 amino acids of the C-terminus (111). Two query patterns were 
used: 
(A): L-P-[SKTAQEHLDN]-[TA]-[GN]-[EDASTV]-X(0,8)-[VIFAGTSML](17)-[RK]-
[RK](2)-X(0,5)>  
(B): L-P-[SKTAQEHLDN]-[TA]-[GN]-[EDASTV]-X(0,8)-[VIFAGTSML](16,20)-[RK]-
[RK](2)-X(0,5)> 
In these patterns mandatory residues are distinguished form alternative residues by the 
bracketing of alternative residues. The gap designated by X (0,8) may be from 0 to 8 amino 
acids. Parenthetical numbers indicate repetition of the preceding residue. The applied 
patterns differ in the allowed number of hydrophobic residue repeats [VIFAGTSML] 
following LPXTG. As more repeats are permitted with pattern (B), greater stringency 
among hits was enforced by decreasing the number of permitted mismatches from 5 with 
pattern (A), to 4 with pattern (B).  
The SignalP 3.0 server was then used to scan fuzzpro positive ORFs for the 
presence of a gram-positive signal sequence (15) within 70 amino acid residues of the N-
terminus, with both the Neural networks (NN) (D-measure cutoff of 0.45) and Hidden 
Markov Models (HMM) applied. Proteins positive for both an N-terminal signal peptide by 
SignalP and a C-terminal tripartite motif were then scanned visually to confirm the 
presence of an LPXTG pattern. Erroneous positive hits trended toward multiple-pass 
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integral membrane proteins as suggested by transmembrane helices prediction performed 
with the TMHMM 2.0 server (http://www.cbs.dtu.dk/services/TMHMM/). For comparison 
identical searches with the described parameters were performed for ORFs predicted from 
complete genome sequences of S. gordonii strain Challis substrain CH1 (GenBank 
accession CP000725), S. mutans UA159 (GenBank accession AE014133), and the 
incomplete genome of S. mitis NCTC 12261, v11.0 (http://www.tigr.org/). 
Bioinformatics survey of predicted S. sanguinis Cwa proteins: Putative S. sanguinis Cwa 
ORFs were annotated by a protein basic local alignment search tool (BLASTP) query of 
the microbial genome database, with an expect-value (positive hits by chance) cutoff of 
1.0. To elucidate similarities and differences between oral streptococcal Cwa proteins, the 
predicted proteins of S. gordonii CH1, S. mitis NCTC 12261, and S. mutans UA159 were 
used as queries to search for homologs in the S. sanguinis SK36 protein database 
(http://www.sanguinis.mic.vcu.edu/blast.html).  
Cwa proteins unique to S. sanguinis SK36 among related streptococcal species, 
unrelated oral bacterial species, and additional agents of infective endocarditis were 
identified using the Phylogenetic Profiler application of the Integrated Microbial Genomes 
(IMG) resources offered by the DOE Joint Genome Institute (http://www.jgi.doe.gov/), 
with an expect-value cutoff of 1e-10. Genomic information available through IMG for 
organisms in (Table 2) was used for identification of unique ORFs of S. sanguinis SK36. 
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Table 2. Subtractive comparison for identification of unique S. sanguinis ORFs 
 
The phylogenetic profiler application of IMG, offered by DOE was used to eliminate 
homologous genes shared by S. sanguinis and 54 streptococcal spp., gram-positive 
pathogens, oral microflora, as well as causative agents of infective endocarditis. The e-
value cut-off for extraction of proteins with homologs was 1e-10. Of the 2272 genes 
predicted for S. sanguinis, 246 did not have significant homologs among genomes 
compared. Eight Cwa protein genes were identified as being unique to S. sanguinis. 
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Table 2. 
 
Order  Species for comparison 
Genes 
remaining 
 S. sanguinis genes prior to comparison  2272 
1 Clostridium perfringens 13 1399 
2 Corynebacterium diphtheriae NCTC 13129 1295 
3 Corynebacterium efficiens YS-314 1258 
4 Corynebacterium jeikeium K411 1246 
5 Enterococcus faecalis V583 945 
6 Fusobacterium nucleatum ssp. nucleatum ATCC 25586 900 
7 Lactococcus lactis ssp. lactis Il1403 803 
8 Porphyromonas gingivalis W83 800 
9 Staphylococcus aureus RF122 760 
10 Staphylococcus aureus ssp. aureus COL 756 
11 Staphylococcus aureus ssp. aureus MRSA252 752 
12 Staphylococcus aureus ssp. aureus MSSA476 752 
13 Staphylococcus aureus ssp. aureus MW2 752 
14 Staphylococcus aureus ssp. aureus Mu50 752 
15 Staphylococcus aureus ssp. aureus N315 752 
16 Staphylococcus aureus ssp. aureus NCTC 8325 752 
17 Staphylococcus aureus ssp. aureus USA300 751 
18 Staphylococcus epidermidis ATCC 12228 748 
19 Staphylococcus epidermidis RP62A 744 
20 Staphylococcus haemolyticus JCSC1435 739 
21 
Staphylococcus saprophyticus ssp. saprophyticus ATCC 
15305 733 
22 Streptococcus agalactiae NEM316 603 
23 Streptococcus mutans UA159 514 
24 Streptococcus pneumoniae R6 453 
25 Streptococcus pneumoniae TIGR4 444 
26 Streptococcus pyogenes M1 GAS 432 
27 Streptococcus thermophilus CNRZ1066 412 
28 Streptococcus thermophilus LMG 18311 407 
29 Treponema denticola ATCC 35405 399 
30 Treponema pallidum ssp. pallidum Nichols 399 
31 Enterococcus faecium DO 397 
32 Fusobacterium nucleatum ssp. vincentii ATCC 49256 395 
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Order  Species for comparison 
Genes 
remaining 
33 Streptococcus suis 89/1591 384 
34 Corynebacterium glutamicum ATCC 13032 (Bielefeld) 382 
35 Corynebacterium glutamicum ATCC 13032 (Kitasato) 382 
36 Lactococcus lactis ssp. cremoris SK11 382 
37 Streptococcus thermophilus LMD-9 379 
38 Lactococcus lactis ssp. cremoris MG1363 378 
39 Streptococcus pyogenes Manfredo 378 
40 Corynebacterium glutamicum R 378 
41 Staphylococcus aureus ssp. aureus JH9 378 
42 Streptococcus suis 05ZYH33 376 
43 Streptococcus suis 98HAH33 376 
44 Campylobacter concisus 13826 374 
45 Campylobacter curvus 525.92 373 
46 Staphylococcus aureus ssp. aureus JH1 373 
47 Staphylococcus aureus ssp. aureus Mu3 373 
48 Staphylococcus aureus ssp. aureus Newman 373 
49 Streptococcus gordonii Challis CH1 249 
50 Eubacterium ventriosum ATCC 27560 247 
51 Actinomyces odontolyticus ATCC 17982 246 
52 Staphylococcus aureus ssp. aureus USA300_TCH1516 246 
53 Peptostreptococcus micros ATCC 33270 246 
54 Eubacterium dolichum DSM 3991 246 
 
 
Putatively unique S. sanguinis SK36 Cwa proteins 
SSA_1663 
SSA_1632 
SSA_1633 
SSA_1634 
SSA_0146 
SSA_0167 
SSA_0273 
SSA_1023 
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Identification of S. sanguinis SK36 sortase homologs: S. sanguinis SK36 sortase-like 
ORFs with homology to published sortase sequences were found by BLASTP analysis of 
predicted proteins of the v.15 contig of S. sanguinis SK36. The following forty-five 
publicly available sortase sequences (www.ncbi.nlm.gov) were queried against predicted 
ORFs of the nearly complete SK36 genome sequence: GI: 1169933 (Shewanella 
oneidensis MR-1); GI: 3238307 (S. aureus ssp. aureus COL); GI: 2859503 (S. aureus ssp. 
aureus MRSA252); GI: 936904 and GI: 939748 (Bacillus subtilis ssp. subtilis str. 168); 
GI: 1201902 and GI: 1201386 (Enterococcus faecalis V58); GI: 1199996 (E. faecalis 
V583); GI: 1028429 (S. mutans UA159); GI: 2650068, GI: 2650116; GI: 2650498, GI: 
2650495, GI: 2650024, and GI: 2650023 (Corynebacterium diphtheriae NCTC 13129); 
GI: 1088124 and GI: 1083901 (Bacillus anthracis str. Ames); GI: 2851511 (B. anthracis 
str. Sterne); GI: 1116387 (Clostridium acetobutylicum ATCC 824); GI: 111657852, GI: 
930404, GI: 930406, and GI: 930405 (S. pneumoniae TIGR4); GID: 4962816 
(Streptococcus. pyogenes str. Manfredo); GI: 901269, GI: 900461, and GI: 900465 (S. 
pyogenes M1 GAS); GI: 891152, GI: 890596, GI: 893453, GI: 893835, GI: 892492, and 
GI: 892801 (Bacillus halodurans C-125); GI: 4916727 (Clostridium difficile 630); GI: 
3036999 (Actinomyces naeslundii T14V); GI: 1099286, GI: 1099285, GI: 1099173, GI: 
1102888, GI: 1097914, GI: 1098275, and GI: 1096358 (Streptomyces coelicolor A3(2)); 
GI: 1470914, GI: 1471438 (Methanothermobacter thermautotrophicus str. Delta H). S. 
sanguinis SK36 ORFs homologous to query protein sequences were recorded, and identity 
to one of three sortases classes (A, B, or C) was used for annotation of S. sanguinis 
sortase-like proteins (59). Tmap (EMBOSS) analysis of S. sanguinis sortase-like proteins 
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indicated hydrophobic transmembrane domains directing both extra-cytoplasmic export of 
the precursor protein, and transmembrane topology of the mature protein 
(http://www.emboss.org). 
MudPIT detection of Cwa proteins: S. sanguinis cell wall-associated protein and 
protoplast fractions were prepared as described above. The protein fractions were subjected 
to LC/LC/MS–referred to below as MudPIT–with the assistance of Dr. Patricio Manque 
(Virginia Commonwealth University). Protein samples were suspended in solubilization 
buffer (7 M urea, 2 M thiourea, 1 % DTT, 2 % Triton X-100, with protease inhibitors; 100 
μM PMSF, 100 μM TLCK, 1 μM pepstatin A, 100 μM leupeptine, 5mM EDTA, 50 μM 
TPCK) and precipitated with a 2D clean-up kit (GE Healthcare). Samples were then 
reduced by the addition of dithiothreitol, alkylated with iodoacetamide, and digested by 
trypsin overnight. Resulting peptides were desalted using C8 cartridges (Michrom 
BioResources) and then subjected to two-dimensional liquid chromatography-MS/MS 
analyses with a Michrom BioResources Paradigm MS4 multidimensional separation 
module, a Michrom NanoTrap platform, and an LCQ DecA XP Plus ion trap mass 
spectrometer. The mass spectrometer was operated in the data dependent mode with the 
four most abundant peptides selected and fragmented to create tandem mass spectra. 
Resulting MS/MS spectra were recorded in the profile mode and proteins identified by 
searching the MS/MS spectra against the S. sanguinis SK36 database using Bioworks v3.2. 
The probability based scoring algorithm of Bioworks v3.2 was used for scoring of peptide 
and protein hits. Cutoffs for protein identification included only peptides with fully tryptic 
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termini and cross correlation scores exceeding 1.9 for singly charged peptides, 2.3 for 
doubly charged peptides, and 3.75 for triply charged peptides. 
 
  
CHARACTERIZATION OF S. SANGUINIS ANAEROBIC 
GROWTH DEPENDENCY ON THE ANAEROBIC 
RIBONUCLEOTIDE REDUCTASE 
 
Introduction 
 
 
Identification of NrdD  
In a previously published screen for S. sanguinis endocarditis virulence 
determinants by random STM an apparent avirulent mutant was identified in which the 
open reading frame SSA_2230 was interrupted. A competitive index assay was also 
used to establish a quantitative value for competitiveness of the mutant, 6-26 relative to 
the parental strain, SK36 in the rabbit model of IE. The mean CI value derived for 6-26, 
0.31, confirmed that insertion mutagenesis of SSA_2230 resulted in a significant 
decrease in competitiveness in vivo (P < 0.05) (198). SSA_2230 shares 84 % amino 
acid sequence similarity to the characterized anaerobic ribonucleotide triphosphate 
reductase (ARNR), NrdD of Lactococcus lactis ssp. cremoris MG1363 (accession 
number: Y_001031637) (260, 261). The sequence similarity between these two proteins 
and with E. coli NrdD sequences resulted in annotation of SSA_2230 as NrdD. 
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Prokaryotic ribonucleotide reductases  
 The ribonucleotide reductase (RNR) catalyzes the conversion of the four 
ribonucleotides, 5’ -di (or tri)-phospho -adenosine, -cytidine, -guanosine, and -uridine, 
to their respective 2’ deoxyribonucleotide (dNTP) species to provide substrates for 
synthesis and repair of DNA. RNR maintenance of cellular deoxyribonucleotide pools 
is regulated allosterically by both precursors and products of the reaction. Three classes 
of RNRs have been identified among microorganisms: class I, class II and class III 
(reviewed in 128). Class I RNRs are further separated into class Ia and class Ib based on 
sequence differences, and dissimilar allosteric regulation (117). Many bacterial species 
encode more than one RNR class to permit adaptation of the species to diverse 
environments. Class I RNRs require oxygen for catalytic activity (203), class II RNRs 
are active irrespective of the presence of O2, and the class III RNRs are inactivated in 
the presence of O2 and therefore only catalyze the synthesis of dNTPs under 
anaerobiosis (125).  
 The classes of RNRs are also distinguished by structural differences, allosteric 
regulation mechanisms, and by cofactors required for deoxyribonucleotide synthesis; 
however the general chemistry governing catalysis is conserved. RNRs act by radical 
chemistry for reduction of the 2’ hydroxyl of ribose. For all RNR classes a one of two 
conserved Cys in the active site of the enzyme is proposed to form a thiyl radical for 
reaction initiation by substrate oxidation (68). The complete enzymatic turnover in 
synthesis of dNTPs is reliant upon additional Cys residues, with the number of 
conserved Cys residues differing between the classes. Class I and II enzymes both 
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encode five essential Cys residues (128), whereas Class III enzymes encode only the 
two conserved Cys at the active site (6). While all RNRs act through a free radical 
mechanism, the generation of the free radical is distinct between the classes.  
The class I enzymes, encoded by genes commonly annotated nrdAB (class Ia), 
or nrdEF (class Ib) form a α2β2 structure, with the α protein (NrdA/NrdE) conferring 
both catalytic and allosteric properties, and the β protein (NrdB/NrdF) providing the 
mechanism for radical generation (116, 128). In the active form the β protein of both 
class Ia and class Ib enzymes contains a stable tyrosyl radical in proximity to a diiron 
oxygen cluster (142, 203). Through long-range transfer the tyrosyl radical is passed to 
the conserved Cys of the active site to generate the requisite thiyl radical. The 
requirement of oxygen for class I RNR function permits catalysis of dNTPs under both 
aerobic and microaerophilic conditions, however the reductase is not active in strictly 
anaerobic atmospheres.  
Class II enzymes may consist of a monomeric polypeptide (as is the case in 
Lactobacillus leichmannii; 235), but more commonly exist as homodimeric proteins. 
Regardless of the protein structure all class II RNRs require adenosylcobalamin, a 
cobalt containing derivative of vitamin B12 for development of the Cys radical in the 
active site. The thiyl radical of the active site is proposed to be generated directly by the 
cleavage of 5’ deoxyadenosylcobalamin bond to form cobalt and a deoxyadenosyl 
radical, and therefore a second class I β-like protein is not required (149). This system is 
independent of O2, and therefore catalytically active in both aerobic and anaerobic 
environments.  
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 Class III RNRs, the anaerobic RNRs (ARNR) are destabilized by O2 with 
activity restricted to anaerobic conditions. Characterization of the L. lactis ssp. 
cremoris, S. aureus, and E. coli ARNR was complicated by residual activity of class I 
RNRs of these organisms in standard anaerobic laboratory growth conditions (77, 116, 
162). To determine ARNR properties in organisms encoding both class I and III 
enzymes, inhibition of the class I enzyme is often performed by growth of strains in the 
presence of hydroxyurea. Class III ARNRs belong to the “Radical S-
adenosylmethionine (SAM)” superfamily of proteins that share a common mechanism 
of free radical generation by the cleavage of SAM (239). ARNRs consist of two 
proteins, commonly annotated as NrdD and NrdG that form a α2β2 structure (118), with 
the catalytic and allosteric sites on the nrdD encoded, α protein (193), and the smaller 
nrdG encoded β protein conferring radical generation. In contrast to class I RNRs, in 
which a tyrosyl radical is formed on the activase β protein and then transferred to the α 
protein active site Cys residue, the free radical of ARNR is generated at a conserved 
Gly of NrdD (the class III α protein) in a mechanism dependent on an iron-sulfur cluster 
bound by NrdG. In this process the [4Fe-4S]2+ cluster is reduced to a [4Fe-4S]+ state by 
reduced flavodoxin (21), which is generated in the bacterial cell by flavodoxin 
reductase and NADPH. The reduced NrdG forms a tight complex with NrdD, and then 
associates with SAM (Fig. 11). SAM bound by the reduced NrdG Fe-S is subsequently 
reductively cleaved to form methionine and a 5’-deoxyadenosyl radical. The 
deoxyadenosyl radical then transfers its spin to the conserved Gly of NrdD in a step 
requiring the transfer of one proton and one electron (from Gly) to deoxyadenosyl, 
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Figure 11. The proposed mechanism for ARNR radical generation  
 
In the first step [1] of ARNR radical generation the [4Fe-4S]2+ cluster of NrdG is 
reduced to a [4Fe-4S]+ state by reduced flavodoxin, which is generated in the bacterial 
cell by flavodoxin reductase (FR) and NADPH. In the second step [2] NrdG in this state 
forms a tight complex with NrdD, and then associates with S-adenosylmethionine (S-
AdoMet). S-AdoMet bound by the reduced NrdG Fe-S is subsequently reductively 
cleaved to form methionine and a 5’-deoxyadenosyl radical. In the third step [3] the 
deoxyadenosyl radical then transfers its spin to the conserved Gly of NrdD and is then 
released as 5’deoxadenosine. The figure shown was adapted from (261). 
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Figure 11. 
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this is then released as 5’deoxadenosine. Formation of the glycyl radical of NrdD 
primes the enzyme for ribonucleoside triphosphate reduction with formate acting as an 
electron donor (reviewed in 128). The NrdD proteins of both L. lactis and E. coli harbor 
the conserved Gly stable free radical at their C-termini. In L. lactis the sequence 
adjacent to the conserved Gly is KRTCGYL (260). The O2 sensitivity of ARNRs is a 
result of cleavage of NrdD at the Gly radical by O2 for inactivation of the ARNR (125). 
Additional conserved features of NrdD include the two active site Cys (6) essential for 
reduction of ribonucleotide substrates to deoxyribonucleotides, and a region sandwiched 
between the NrdD homodimers that governs the binding of allosteric effectors for 
regulation of protein activity (143).  
 
Allosteric regulation of RNR activity 
 RNRs are allosterically regulated by dNTPs and ATP for synthesis of balanced 
DNA precursor pools in the cell. These allosteric enzymes contain prototypical distinct 
sites for substrate binding (the active/catalytic site), and association of the regulatory 
effector. Binding of the effector subsequently causes conformational changes in the 
enzyme that affect the substrate binding site and catalytic activity of the protein. 
Regulation of ARNRs by this mechanism has been studied in E. coli, the Escherichia 
bacteriophage T4, and L. lactis (5, 70, 260). The specificity of the four RNR substrates 
is determined by binding of the allosteric effector to the specificity site (S-site), which 
induces necessary structural changes for substrate binding. The effectors that associate 
with the S-site in all RNR classes are deoxyribonucleoside 5’triphosphate products 
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dATP (and in the case of T4 ARNR, ATP), dTTP and dGTP. The general scheme for 
allosteric regulation, determined for the class Ia RNR for E. coli includes the following 
progressive reduction of ribonucleoside 5’ diphosphate (NDP) precursors: binding of 
dATP at the S-site promotes the binding and reduction of the pyrimidines CDP and 
UDP; binding of dTTP at the S-site both inhibits the reduction of CDP and UDP and 
initiates the reduction of GDP; and binding of dGTP inhibits the reduction of GDP and 
promotes the reduction of ADP (reviewed in 128). In the case of Class I RNRs the 
substrates reduced are NDPs, and products are deoxyribonucleoside 5’diphosphates 
(dNDPs). For class II and III RNRs the substrates are 5’triphosphates (NTPs), for 
production of dNTPs. Class Ia RNRs contain a general activity site (the A site) in 
addition to the specificity site, which is competitively bound by ATP or dATP to turn 
on or off the enzyme, respectively (Fig. 12). Two allosteric sites have been identified 
for E. coli and L. lactis ARNRs; however only one site was found in the T4 ARNR (5). 
In both E. coli and L. lactis experimental evidence indicates that two effector binding 
sites are exclusively associated with ATP (and dATP); or dATP, dGTP and dTTP (Fig. 
12). The site bound exclusively by the ATP effector is referred to as the pyrimidine site, 
as the association with ATP results in reduction of UTP and CTP substrates. The other 
effector binding site- bound by dGTP and dTTP is termed the purine site, in that ADP 
and GDP substrates are reduced. Association with dATP at a threshold concentration at 
either site results in enzymatic inactivation (70, 260). Through these regulatory 
mechanisms a balanced supply of dNTPs is created for the replication of DNA. 
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Figure 12. Effector binding for allosteric regulation of Class Ia and ClassIII RNRs  
 
The schematic shown includes the proposed mechanisms for allosteric regulation of 
class Ia and III RNRs. The association of effector molecules with specificity site of the 
class Ia RNR and the pyrimidine and purine sites of the class III ARNR are indicated. 
The enzymatic activity is induced by association of the class Ia active site with ATP, 
whereas association with dATP turns the enzyme off. Regulation is different with the 
class III ARNR, in that a single activity site does not exist. Instead pyrimidine and 
purine sites have been identified. These are named to indicate the substrate resulting 
from association with a specific allosteric effector. As for class Ia RNRs, binding of 
dATP at a certain threshold concentration is thought to result in enzymatic inactivation. 
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Figure 12. 
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Transcriptional regulation of RNRs in E. coli 
Expression analysis of regulation of E. coli RNRs indicates they are 
differentially transcribed in response to O2 tension, and exposure to agents of oxidative 
stress. E. coli encodes class Ia, class Ib and class III RNRs. Transcription of both 
aerobic RNRs is induced under aerobic growth conditions; however the capacity for 
aerobic growth is conferred for the most past by the class Ia RNR (115). In contrast, 
under oxidative stress expression of the class Ib RNR is enhanced, and it has been 
proposed that this RNR in E. coli responds to DNA damage resulting from oxidative 
stress (174, 208).The expression of the ARNR operon in E. coli is upregulated under 
anaerobic conditions by the major aerobic/anaerobic shift regulatory protein FNR. FNR 
directly associates with FNR binding sites of the nrdDG promoter to activate 
transcription of ARNR operon. Deletion of FNR resulted in increased anaerobic 
expression of nrdA, thus indicating that under anaerobiosis FNR inhibits expression of 
the class Ia RNR. The mechanism of FNR nrdAB regulation is thought to be indirect as 
no putative FNR binding sites appear in the promoter region of the nrdAB operon (27). 
Negative regulation of E. coli RNRs is through the NrdR regulatory protein that 
associates directly with promoters for class Ia, Ib and III RNR genes via NrdR binding 
sites (262). With E. coli as an example it is assumed that in all prokaryotes encoding for 
RNRs expression is regulated at the level of transcription by both positive and negative 
regulatory proteins.  
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Rationale 
 
 
 
 
NrdD is the essential α-component of the ARNR complex formed by the 
association of an NrdD homodimer with the β-component, NrdG, therefore the 
anticipated outcome of nrdD mutation is sensitivity to entirely reduced atmospheres 
(125). It was hypothesized that 6-26 would grow only in aerobic atmospheres. Dr. 
Sehmi Paik demonstrated in a time-course growth experiment that 6-26 grew 
indistinguishably from SK36 under aerobic conditions (Fig. 13). When the same 
experiment was conducted under supposed anaerobic conditions 6-26 exhibited a slower 
growth rate than SK36, but did reach stationary phase within 8 h of subculture (Fig. 13) 
(196). The observation that anaerobic growth was not entirely attenuated in 6-26 caused 
Dr. Paik to speculate that 6-26 may have acquired an extragenic suppressor mutation 
permitting anaerobic growth. Dr. Paik attempted to reconstruct the nrdD mutation by 
PCR amplification of the nrdD::magellan2 region of 6-26 and cloning of the amplicon 
in the suicide vector pVA2606, to create pJFP16. SK36 transformed with pJFP16 
yielded three Cmr clones, JFP20, JFP21 and JFP22. These strains were compared to 
SK36 and 6-26 by surface plating on TSA with or without Cm, and growth under 
reduced oxygen in the anaerobe jar or in the anaerobe chamber. Dr. Paik found that S. 
sanguinis strains JFP20, JFP21, and JFP22 all exhibited similar growth to SK36 and 6-
26 when incubated in the anaerobe jar and in the anaerobe chamber (Fig. 14). 
 
97 
Figure 13. Growth study of SK36 and 6-26 
 
Growth studies were performed for SK36 and the STM mutant, 6-26 in 200 μl volumes, 
with the optical density at 450 nm recorded at ten minute intervals. In independent 
experiments SK36 and 6-26 were cultured aerobically (filled symbols), or under an 
ostensibly anaerobic (reduced oxygen) atmosphere (empty symbols) to compare the 
growth trends of the two strains as a function of O2 availability (196).  
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Figure 13. 
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Figure 14. Growth of S. sanguinis ARNR mutants under different O2 tensions  
 
The growth of S. sanguinis SK36 was compared with that of ARNR mutant strains on 
agar plates. Cells were plated on either TSA plates or on TSA containing 
chloramphenicol (‘+ Cm’), and grown under reduced O2 in an anaerobe jar or in an 
anaerobe chamber for 2 days. SK36, the parental, WT strain; 6-26, the original STM 
mutant; 1, JFP20; 2, JFP21; 3, JFP22; the JFP20, JFP21, and JFP22 strains were re-
created ARNR transposon insertion mutants (196).  
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One unexpected outcome of this experiment was that anaerobe chamber growth of 6-26, 
JFP20, JFP21 and JFP22 was attenuated on TSA with Cm, suggesting that expression of 
Cm acetyltransferase (CAT) in these strains had an additional negative effect on growth 
(Fig. 14) (196). As these studies failed to demonstrate a growth defect on TSA under 
our standard laboratory procedure for imposing anaerobiosis we sought to develop an 
in-frame deletion of nrdD for further analysis of this locus. This strategy was intended 
to test the possibility of an extragenic suppressor mutation in 6-26, as well as avoidance 
of polar effects owing to transposon insertion, and to negate apparent growth 
suppression owing to CAT expression.  
 
102 
 
 
 
Results 
 
 
 
 
Development of JFP27 
 The nrdD locus of S. sanguinis SK36 includes nrdD preceded upstream by a 
putative membrane protein gene (SSA_2231), downstream by a hypothetical protein 
gene (SSA_2229) overlapping with the 3’ end of nrdD, two acetyltransferase genes 
(SSA_2228 and SSA_2227), and the ARNR β protein encoding gene nrdG (SSA_2226) 
(Fig. 15). The strategy for mutagenesis of nrdD included deletion of conserved C-
terminal residues (KRTCGYL) that encompass the site of glycyl radical formation, and 
maintenance of the 3’ end of the gene to avoid mutagenesis of the downstream 
hypothetical protein gene (SSA_2229). Gene SOEing was used to create an in-frame 
deletion construct with removal of the central 705 aa of the 731 aa sequence, for fusion 
of the first 12 codons with the last 14 codons of nrdD. The plasmid containing this 
construct was used as transforming DNA with competent SK36 cells. As no selective 
marker is conferred by the mutagenic construct, S. sanguinis colonies on TSA agar were 
replica plated and grown under a reduced oxygen condition (anaerobe jar) or in an 
anaerobe chamber for identification of clones incapable of anaerobic growth. All 100 
clones screened grew under both conditions, and therefore this screening strategy was 
unsuccessful. Twenty replica plated clones were selected, and cultured in BHI 
overnight. A boiled cell preparation of each clone was PCR amplified for size 
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Figure 15. The nrdD locus of S. sanguinis  
 
The structure of the nrdD locus is indicated for the strains and plasmids listed on the 
left. Potential terminators are indicated as a circle above a vertical line. The position and 
orientation of the transposon in strain 6-26 are indicated by the flag. Gene designations 
are as follows: Mem, putative membrane protein; nrdD, anaerobic ribonucleotide 
reductase gene; hypo, a hypothetical protein gene; Ac1, putative acetyltransferase gene; 
Ac2, second putative acetyltransferase gene; nrdG, anaerobic ribonucleotide reductase 
small subunit gene; wzg, ortholog of putative transcriptional regulator wzg of S. 
gordonii. 
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Figure 15. The nrdD locus of S. sanguinis 
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determination by gel electrophoresis for differentiation between strains with an intact 
vs. deleted nrdD. Three of the twenty clones screened exhibited a product size 
indicating the mutation of nrdD (data not shown). The clone chosen for further 
characterization, designated JFP27, exhibited normal growth on agar in anaerobe jars 
under reduced O2. Therefore JFP27, 6-26 and SK36 were grown under the same 
reduced O2 condition prior to analysis of anaerobic sensitivity.  
 
Optimization of the soft-agar growth assay 
 The conundrum presented by persistent growth S. sanguinis nrdD mutants on 
agar under assumed anaerobic conditions, meant that an alternative technique was 
needed for characterization of these strains. In the soft-agar assay chosen, oxygen-
reactive dye indicators were mixed into the culture tube for estimation of oxygen 
gradients in the agar. Preliminary soft-agar assays were conducted in snap-top 14-ml PS 
round-bottom tubes with TSB-LMP agarose supplemented with resazurin, methylene 
blue, or no dye indicator at all. Following anaerobe chamber pre-incubation of tubes for 
48 h, stationary phase SK36 was added. Incubation at room temperature for 30 minutes 
following inoculation with SK36 was sufficient for solidification of the agar. Tubes 
were then removed from the anaerobe chamber; the tops loosened to establish an 
oxygen gradient within the agar, and grown at 37 ºC for 24 hours. Visual inspection of 
TSB-LMP agarose tubes containing dye indicated that Falcon tubes were not an ideal 
choice for this assay, as pink (resazurin) or blue (methylene blue) color was observed 
throughout the length of the tube (data not shown). The PS tubes used may have been 
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porous to oxygen during aerobic incubation. In support of this, dissection of the agar 
confirmed that dye reactivity was exclusively at the walls of the tube. 
 Glass Hungate tubes were then used for comparison of the oxygen dye 
indicators, resazurin and methylene blue for soft-agar growth of SK36. As described 
above, TSB-agarose was driven to anaerobiosis by pre-incubation in the anaerobe 
chamber. Following inoculation of SK36, and agar solidification, the tubes were 
incubated aerobically. An image taken 2 minutes after removal of tubes from the 
anaerobe chamber demonstrates the initial reactivity to oxygen at the agar surface (Fig. 
16). These tubes lacked any coloration when in the anaerobe chamber. The zones of 
reactivity increased after aerobic incubation overnight; however they were restricted to 
the very top of the tubes, suggesting that an anaerobic state was achieved at greater 
agarose depths (Fig. 16). As shown in Figure 16, the depth of oxygen reactivity was 
greater in the control tube without SK36, than in the presence of streptococci, thus 
indicating consumption of oxygen for growth of this facultative anaerobe. In the studies 
performed comparing resazurin and methylene blue it became apparent that methylene 
blue was restrictive for SK36 growth under the conditions used. While growth of SK36 
was observed in aerobic zones of TSB-LMP agar, no growth occurred in the region of 
methylene blue reactivity (data not shown). This was not an issue when resazurin was 
used as a dye indicator. This observation, in addition to the greater reduction potential 
of resazurin made the magenta indicator a logical choice for further analysis of S. 
sanguinis strains.
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Figure 16. Optimization of the soft-agar assay 
 
Two different dye indicators were investigated for oxygen detection in the soft-agar 
assay, resazurin (+R) and methylene blue (+M). The molten soft-agar was driven to 
anaerobiosis in an anaerobe chamber. Stationary phase cells of S. sanguinis SK36 were 
inoculated into half the soft-agar tubes (SK36) and images were taken of the tubes 2 
minutes after removal from the anaerobe chamber (2 min.) for evidence of dye 
reactivity. The tubes were then incubated aerobically at 37 ºC for 21 hours to permit 
growth of SK36. Growth and oxygen densities were documented photographically.
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Comparison of S. sanguinis strains by the soft-agar growth assay 
 Growth comparisons of SK36, JFP27 and 6-26 were performed in glass Hungate 
tubes in the presence or absence of resazurin, as described above. The parental strain 
SK36 consistently grew throughout the tube, in aerobic (dye indicated) and anaerobic 
zones (Fig. 17). In contrast the growth of JFP27 and 6-26 was restricted to oxidized 
agar, indicated by the pink hue of the oxidized resazurin. This suggests that sensitivity 
of 6-26 and JFP27 to anaerobic conditions is attributed to the loss of NrdD expression.  
To confirm this, we attempted to complement NrdD strains with the nrdD gene 
expressed from its native promoter. Sequence analysis predicted a possible terminator 
149 bp upstream of nrdD (29, 30). The regions preceding nrdD from S. sanguinis, two 
strains each of S. pyogenes and S. pneumoniae, S. mutans, and S. agalactiae were 
compared for conservation of promoter elements among streptococci. With the 
exception of SK36, all other species shared potential -35, -16, and -10 promoter 
sequence elements (274) and other potential promoter elements in the 59 bp upstream of 
nrdD (Fig. 18). As a homologous region was not identified for S. sanguinis SK36, it 
appears that an evolutionarily divergent promoter may regulate the expression of nrdD 
in S. sanguinis.  
The plasmids pJFP29 and pJFP30 contain nrdD preceded by 337 or 36 
nucleotides, respectively, cloned into the E. coli-Streptococcus shuttle vector pVA838. 
Plasmid pJFP29 was designed to include the possible terminator and the postulated 
subsequent native promoter of nrdD (Fig. 15).  
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Figure 17. Soft-agar growth of S. sanguinis nrdD mutants 
 
S. sanguinis strains SK36, 6-26, and JFP27 were compared by a reduced soft-agar 
growth assay. Tryptic soy broth soft-agar with or without resazurin (TSA+R, or TSA, 
respectively) was driven to anaerobiosis in an anaerobe chamber. Stationary phase cell 
of SK36, 6-26 or JFP27 were then added to the soft-agar and the tubes incubated 
aerobically to create an oxygen gradient within the soft-agar. The negative control 
lacking streptococci is shown for indication of the gradient of oxygenated (pink) and 
reduced (yellow) agar. S. sanguinis SK36 exhibited the wild-type phenotype of growth 
in both oxygenated and reduced zones, whereas the nrdD mutants, 6-26 and JFP27 
displayed growth restricted to agar containing oxygen. 
 
 
111 
 
 
 
 
Figure 17. 
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 Figure 18. Identification of putative nrdD promoter elements 
 
Regions upstream from the nrdD gene in the species indicated were aligned using the GCG program PILEUP, with default 
parameters. Gray highlighting indicates conserved promoter elements. Potential transcriptional start sites are indicated by a 
single underline. Start codons for nrdD and potential ribosome binding sites are indicated in bold. Sources and accession 
numbers for the sequences are: Pn R6, S. pneumoniae R6 (AE008401); Pn TIGR4, S. pneumoniae TIGR4 (AE007335); Py, S. 
pyogenes M1 (AE006630, AE006631); Py 8232, S. pyogenes MGAS8232 (AE010118); Sag, S. agalactiae 2603V/R 
(AE014286); Sm UA159: S. mutans UA159 (AE015029, AE015030); Ss SK36: S. sanguinis SK36 (4806195). 
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Figure 18. 
 
 
 
Pn R6 TGTATTTTTAAAATTTTAGATTTTTAACACAAGATATTGATTTTTCTTTTTAGAGTGGTATAATACTTTTTAGAAAGAACATTTTAGAAAAGAGCATG  
Pn TIGR4 TGTATTTTTAAAATTTTAGATTTTTAACACAAGATATTGATTTTTCTTTTTAGAGTGGTATAATACTTTTTAGAAAGAACATTTTAGAAAAGAGCATG  
Py M1 AATATATTGTTTCGAGCAAAAACTTGACACAATATATTGATTTTTTTAGTTGTCGTGATATAATAGTTCCGTAAGGAGATTTGATATG~~~~~~~~~~  
Py 8232 AATATATTGTTTCGAGCAAAAACTTGACACAATATATTGATTTTTTTAGTTGTCGTGATATAATAGTTCCGTAAGGAGATTTGATATG~~~~~~~~~~  
Sag AATATATTGTTCTGAGCAAAAACTTGACACAATATATTGATTTTTTTTCTTTGCATGCTATAATTGTCACTGGAGGATATTTCACATG~~~~~~~~~~  
Sm UA159 AATATATTGTTCT.AAATTTTTTTTACCACAATATATTGATTTTTTTCTTTCTTGTGTTATAATAGCTTCTGTAAGGAGAAAGACGTATG~~~~~~~~  
 
 
Ss SK36 CTGTCGGAGATTCTTGGAATTTCTTAGCAAGCGATAGGTTTAAAGAGACTTGATTTGTCCTAAGGGCAGAGAAAAGGATGTGTTCGTGATG~~~~~~~ 
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To exclude the possibility of nrdD being expressed from a plasmid-borne 
promoter, pJFP30 was created, in which the nrdD gene was preceded by 36 bp-enough 
to contain a ribosome binding site but not a complete promoter (Fig. 15).  
S. sanguinis SK36, 6-26 and JFP27 were each transformed with pVA838, 
pJFP29, and pJFP30. Erythromycin-resistant transformants were screened for the nrdD 
insert by PCR amplification of boiled cell preps of isolated clones with primers 
pVA838-2939 and pVA838-5331 that flank the insertion site in pVA838. PCR products 
analyzed by gel electrophoresis confirmed the presence of the plasmid-borne nrdD 
insert in strains transformed with pJFP29 and pJFP30 (data not shown).  
Complementation of the NrdD mutant phenotype in 6-26 and JFP27 was then evaluated 
by soft-agar studies. For the control strain, SK36 growth was unaffected by 
transformation with pVA838, pJFP29 or pJFP30, as all strains grew throughout the tube 
(typically 7.0 cm in depth) (Fig. 19A and 19B). The nrdD mutant strain JFP27 
containing pJFP29 exhibited growth that was indistinguishable from that of parent 
strain, SK36. In contrast pJFP30 failed to complement the growth of JFP27, suggesting 
that complementation of JFP27 by pJFP29 was due to expression of nrdD from its 
native promoter (Fig. 19A and19B). The complementation observed for JFP27 (pJFP29) 
additionally confirms that NrdD is essential for growth in an entirely reduced, anaerobic 
condition.  
With STM mutant 6-26, typical dense growth in the reduced agar was not 
restored by either pJFP29 or pJFP30. The soft-agar growth of 6-26 (pJFP29) and 6-26 
(pJFP30) was distinctive, however, in that isolated colonies were observed growing in 
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Figure 19. Soft-agar comparison of S. sanguinis plasmid transformants 
 
A) S. sanguinis strains were inoculated into anaerobic soft-agar tubes and then 
incubated overnight with exposure to ambient air to create an oxygen gradient. 
Photographs were taken of the tubes after overnight growth. The strains indicated on the 
left, containing vector alone (pVA838) or vector plus nrdD constructs (pJFP29 and 
pJFP30) were inoculated into tubes with or without the oxygen indicator dye resazurin 
(right and left tubes in each pair, respectively).  
 
B) Depth of growth in tubes without resazurin was measured in cm with a standard ruler 
and the percent growth determined by dividing the zone of growth by total agar depth 
and multiplying by 100. Values are averages ± standard deviations for three samples 
obtained on at least two separate occasions. Asterisks indicate results significantly 
different from those for SK36 (P < 0.001). 
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Figure 19. 
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the reduced agar (Fig. 19A). (Smaller spots apparent in some of the other tubes are 
bubbles in the agar rather than colonies. These were easily distinguished by the 
lenticular disk morphology of the colonies.) This phenotype was not observed for 6-26 
(pVA838), suggesting that plasmid-borne nrdD caused this aberrant growth. As wild-
type turbid growth was not restored in 6-26 containing pJFP29 or pJFP30 we speculated 
that a specific event occurring in a sub-set of cells resulted in the formation of 
individual colonies. A plausible explanation of this observation is low-frequency 
recombination between nrdD of pJFP29 or pJFP30 and the corresponding sequence of 
nrdD flanking the transposon at the chromosomal locus of this gene. To further 
investigate this possibility colonies of 6-26 (pJFP29) and 6-26 (pJFP30) were isolated 
from the reduced agar by removal of turbid agar at the top of the tube and extraction of 
colonies from deep in the reduced agar with a sterile pipette tip. The collected colony 
was cultured in liquid broth overnight, and cells prepared for amplification with 
chromosome specific primers flanking nrdD (ARTR-SalI-22495-F and ARTR-SalI-
20031-R) for assessment of the genomic nrdD region. Analysis of the PCR products by 
gel electrophoresis indicated that the transposon had been lost from the genomic nrdD 
in the 6-26 (pJFP30) cells, in that the same size amplicon was observed for SK36 cells 
(Fig. 20A). In contrast, the size of the 6-26 (pJFP29) PCR product indicated that the 
transposon was still present in the nrdD gene in these cells (Fig. 20A).  
Overnight cultures of isolated 6-26 (pJFP29) and 6-26 (pJFP30) colonies were 
also regrown in soft-agar. Dense growth was observed for both strain variants 
throughout the tube, a phenotype similar to the wild-type (Fig. 20B). Agar with turbid 
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growth was extracted from these tubes and grown in liquid culture overnight for 
preparation of cells for amplification of genomic nrdD, as described above. The gel 
electrophoresis pattern of these PCR products was similar to the isolated colonies in that 
genomic nrdD appeared to be restored in 6-26 (pJFP30), whereas the transposon 
interrupting nrdD was maintained in 6-26 (pJFP29) (Fig. 20A). Therefore the 
mechanism accounting for restored growth in reduced agar was distinct between these 
strain variants.  
 
CAT expression does not affect growth in soft-agar 
 Dr. Sehmi Paik Lee observed that strains 6-26, JFP20, JFP21 and JFP22, 
expressing CAT from the magellan2 mini-transposon were hyper-sensitive to growth in 
an anaerobic atmosphere (196). To determine whether this CAT sensitive phenotype 
persisted in the soft-agar assay, the growth of a hypervirulent STM mutant, 3-24 was 
compared to SK36 by both surface plating in the presence and absence of 
chloramphenicol, and soft-agar culturing in the presence and absence of 
chloramphenicol. For surface plating the strains were grown in an anaerobe chamber 37 
ºC incubator for two days. Soft-agar growth experiments were performed as described 
above.  
 Reduced growth on plates containing chloramphenicol was observed for the 
transposon insertion mutant, 3-24 when compared to lawn formation on plates without 
the selective antibiotic (Fig. 21A). However, 3-24 exhibited soft-agar growth through
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Figure 20. PCR detection of transposon insertion in 6-26 
 
A) Primers flanking nrdD at the genomic locus were used for PCR amplification of the 
nrdD gene, with washed cell preparations as template. SK36 was used as a control for 
reversion at the nrdD locus (lane 1), and compared to isolated 6-26 (pJFP30) (lane 2) or 
6-26 (pJFP29) (lane 4) colonies. PCR amplification was also performed on washed 6-26 
(pJFP30) (lane 3) or 6-26 (pJFP29) (lane 5) cells isolated from turbid agarose. The 
expected amplicon for SK36 was 4.4 kb, whereas the presence of the transposon within 
nrdD would result in a 5.8 kb product.  
 
B) Isolated 6-26 (pJFP29) and 6-26 (pJFP30) colonies were regrown in reduced soft-
agar (+). Control soft-agar tubes for each strain that lack cells, yet containing resazurin 
are also shown (—). 
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Figure 20. 
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Figure 21. Soft-agar evaluation of 3-24 
 
S. sanguinis 3-24 and SK36 were compared for growth on the surface of TSA plates 
with (TSA+Cm) or without (TSA) chloramphenicol. Plates were incubated at 37 ºC in 
an anaerobe chamber. 3-24 exhibited decreased growth on a plate containing 
chloramphenicol, despite the cat gene expressed by this strain (A). SK36 grew well on 
TSA, but did not grow in the presence of chloramphenicol, as anticipated (B). The 
reduced soft-agar assay was then used for anaerobic culture of 3-24 and SK36 in the 
presence (TSA+Cm) or absence (TSA) of chloramphenicol. The oxygen dye indicator, 
resazurin was included in duplicate tubes for visualization of the oxygenated zone of 
soft-agar (+R). 3-24 grew well in the presence and absence of chloramphenicol when 
cultured in anaerobic soft-agar (C), with turbidity similar to wild-type SK36 in TSA 
alone (D). Spots visible in soft-agar tubes are bubbles introduced during inversion to 
mix cells with the media. 
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Figure 21. 
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the entire tube in the presence and absence of chloramphenicol, which was 
indistinguishable from SK36 (Fig. 21C and 21D). These observations suggest that the 
defect in growth on an agar surface imposed by chloramphenicol selection does not 
occur when a strain is embedded in agar.  
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Discussion 
 
 
 
 
 S. sanguinis, a facultative anaerobe, possess both class Ib and class III RNRs to 
permit de novo deoxyribonucleotide synthesis in the diverse atmospheres encountered 
by this organism. The extreme O2 sensitivity of class III RNRs mandates 
deoxyribonucleotide synthesis by class Ib RNRs under growth atmospheres ranging 
from aerobic to microaerophilic (125). Growth observed for S. sanguinis mutants 6-26, 
JFP20, JFP21, JFP22 and JFP27 under our standard anaerobic conditions suggested that 
under trace amounts of O2 the class Ib RNR remains catalytically active. Growth studies 
of E. coli and S. aureus ARNR mutants provide additional evidence of residual activity 
of class I RNRs at low levels of oxygen, with growth defects owing to nrdDG mutation 
most apparent when mutants were cultured in the presence of hydroxyurea, an inhibitor 
of class I RNRs (77, 162). A soft-agar assay previously used for evaluation of the P. 
gingivalis oxidative stress response was employed for evaluation of anaerobic growth of 
S. sanguinis mutants (246). The oxygen reactive dye resazurin was incorporated into 
soft-agar to establish the extent of oxygen permeability in the growth medium. Turbid 
growth of JFP27 and 6-26 was reproducibly restricted to oxygenated zones (as indicated 
by resazurin), and therefore putatively reliant on the class Ib RNR for dNTP synthesis. 
The restricted growth observed for 6-26 and JFP27 suggests that transposon insertion 
mutagenesis or deletion of nrdD both result in anaerobic growth inhibition.  
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Our efforts to complement the mutant phenotypes of these strains suggest a 
model for the transcriptional organization of the nrdD locus in S. sanguinis. The 
genomic locus of nrdD in S. sanguinis includes nrdD preceded upstream by a putative 
membrane protein gene and downstream by a 3’ overlapping hypothetical protein gene, 
two acetyltransferase genes and nrdG, which encodes the β-subunit of the ARNR 
holoenzyme. Complementation of the in-frame nrdD deletion mutant JFP27 by pJFP29 
but not pJFP30 suggests that the nrdD promoter is contained within the pJFP29 
construct. Through nucleotide sequence comparison of the upstream, intergenic region 
of S. sanguinis nrdD to other streptococci it was determined that putative promoter 
elements conserved for other species do not occur in S. sanguinis. Therefore a unique, 
unidentified promoter may regulate the expression of nrdD in S. sanguinis.  
The failure of pJFP29 to complement the nrdD mutation in 6-26 suggests that 
the transposon mutation was polar on the expression of downstream genes. In 6-26 
(pJFP30) occasional recombination between the chromosomal and plasmid borne nrdD 
gene resulted in restoration of the genomic nrdD gene and transcription of the 
remainder of the operon, yielding colony formation in reduced soft-agar. This was 
likely not observed for JFP27 bearing pJFP29 or pJFP30 because of the limited 
sequence shared by the genomic and plasmid nrdD loci (72 and 260 bp at the 3’ and 5’ 
ends, respectively of genomic nrdD). Yet isolated colonies in reduced soft-agar were 
also observed for 6-26 (pJFP29) despite the maintenance of the transposon insertion at 
the genomic locus. Thus it appears that restoration of growth in 6-26 (pJFP29) results 
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from an uncharacterized mutation restoring expression of chromosomal genes 
downstream of nrdD.  
Analysis of the reduced soft-agar growth of an unrelated STM mutant, 3-24 
demonstrated that anaerobic growth sensitivities of STM mutants on chloramphenicol 
plates are circumvented by this culturing strategy. A layer plating technique was used 
for competitive index studies of STM mutants, with bacteria in soft-agar overlaid with 
1.5 % agarose with antibiotic, which negated the problem of chloramphenicol selection 
by surface plating (198). The apparent sensitivity of streptococci to chloramphenicol 
selection under anaerobic conditions has not been previously described, and the 
mechanism of this growth inhibition is unknown. The observation that S. sanguinis 
selection in chloramphenicol under reduced O2 is possible when strains are embedded in 
agar allows for reliable characterization of STM mutants.  
 The objective of the experiments described here was to characterize whether the 
S. sanguinis nrdD gene was required for growth under anaerobiosis, as previously 
demonstrated for other bacterial species. Anaerobic growth attenuation of JFP27 and 6-
26 in reduced soft-agar indicated that nrdD expression was essential. Aside from 
confirming this in vitro phenotype attributed to nrdD, isolation of 6-26 as an avirulent 
strain by STM suggests that regions of the vegetation in IE are anaerobic. Analysis of 
IE by STM potentially would identify different classes of virulence determinants in 
strains associated with the vegetation depending on the vegetation microenvironment 
encountered. At the surface of the vegetation bacteria must be able to colonize the 
platelet-fibrin matrix and contend with host defenses at the blood interface. Within the 
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vegetation bacteria potentially encounter reduced levels of nutrients and oxygen as a 
result of bacterial accruing and progressive fibrin stratification (64). To our knowledge 
oxygen levels within the vegetation have not been measured. A survey of S. aureus 
STM strains in an endocarditis model identified 5 anaerobic mutants that were 
attenuated in vivo (50). Theses studies indicate that the interior of the vegetation is low 
in oxygen despite the circulating oxygenated blood at the surface of the vegetation, and 
that expression of anaerobic specific genes (in the case of S. sanguinis, nrdD) is 
required for persistence in vivo. 
 
  
DEVELOPMENT OF GENETIC TOOLS FOR ANALYSIS 
OF S. SANGUINIS 
 
Rationale 
 
 
Among the viridans group streptococci, Streptococcus sanguinis is the most 
common streptococcal agent of IE (181). An in vivo screening for S. sanguinis SK36 IE 
virulence determinants by random signature-tagged mutagenesis identified 5 avirulent 
mutants with transposon insertions in ORFs encoding housekeeping genes or genes 
necessary for survival under anaerobic conditions (198). The lack of identification of 
classical virulence factors, e.g., those facilitating adhesion in colonization, was 
surprising given the abundance of putative virulence factors predicted from the 
complete SK36 genome sequence (285). Therefore a need exists for development of 
genetic tools to facilitate further screening of streptococcal factors required for 
development of disease.  
To screen mutants for defects in the rabbit model of infective endocarditis it is 
best to inoculate a test strain along with a virulent control strain. In this way factors 
contributing to inter-rabbit variation including pre-infection vegetation size, 
physiological differences and immune competency can be accounted for, as both strains 
encounter the same conditions. The co-administration of strains in this experimental 
design requires selective markers for distinguishing between strains recovered in a 
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complex pool comprising both the experimental strain of unknown virulence, and the 
control. It is commonplace to create marked genomic mutations using antibiotic 
resistance cassettes; however a conundrum exists as to the best method for selection of a 
control strain. Using a subtractive approach to estimate the recovery of an unmarked 
control strain may be misleading due to the assumption that both strains have equal 
plating efficiency. Therefore an attractive alternative would include exclusive selection 
of the control strain from a multiple strain pool. A control strain with a selectable 
marker would also be useful for evaluation of unmarked mutant strains, for example an 
in-frame deletion mutant. This type of comparison is not feasible with SK36 as a 
control. In addition, the development of a collection of selective marker constructs 
would permit us to add a selectable marker to an in-frame deletion mutant, at the same 
locus as the competitive control. This scenario would permit the detection of 
phenotypes entirely determined by in-frame deletion of a gene of interest.  
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Results 
 
 
 
 
Identification of SSA_0169 
 The S. sanguinis SK36 genome is more compact than published genomes for 
other streptococcal species, with an average intergenic region of 115 bp (vs. average 
intergenic region lengths of 130 to 177 bp) (285). Given the proximity among predicted 
ORFs we sought to identify an insertion site with minimal risk of affecting important 
genes or operons. A 2.225 kb SK36 chromosomal region including a putative 644 bp 
stretch of non-coding DNA (shown in brackets in Fig. 22) was cloned into the suicide 
vector pVA2606 to create pJFP34. A unique NcoI site within the predicted non-coding 
region of the insert was employed for cloning of pSerm, an erythromycin resistance 
cassette that is expressed in E. coli and streptococci (47). The cassette used is optimal 
for our strategy as expression of pSerm is not reliant on an external promoter. This 
cassette was engineered by PCR to fuse the -35 region from the native ami operon S. 
pneumoniae promoter, pA, proximal to the -10 region and 16 bp upstream of pAMβ1 
encoded erm (47).  
The resulting plasmid containing pSerm, pJFP36 was transformed into S. 
sanguinis SK36 to generate JFP36. In the initial annotation of the SK36 genome 
sequence, no open reading frame (ORF) was predicted for the 644 bp region between 
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SSA_0168 (0168) and SSA_0170 (0170) (Fig. 22). However, after creation of strain 
JFP36, a subsequent GLIMMER analysis predicted the SSA_0169 (0169) ORF. This 
ORF encodes a 65 amino acid hypothetical protein that lacks homology to any proteins 
of known function. The predicted ORF is 303 bp downstream from the 0168 gene, and 
if co-transcribed, 0169 would be the last gene of the operon. The flanking open reading 
frames, 1068 and 0170, are also hypothetical. 
 
Transcriptional analysis of 0169 
As 0169 was predicted to encode a small, non-conserved hypothetical protein 
we wanted to determine whether expression of this ORF occurs. Quantitative (real-time) 
reverse transcriptase PCR was used to determine whether 0169 transcript was detectible 
during in vitro culture under various oxygen tensions, including aerobic culture, 6 % O2, 
and anaerobic culture. We determined that transcription of 0169 is variable under the 
conditions tested, with the least expression occurring under reduced oxygen or 
anaerobic conditions that are typical in laboratory culture (Fig. 23). In contrast, ~80-fold 
more 0169 transcript was detected in S. sanguinis SK36 cultured aerobically relative to 
anaerobic and 6 % O2 conditions, indicating that expression of 0169 is enhanced during 
aerobic growth.  
An in vitro growth comparison of S. sanguinis SK36 and JFP36 was then 
performed to determine whether interruption of 0169 by pSerm affected growth under 
aerobic conditions. As shown in Figure 24, JFP36 and SK36 grew similarly, suggesting 
that mutation of 0169 did not influence growth of JFP36. 
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Figure 22. The 0169 locus of S. sanguinis SK36 
 
The 0169 locus is shown. The 0169 gene putatively encodes a 65 aa protein. This ORF 
was mutated for development of S. sanguinis SK36 derivatives selectable by antibiotic 
resistance determinants. In the initial annotation of the S. sanguinis SK36 genome 
sequence 0169 was not identified, and this cloning region was selected based on an 
apparent 644 bp non-coding region. However, a subsequent GLIMMER analysis did 
identify the ORF 0169, which is flanked on by two hypothetical ORFs, 0168 (upstream) 
and 1070 (downstream). The region shown in brackets (2.225 kb) was cloned into the E. 
coli vector pVA2606 for creation of pJFP34.  
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Figure 22.  
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Figure 23. qRT-PCR detection of an 0169 transcript  
 
S. sanguinis SK36 was cultured aerobically (O2+), in an anaerobic atmosphere (O2-), or 
in 6 % O2 for five hours. The amount of RNA transcript of 0169 and 16S rRNA was 
then determined from RNA extracted from cells grown under the different O2 tensions. 
The fold change in transcript abundance relative to the 6 % O2 condition is shown. 
RiboGreen fluorescence of nucleic acid was used to normalize samples for differences 
in the efficiency of reverse transcription. Values depicted represent the mean and SEM 
16S rRNA and 0169 transcript levels from three independent samples. 
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Figure 23.  
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Figure 24. Aerobic growth comparison of JFP36 and SK36 
 
S. sanguinis SK36 and JFP36 stationary phase cells were diluted 200 fold in BHI, and 
the growth of the subcultured cells monitored over a 20 hour period by recording the 
optical density at 450 nm every 10 minutes. The growth study was performed in a PS 
96-well plate, with cells incubated aerobically at 37 ºC. Growth to 13 hours is shown to 
emphasize the similarity between SK36 and JFP36 in the log growth phase. 
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Figure 24. Aerobic growth comparison of JFP36 and SK36 
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Characterization of JFP36 biofilm formation  
To investigate the impact of pSerm insertion in JFP36 on biofilm development, a 
previously described semi-quantitative assay was used (76). S. sanguinis SK36 served 
as a positive control in this assay, and its isogenic mutant, VT1614, served as a negative 
control. In VT1614, srpA is interrupted by the kanamycin resistance gene, aphA-3 
(204). The S. parasanguinis SrpA homolog, Fap1 was required for wild-type biofilm 
formation in the presence of 1 % glucose (76). JFP36 biofilm formation was 
indistinguishable from SK36 (Fig. 25) in the presence of glucose (P= 0.25) and sucrose 
(P= 0.11), and for both JFP36 and SK36, biofilm formation in 1 % glucose was 
significantly greater than that of VT1614 (P < 0.001). Therefore, mutation of 0169 did 
not alter biofilm development under the conditions tested.  
 
Genetic Competence of JFP36  
The capacity for genetic manipulation is invaluable for studying microbial 
pathogenesis. S. sanguinis is naturally competent and readily transformable when 
provided extracellular DNA in the presence of CSP and animal serum. One potential 
future use of JFP36 is the employment of this strain as a genetic background for in-
frame deletions in genes of interest. Therefore we sought to compare transformation 
frequency and efficiency between SK36 and JFP36, to determine whether this 
application of JFP36 is feasible. The plasmid used as transforming DNA, pJFP16 gives 
reproducibly high transformation frequencies and efficiencies, and integrates the cat 
gene into the chromosome in single copy. As shown in Table 3, JFP36 was competent 
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Figure 25. Biofilm comparison of S. sanguinis SK36 and JFP36 
 
S. sanguinis SK36, JFP36 (Δ0169), and VT1614 (ΔsrpA) were grown to early stationary 
phase in BHI, and then subcultured (1:100) in biofilm medium with 1 % glucose 
(BM+Glu), or 1 % sucrose (BM+Suc). Strains were grown under static conditions in PS 
microplates at 37 ºC, 6 % O2 for 20 hours. Biofilm formation as determined by CV 
staining was quantified at 600 nm. Assays were performed in triplicate, in three 
independent experiments, means and SD are shown. ***= P < 0.0001 
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Figure 25. 
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Table 3. Genetic competence comparison of SK36 and JFP36 
 
S. sanguinis strain  Transformation frequency‡   Transformation efficiency¥ 
SK36    27.38 %   8.6 x 107 CFU µg-1 DNA 
JFP36    27.13 %   8.25 x 107 CFU µg-1 DNA 
 
‡: The ratio of transformants (Cmr conferred by homologous recombination of the 
pJFP16 encoded nrdD::cat) to total colony forming units 
¥: The number of transformants (Cmr) per µg of pJFP16 transforming DNA 
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for uptake and recombination of pJFP16 transforming DNA with transformation 
frequencies and efficiencies similar to wild-type. 
 
Analysis of JFP36 competitiveness in vivo.  
S. sanguinis JFP36 was then tested for competitiveness in the rabbit model of IE 
by a competitive index (CI) assay. In this experiment early stationary phase SK36 and 
JFP36 were co-inoculated into four catheterized rabbits and infection monitored 20 
hours post-inoculation. The CI (competitiveness value of JFP36) value was determined 
by dividing the ratio of JFP36 to SK36 recovered from the rabbit by the ratio of JFP36 
to SK36 in the inoculum. A mean CI value of 1.22 (range 0.4 to 1.7) was obtained from 
the four rabbits. Because a CI value of 1 indicates equal competitiveness between the 
two strains, this CI value confirms that competitiveness of JFP36 is not significantly 
different from SK36 (P= 0.52). Therefore JFP36 would serve as a valid control strain in 
future in vivo competitive index assays, and would permit direct discrimination between 
wild-type and one or more mutant strains on plates containing different antibiotics.  
 
Development of JFP56 and JFP76 
 Maintenance of competitiveness in JFP36 confirms that manipulation of 0169 is 
not detrimental in vivo. We chose to develop additional novel S. sanguinis strains with 
different antibiotic resistance markers at the 0169 locus to increase the applicability of 
this tool. In the design of a spectinomycin resistant derivative of SK36, the aad9 
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resistance cassette from pR412 (161) was cloned into a linker central to the 0169 
segment of pJFP46 for creation of pJFP56.  
 Expression of the plasmid pR412 encoded aad9 is controlled by a strong, 
synthetic promoter which includes the 5’ region of the native ami operon pneumococcal 
promoter, pA fused to the 3’ region of the aad9 promoter to permit optimal expression 
of spectinomycin resistance in S. pneumoniae (56) (similar to the promoter of pSerm, 
described above). The pJFP56 insert maintained the synthetic aad9 promoter adjacent 
the aad9 gene. S. sanguinis SK36 was subsequently transformed with pJFP56 for 
identification of the spectinomycin resistant strain, JFP56. Expression of aad9 at the 
0169 locus of S. sanguinis was evidenced by successful selection of the JFP56 strain.  
A tetracycline resistant S. sanguinis strain was also developed by cloning of the 
tetM gene from pJM133 (88) into the linker transecting 0169 in pJFP46 for creation of 
pJFP76. The class M tetracycline resistance determinant, tetM originates from the 
Tn916 composite conjugative transposon of E. faecalis (231). In pJM133 tetM 
transcription was controlled by a native aad9 promoter of the E. faecalis plasmid, 
pD255, aad9 resistance determinant (205). The promoter controlling expression of tetM 
is constitutively expressed in both E. coli and streptococci and therefore ideal for our 
purposes in this study. S. sanguinis SK36 was transformed with the tetM containing 
plasmid, pJFP76, for isolation of the tetracycline resistant strain JFP76. DNA 
sequencing of tetM in the 0169 locus of JFP76 indicated that the actual cassette used 
shared greater identity with tetM of the S. pneumoniae Tn1545 determinant (GI:48189) 
than the tetM gene of Tn916. The mosaic nature of tetM alleles has been previously 
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investigated by sequence alignment for identification of sequence polymorphisms. It is 
of interest that allelic variation observed in nature was attributed to differing 
homologous recombination between two distinct tetM alleles of Tn916 S. aureus and 
Tn1545 of S. pneumoniae. The evolution of mosaic tetM alleles would have been 
facilitated by the conveyance of these determinants on mobile conjugative transposon 
elements (192).  
  
Analysis of JFP56 and JFP76 competitiveness in vivo and in vitro  
 An in vitro growth study of JFP36, JFP56 and JFP76 was conducted for 
verification that growth of these strains was similar under our typical laboratory culture 
conditions. The growth study results shown in Figure 26 confirmed that insertion of 
different resistance determinants in 0169 had no effect on the growth phenotype of 
these strains, in that all strains exhibited identical growth patterns in the period studied. 
 Competitiveness of JFP56 and JFP76 was determined by comparison to the 
competitive erythromycin resistant strain, JFP36 by the competitive index assay. In past 
CI analyses our lab has directly compared two strains in vivo by co-inoculation into a 
previously catheterized rabbit (198). In this study we chose to co-inoculate the three 
strains with different selective makers, JFP36, JFP56 and JFP76 for a direct comparison 
of strains encountering shared selective pressures in vivo. For this purpose the three 
strains were adjusted to an equal optical density corresponding to ~ 5 x 107 to 1 x 108 
CFUs for co-administration intravenously. The inoculum received by the rabbits was 
determined to be 6.11 x 108 CFUs, with JFP36, JFP56 or JFP76 accounting for 16.9 %, 
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75.3 % or 7.9 % of the inoculum, respectively. Bacteria were recovered from aortic-
valve associated vegetations 20 hours later and plated on TSA containing the 
appropriate antibiotic for selection of the erythromycin, spectinomycin, or tetracycline 
resistant strain. The CI values were then determined for JFP56 or JFP76 relative to the 
control, JFP36 by dividing the ratio of the unknown (JFP56 or JFP76) to JFP36 
recovered from the rabbit, by the unknown to JFP36 ratio in the inoculum. The mean CI 
values determined for JFP56 and JFP76 are depicted and described in Figure 27. JFP76 
was determined to be equally competitive to JFP36 with a mean CI value of 0.83 (P= 
0.2735), which suggests that JFP76 is also applicable as a competitive control for future 
studies. The mean CI value for JFP56 of 0.38, suggested that competitiveness of JFP56 
was significantly reduced as a result of aad9 expression at the 0169 locus (P= 0.0470). 
However, the percentage of JFP56 in the inoculum was much higher than expected and 
thus indicated that an error in plating may have occurred.  
 We chose to repeat the direct CI comparison of JFP56 and JFP36 by intravenous 
co-inoculation of the two strains into catheterized rabbits. In this experiment the rabbits 
received a total inoculum of 1.28 x 109 CFUs of which 52.3 % was JFP56, and 47.7 % 
JFP36. The competitiveness of JFP56 was determined by recovery of bacteria 
associated with aortic valve vegetations at 20 hours post-administration of strains, as 
described above. The mean CI value for JFP56 relative to JFP36, 0.96, indicated that 
JFP56 was as competitive as the wild-type strain (P= 0.6932) (Fig. 27). 
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Figure 26. In vitro growth comparison of JFP36, JFP56 and JFP76 
 
Early-stationary phase cultured cells of S. sanguinis JFP36, JFP56 and JFP76 were 
adjusted to an equal optical density at 660 nm, and then subcultured (1:100) in BHI for 
an overnight growth assay. The growth study was performed in a 96-well PS plate, at 37 
ºC, with the optical density at 450 nm recorded every 10 minutes. Growth to 12 hours is 
shown to emphasize the similarity between the log growth curves of JFP36, JFP56 and 
JFP76. 
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Figure 26. 
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Figure 27. CI comparison of JFP56 and JFP76 to JFP36 
 
S. sanguinis strains expressing different resistance determinants at the 0169 locus were 
compared for competitiveness in the rabbit model of IE to determine whether the strains 
could serve as virulent controls in future experiments. In two separate experiments 
JFP56, JFP76 and JFP36 were compared by co-inoculation of the three strains (Ф), or 
co-inoculation of JFP56 and JFP36 only (ζ) into previously catheterized rabbits. Rabbits 
were sacrificed 20 hours later for recovery of bacterial strains by plating on selective 
antibiotics. The CI value for the two strains of unknown competitiveness, JFP56 and 
JFP76 was determined by comparison to the control competitive strain, JFP36 for each 
rabbit. In the graphical representation the dotted line at 1 indicates the value for equal 
competitiveness. Each symbol represents a CI value from one rabbit, and the bar 
indicates the mean CI value. In the triple strain comparison JFP56 was significantly less 
competitive than JFP36 (*= P < 0.05), whereas JFP76 was equally competitive to 
JFP36. Reevaluation of JFP56 resulted in a CI value indicative of equal 
competitiveness. The actual mean CI and range of value observed for each strain are 
shown in the table. 
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Figure 27. 
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Strain Phenotype CI (Range) 
JFP56Ф; JFP56ζ Less Competitive; Competitive 0.38 (0.26 - 0.56); 0.96 (0.84 - 1.27) 
JFP76Ф Competitive  0.83 (0.66 - 1.03) 
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 The evenly divided inoculum ratio in the JFP56 and JFP36 CI experiment 
provided these strains an equal opportunity for colonization and growth, and would 
therefore result in a more reliable CI score. Even combining the CI values from the two 
experiments evaluating JFP56 does not result in a mean CI value (0.6) significantly 
different from an equal competitiveness value of 1 (P= 0.0810). 
 From these experiments we concluded that competitiveness of JFP56 and JFP76 
in vivo was unaffected by the resistance determinant used, and these strains, in addition 
to JFP36 could act as controls for screening and identification of mutants attenuated in 
the rabbit model of IE.  
 In a final set of experiments an in vitro competitiveness assay was used to 
compare the growth of JFP56 or JFP76 to JFP36 during co-culture. This type of 
experiment indicates whether in vivo findings may be construed by phenotypes 
unrelated to in vivo conditions, instead owing to effects of co-culturing of strains or 
general differences in the growth rates of strains. For this experiment strains were 
adjusted to an equal optical density and then co-cultured in vitro for the typical infection 
duration (~20 hours). The in vitro CI value was derived by comparing CFUs of strains 
following co-culture, to CFUs before co-culture (“the inoculum”); with a CI value of 1 
suggesting strains grow equally well during co-culture in vitro. The mean in vitro CI 
value for JFP56 or JFP76 relative to JFP36 was determined by two independent 
experiments performed in triplicate. The CI values obtained for JFP56 and JFP76, 1.31 
and 1.51, respectively suggest that co-culturing of these strains with JFP36 in vitro 
results in growth significantly greater than JFP36 (P= 0.0086, P= 0.0005, for JFP56, 
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and JFP76). The observed in vitro phenotype was attributed to a greater number of 
JFP56 or JFP76 CFUs recovered following co-culture, as the ratio of JFP56 or JFP76 to 
JFP36 in the inoculum was similar to that observed during in vivo analysis. The shared 
core genome of these strains suggests that difference in growth in vitro, as determined 
by CFU formation is an artifact of the selective marker used. The similar in vivo CI 
values for JFP36, JFP56 and JFP76 (discussed above) indicate that additional selective 
pressures encountered in vivo result in comparable growth of these strains in the animal 
model for a recovery to inoculum ratio closer to 1.  
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Discussion 
 
 
 
 
We intended to develop a system for integration of selective markers into the 
chromosome of S. sanguinis SK36, while maintaining WT phenotypes of this species. A 
scan for non-coding sections of the S. sanguinis genome sequence prompted the use of a 
predicted intergenic region separating two opposing, hypothetical ORFs, 0168 and 
0170. Following the development and preliminary characterization of JFP36 an ORF 
was identified for this intergenic region, 0169, that was inactivated by insertion of the 
erythromycin resistance gene. The 0169 ORF putatively encodes a 65 amino acid 
protein with no homology to previously characterized proteins. In addition, the 0169 
locus is non-conserved among closely related streptococcal species (Integrated 
microbial genomes resource (http://img.jgi.doe.gov/cgi-bin/pub/main.cgi)). Despite the 
novelty of this ORF, and indications that 0169 was a pseudogene, a 0169 transcript was 
detectible by qRT-PCR. The transcriptional analysis of 0169 confirmed expression of 
the ORF was greatly increased during aerobic culture, which is an atypical condition for 
typical laboratory growth of S. sanguinis. The unintended manipulation of 0169 did not 
have any consequence on relevant in vitro phenotypes of S. sanguinis, including 
doubling time during in vitro growth, biofilm formation, and competence for DNA 
transformation. Most important for the objective of this work, JFP36 was equally 
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competitive to SK36 in vivo, and therefore appropriate for use in future competitive 
index assays.  
 The proven maintenance of virulence in JFP36 resulted in the development of 
two additional derivatives of SK36 with unique resistance markers, JFP56 and JFP76. 
Competitive index comparisons of JFP56 and JFP76 in the rabbit model of IE 
confirmed both exhibited the virulent phenotype. The in vitro growth comparison of 
JFP36, JFP56 and JFP76 suggested that doubling times of these strains were similar. 
Contrary to our expectation in vitro co-culture of JFP36, JFP56 and JFP76 resulted in 
different recovery ratios of the three strains, with growth of JFP36 apparently attenuated 
during co-culture. This phenomenon is most likely caused by the antibiotic determinant 
gene, as this is the only substantial difference between the strains. However, the effect 
is independent of selective expression of the resistance marker since no selective 
antibiotics were present in the liquid growth medium at the time of co-culture. One 
possible explanation is that expression of the resistance determinant may affect cell 
viability at greater cell densities indicative of stationary growth phase cells. In the 
infective vegetation streptococci may reach a cell density of 108 to 1010 within 20 hours, 
which is similar to the streptococcal density per ml following overnight culture. 
However, selective pressures encountered in vivo may result in slower growth rates than 
in vitro, so that cells spend less time at stationary phase prior to plating for enumeration 
of surviving streptococci. If viability for a strain is decreased in stationary phase, then 
less of that strain would be recovered by plating. Unfortunately the distinguishing host 
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pressures that might influence growth of these strains can not be replicated in the 
laboratory.  
 The genomic tools developed in this chapter will enhance the screening and 
identification of novel determinants for IE. Since it is often desirable to insert antibiotic 
resistance markers and other exogenous genes into the chromosome, potential future 
applications include exploitation of the 0169 chromosomal site for ectopic expression of 
native genes to allow for complementation of mutations elsewhere in the genome.
 
  
A COMPREHENSIVE ANALYSIS OF S. SANGUINIS CELL 
WALL-ASSOCIATED PROTEINS IN EARLY IE 
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Cwa proteins as mediators of pathogenesis 
 The Cwa protein class of surface exposed proteins was first identified by 
detection of a common C-terminal LPXTG (aa abbreviations are described in Appendix 
C) sorting motif among 6 cloned gram-positive surface proteins (72). The prevalence of 
this protein class in gram-positive species is evidenced by the identification of proteins 
containing this motif in nearly all published genome sequences (25, 49). Cwa proteins 
are considered particularly important in pathogenesis as many have been grouped as 
MSCRAMMs mediating adhesion to adhesive matrix molecules of host tissue and host 
cells. Previously described streptococcal MSCRAMM adhesins include the S. pyogenes 
M family proteins Emm, Mrp and Enn (reviewed by 185), and viridans streptococcal 
antigen I/II, and Csh homologs (152, 169). Enzymatic functions have also been ascribed 
to multiple streptococcal Cwa proteins. Streptococcus pyogenes C5a peptidase and the 
S. pneumoniae neuraminidase modulate host immune components and sialylated 
proteins, respectively to putatively enhance pathogenesis (191, 279). Cwa proteins of S. 
mutans, β-d-fructosidase and dextranase are considered important for nutrient storage 
and acquisition (24, 48).  
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Cell surface localization of Cwa proteins 
Cwa proteins are typified by two signal sequences that direct, first the 
extracytoplasmic export of the precursor protein, and second the covalent linkage of the 
protein to the cell wall. Extracytoplasmic trafficking and export of the precursor Cwa 
protein is specified by a gram-positive type I N-terminal signal (leader) peptide 
sequence. The leader peptide includes an N-terminal region with positively charged 
amino acids, followed by a central hydrophobic region, and then a C-terminal region 
containing hydrophilic residues (reviewed in 266). The presence of the leader peptide 
drives Sec-dependent secretion of the precursor protein through a translocase channel. 
The mediators of Sec secretion have been determined for E. coli, and partly 
characterized in B. subtilis. S. sanguinis homologs to proteins described below are 
indicated parenthetically.  
 In the putative system for translocation in Bacillus subtilis, based on E. coli, 
export is considered co-translational. This mode of transport in E. coli initiates with the 
signal recognition particle (SRP: Ffh (SSA_1167) + 4.5S RNA) binding to the leader 
peptide of the nascent polypeptide as it emerges from the ribosome. Binding of SRP to 
the polypeptide arrests protein translation until association with FtsY (SSA_1557), and 
subsequent targeting of the complex to the Sec translocase at the cytoplasmic 
membrane. Following association with the translocase, translation resumes as the 
protein is transported across the membrane through a SecYEG heterotrimer (SSA_0127, 
SSA_2208, and SSA_1604 respectively) translocase channel. The SecA ATPase 
(SSA_0543) associates with the channel to couple the energy from ATP binding and 
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hydrolysis to the stepwise translocation of the Cwa protein precursor (reviewed in 288). 
In E. coli, SecD and SecF are large integral membrane proteins that form a 
heterotrimeric complex with YajC and associate loosely SecYEG in a supramolecular 
translocase complex (62). In B. subtilis, SecD and SecF are fused into a single 
membrane protein that potentially contributes to the efficiency of protein secretion (26). 
As described for S. mutans, S. sanguinis SK36 lacks a SecDF homolog, yet does encode 
a YajC-like protein (SSA_1792) (91).  
 As the precursor protein emerges from the translocase, the type I leader peptide 
is recognized and cleaved by a membrane spanning type I signal peptidase (SSA_0351, 
SSA_0849). The mature N-terminus of the Cwa protein is then exposed, and the 
remaining signal peptide degraded. Recent studies in S. pyogenes have revealed that the 
leader peptide also directs the cell wall location of the Cwa protein. For example, the 
leader peptide of the M protein directs localization at the cell division septum, whereas 
the protein F leader peptide results in emergence of the protein at the old division pole 
(39).  
Studies concerning the cellular location of the Sec machinery in S. pyogenes 
resulted in the coining of the term “ExPortal” to describe the translocase localization to 
a single site at the extreme pole of the cell (220). This is distinct from the reported 
helical pattern assumed by Sec machinery on the cell surface of B. subtilis (37). 
Immunogold labeling suggests that in S. mutans SecA and the transpeptidase enzyme, 
sortase A, required for Cwa protein surface anchoring, are co-localized at a single 
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position on the cell surface. Therefore the site of protein translocation may also be the 
site of protein anchoring by sortase A (107).  
An accessory sec locus with sec homologs, secA2 (SSA_0836) and secY2 
(SSA_0832) was identified in S. gordonii. These proteins mediate the selective 
transport of a single serine-rich Cwa protein, GspB. In concert with specialized 
transport, GspB contains an unusually long leader peptide (17). The accessory sec locus 
of S. gordonii is conserved in S. sanguinis, and is adjacent to a serine rich protein in this 
species as well. Therefore the specialized export of this protein is likely shared between 
these species.  
Following Sec-dependent export, the C-terminal sorting signal of the Cwa 
protein drives sortase transpeptidase-dependent anchoring of the protein to the cell wall. 
The sorting signal is ~40 amino acids in length and consists of a tripartite motif with an 
N-terminal LPXTG-related pattern, followed by a hydrophobic domain, and a positively 
charged tail at the extreme C-terminus of the protein (reviewed in 255). It is thought 
that the hydrophobic region and positively charged terminus retain the Cwa protein in 
the membrane until association with sortase occurs. Evidence of intermediate 
membrane association is in the observation that mutation of LPXTG abolishes cell wall 
linkage; however the protein is not secreted from the cell, as has been observed with 
complete loss of the tripartite motif (227).  
Genomic sequence scanning of gram-positive organisms has revealed that 
almost all encode sortase-like proteins, and many encode multiple sortase paralogs (49, 
199). All sortase homologs contain a signature active site motif, LXTC, with Leu, Thr 
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and Cys residues conserved (109). A comprehensive analysis of 241 bacterial genomes 
(96 species of bacteria) resulted in the grouping of similar sortase-like proteins 
(determined by BLAST scores, and confirmed by Hidden Markov Modeling (HMM)). 
Six sub-family groups were proposed in all, including five occurring in gram-positive 
organisms: subfamily A sortases (referred to here as the class A sortases, and sortase 
A), subfamily B sortases (referred to as class B sortases, and sortase B), subfamily 3 
sortases (referred to below as sortase C, SrtC), subfamily 4 sortases, and subfamily 5 
sortases; as well as a sixth subfamily unique to gram-negative organisms (49). Putative 
substrates of the sortase subfamilies could be delineated based on proximity to a 
putative requisite sortase and the observation of distinct cell wall sorting motifs within 
these groups. The majority of putative cell wall-associated protein substrates rely on a 
“housekeeping” sortase of the sortase A (SrtA) class for cell wall anchoring. Genes 
encoding SrtA are ubiquitous among low G+C content gram-positive bacteria (59). 
The most well characterized sortase family protein, SrtA of S. aureus, catalyzes 
the covalent linkage of the Cwa protein to the lipid II precursor of peptidoglycan (PG) 
in a reaction sensitive to the cell wall synthesis inhibitory antibiotics vancomycin and 
moenomycin (258). 
The specific structure of PG differs between species, but several elements are 
conserved, including the PG glycan strands composed of repetitive disaccharide units, 
N-acetylglucosamine-(β1-4)-N-acetylmuramic acid (GlcNAc-MurNAc) (80). In mature 
PG the glycan polymers are adjoined to peptide chains (in S. sanguinis the peptide 
moieties include L-Ala-D-iGln-L-Lys-D-Ala; 19), which are cross-linked by short cell 
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wall peptide cross-bridges. Biosynthesis of PG initiates in the cytoplasm of the cell with 
MurNAc and the L-D-peptide chain associating to form Park’s nucleotide. This Park’s 
nucleotide precursor is then linked by a phosphodiester linkage to the membrane bound 
carrier, undecaprenol phosphate to create the membrane bound lipid I form. Addition of 
GlcNAc and cross-bridge modification at the ε-amino of L-Lys (the crossbridge in S. 
sanguinis is dialanine, Ala2; 19) generates the lipid II precursor. Lipid II is then 
translocated across the cytoplasmic membrane. 
In the transpeptidation reaction catalyzed by SrtA a covalent linkage occurs 
between the Cwa protein and the lipid II precursor of PG. The sortase enzyme cleaves 
the LPXTG pattern between the Thr and Gly residues. The conserved SrtA active site 
Cys residue captures the cleaved polypeptide as a thioester-acyl enzyme intermediate. 
Catalysis is completed by the nucleophilic attack of the amino group of (in the case of 
S. sanguinis, Ala2) the crossbridge of lipid II. Penicillin binding proteins then perform 
transglycosylation reactions to extend the glycan chain, and transpeptidation reactions 
that increase crossbridge crosslinking (between the peptide D-Ala at position 4 and the 
amino group of Ala2) to strengthen the PG (258). These final reactions yield the mature 
gram-positive cell wall.  
 
Sortase A structure and function 
Sortase A is a type II transmembrane protein with an N-terminus rich in 
hydrophobic residues, which serves as a signal peptide directing extra-cytoplasmic 
export of the precursor protein; and as a stop-transfer signal for anchoring to the 
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cytoplasmic membrane. Certain features of the sortase protein sequence are not 
conserved among other class A sortases, including the signal peptide, membrane anchor 
and a short linker domain extending from amino acid 26-59 (109). Functional studies of 
N-terminally truncated S. aureus SrtA, SrtAΔN59 revealed that the first 59 residues were 
not required for cleavage of a d-LPETG-e fluorophore (e) substrate and, therefore are 
unlikely to contribute to SrtA function in vitro. In contrast residues 60-206 compose the 
catalytic core of sortase A and are conserved among gram-positive species. A 
recombinant SrtA protein excluding the non-conserved N-terminal residues (1-59) was 
used to elucidate the structure of this enzyme by nuclear magnetic resonance (NMR). 
SrtA forms an 8-stranded β-barrel fold with 2 short helices and several loops (109). The 
active site of the protein is arranged around the catalytically essential thiol containing 
side-chain of Cys-184, and includes the conserved residues LXTC. Strands β6 and β 7 
of SrtA form the floor of a hydrophobic depression, with walls formed by loops 
connecting sequential β strands (109). This hydrophobic pocket encompasses the 
protein catalytic site, and accommodates the hydrophobicity of the sorting signal 
(LPXTG) substrate (257).  
The in vitro hydrolytic and transpeptidation activities of sortase are stimulated 
by Ca2+, and are partially activated by alternative divalent cations Mn2+ and Mg2+ (182). 
This dependence on extracellular Ca2+ is functionally relevant as S. aureus would 
encounter extracellular calcium concentrations of 1.5 mM or greater during entry into 
human tissues and roughly 2.5 mM Ca2+ in human serum, suggesting that the rate of 
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sortase catalyzed anchoring of surface proteins would increase during the onset of 
infection (109, 182).  
 Seminal studies assessing the contribution of sortase to virulence in an animal 
model were all performed using S. aureus SrtA (163, 254, 257). Expression of SrtA has 
also been linked with virulence and colonization phenotypes in multiple gram-positive 
pathogens through in vivo and in vitro analyses (42, 200, 287). As the defect in 
previously characterized srtA mutants is in cleavage and anchoring of surface proteins, 
and not protein-secretion preceding the sortase step, protein-lipid II precursors 
accumulate. A sub-cellular localization experiment detecting SrtA protein substrates 
revealed that precursor Cwa proteins accumulated in cytoplasmic, membrane and cell 
wall fractions of an S. aureus srtA mutant, whereas Cwa proteins were only detected in 
the cell wall fraction of wild-type staphylococci (163). In a similar comparison with S. 
pyogenes studying M protein localization, M protein was detected in the cell wall and 
supernatant fraction of the wild-type strain, and exclusively in the supernatant of a srtA 
mutant derivative strain (12). Though cytoplasmic membrane secretion of SrtA 
substrates may be intact, without a functional SrtA transpeptidase, SrtA-dependent 
adhesins exhibit a loss of function in vitro (163). SrtA has recently emerged as a 
protective vaccine candidate in a study evaluating an S. aureus polyprotein DNA-vector 
vaccine combining the extra-membrane portion of SrtA with the fibronectin and 
fibrinogen binding portions of FnbB and ClfA. The polyprotein vaccine caused a 
polarized Th1 effect and significantly increased survival of mice challenged 
intravenously with S. aureus (78). 
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Sortase B attributes 
 In S. aureus and Bacillus anthracis, SrtB is required for anchoring a heme-iron 
scavenging protein, IsdC (157, 165). In both species SrtB and IsdC are encoded in an 
operon with additional genes composing a putative iron acquisition system. The operon 
is under the control of the ferric uptake repressor, Fur. Under iron replete conditions Fur 
inhibits transcription of these genes. In S. aureus the SrtB substrate, IsdC contains the 
sequence NPQTN in place of the typical LPXTG sorting signal (the isdC homolog in B. 
anthracis contains NPKTG) (165). Two additional iron surface determinants in the S. 
aureus operon, isdA and isdB encode proteins contain the SrtA LPXTG sorting signal, 
and are anchored by SrtA. The susceptibility of these different surface determinants to 
extracellular proteases revealed that sortase substrates of the isd locus are differentially 
surface exposed (164). Both IsdA and IsdB are susceptible to proteolytic cleavage; 
whereas IsdC is susceptible to proteinase K degradation only after lysostaphin treatment 
of the cell wall (159, 164). The model of Isd mediated heme-iron uptake includes IsdA, 
IsdB and another SrtA substrate IsdH acting as receptors for hemoprotein ligands, 
followed by passage of heme through the cell wall via IsdC (reviewed in 158).  
Biochemical analysis of the anchor structure of IsdC of S. aureus revealed that 
the NPQTN sorting signal is also cleaved between the Thr and Gly residues, and then 
covalently linked to the Gly5 crossbridge, as has been described for SrtA substrates. 
However IsdC was linked to PG fragments with less crosslinking than typically 
observed for SrtA candidates. Marraffini and Schneewind proposed that this 
observation, coupled with non-uniform cell surface distribution of the IsdC is attributed 
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to linking of IsdC to an assembled cell wall fragment, rather than the lipid II precursor 
of PG (160).  
 The structures of S. aureus and B. anthracis SrtB proteins have been 
determined, and are very similar. Like SrtA, the core of the S. aureus SrtB enzyme is 
formed by an eight stranded β-barrel. The β6/β7 loop, discussed above imparts the 
substrate specificity of S. aureus SrtA and SrtB (18). Evaluation of L. monocytogenes 
and S. aureus SrtB in pathogenesis suggests that this protein is not required for 
establishing infection, but does contribute to persistence in infected tissues (165, 187).  
 
Sortase C attributes 
Like SrtB, SrtC is encoded by a subset of gram-positive species, and has been 
characterized as the mediator of gram-positive surface pilus formation in important 
gram-positive pathogens including Actinomyces naeslundii, Corynebacterium 
diphtheriae, S. pyogenes, Streptococcus agalactiae, S. pneumoniae, and Enterococcus 
faecalis (13, 58, 155, 173, 183, 256). Gram-positive pili are encoded by cwa genes 
typically clustered in an operon with a class C sortase, which is responsible for 
polymerizing the pilin subunits on the gram-positive cell surface (175, 229). Alignment 
of the pilus locus Cwa protein substrate sequences led to the identification of a two 
conserved motifs additional to the N-terminal signal peptide, and C-terminal sorting 
signal. Pilin protein conserved motifs include a central “pilin motif” that contains a 
conserved Lys residue in the consensus sequence WxxxVxVYPK (259), and an “E box” 
with the amino acid residues YxLxETxAPxGY (256). Analysis of the C. diphtheriae 
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SpaA precursor demonstrated that the Lys of the pilin motif was essential for pilin 
polymerization. In the suggested model for polymerization a C. diphtheriae SrtC 
homolog cleaves between the Thr and Gly residues of the LPXTG pattern to create an 
acyl enzyme intermediate, as described above. The ε-NH2 of the conserved Lys then 
performs nucleophilic attack at the sortase acyl enzyme for crosslinking of two adjacent 
SpaA subunits by a transpeptide bond (158); repetition of this process would yield the 
elongated pilus structure.  
In species examined thus far Cwa proteins clustered with the cognate SrtC are 
differentially assembled into the pilus structure. A major pilin subunit constitutes the 
backbone of the pilin shaft, and contains the pilin motif. The E box mediates association 
of the pilus backbone with decorative, accessory Cwa subunits also encoded in the pilus 
locus (256, 259). These accessory pilin proteins may associate with the pilus structure at 
the pinnacle of the pilus, or along the length of the pilus (229).  
In C. diphtheriae analysis of sortases mediating Cwa pilus assembly and cell 
surface anchoring of pilus structures revealed that the major housekeeping sortase (class 
A sortase) SrtF can catalyze the cell wall anchoring of both pilin monomers and pili, but 
cannot polymerize pilin subunits. Modulation of SpaA pilin subunit expression revealed 
that SrtF is critical for pilus anchoring when SpaA is abundant (244). These findings 
suggest that multiple sortases are involved in gram-positive pilus assembly, and the 
transpeptidases may be hierarchal in establishing the functional, surface-exposed pilus.  
 
 
 
166 
Predictive patterns of Cwa proteins 
Essential residues for specific activity of S. aureus SrtA were determined using 
Dnp chromophore-linked A-L-P-X-T-G sorting pattern pentapeptides, with all naturally 
occurring amino acids (excluding C and W) tested at each underlined position (133). 
The authors concluded that alternative residues at positions 1, 2, and 4 were minimally 
tolerated; and G at position 5 essential for catalysis. Therefore the kinetically preferred 
substrate for S. aureus SrtA contains the L-P-X-T-G pattern (133). This specific pattern 
with few alternative residues permitted has been adapted for identification of novel SrtA 
substrates within translation products of sequenced genomes of S. epidermidis RP62A, 
and S. aureus strains by in silico methods (28, 219).  
A survey of 65 published cell wall-associated proteins from multiple gram-
positive species confirmed the essentiality of L-P at positions 1 and 2, as these were 
conserved in all identified sequences; however, a variety of amino acids were observed 
in positions 3 to 6. That sequences analyzed were derived from diverse genetic origins 
suggests flexibility in positions 5 and 6 that may be species dependent (111). Janulczyk 
and Rasmussen adapted their observations of conserved residues within the L-P-X-T-G 
pattern, spacing and relative frequency of residues in the hydrophobic domain, and the 
percent occurrence and positioning of C-terminal positively charged residues for 
development of a predictive tripartite pattern less stringent than classical patterns. This 
recognition of variability within the tripartite pattern resulted in a pattern search tool 
applicable for prediction of previously uncharacterized proteins in numerous gram-
positive species (111).  
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Transposable elements 
Transposons are genetic elements capable of mobilizing between DNA sequences. 
Transposon elements have been identified in the genomes comprising Eubacteria, 
Archaea and Eukarya (93). In addition to contributing to natural genomic diversity, 
transposons also have vast applications in molecular biology. In bacterial species 
transposons have been adapted for insertion mutagenesis techniques on the genomic 
scale, as well as for specific analysis of individual genes.  
In general, transposons are composed of discrete DNA segments, and the 
complexity of these regions determines the transposon type. The most simple 
transposable elements, referred to as insertion sequence elements include gene(s) 
mediating transposition (mobilization of the transposon) flanked by inverted repeat (IR) 
sequences- which are recognized by the transposase (Tnp) enzyme during transposition 
(Fig. 28). In contrast, composite transposons encode additional genes, like antibiotic 
resistance cassettes. An example composite transposon is Tn5 (Fig. 28). Tn5 contains 
two inversely oriented copies of the IS50 element separated by genes encoding 
resistance to Kn, bleomycin, and streptomycin. Conjugative transposons display hybrid 
properties of transposons, plasmids, and bacteriophages. These transposons can mediate 
their own transfer from a donor DNA molecule in one bacterial cell to a target molecule 
in another cell. For example, the conjugative transposon Tn916 excises from donor 
chromosomal DNA to form a covalently closed circular molecule that is passed to a 
recipient cell via conjugal transfer (38). Modified transposons, like the mariner-based 
mini-transposon, magellan2, which does not encode Tnp, have also been developed for
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Figure 28. Genetic organization of transposons 
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researcher-controlled transposon mobilization (Fig. 28) (139).  
 
In vitro transposition and mariner-Himar1 transposons 
 In the most simplistic format in vitro transposition requires only the transposon 
terminal inverted repeats, purified Tnp, target DNA, and a simple reaction buffer 
providing essential cations. The efficiency of this technique depends on the insertion 
site preference of the Tnp, and the catalytic activity of the Tnp used. Native Tnps have 
evolved for inefficient transposition as a mechanism for maintenance in their resident 
genome. For example, the wild-type Tnp of Tn5 does not perform transposition in vitro, 
and is extremely inefficient in vivo (213). To circumvent the inactivity of this Tnp, 
researchers have identified multiple classes of hypermutations that increase catalysis by 
orders of magnitude. The sites of mutagenesis enhancing transposition have indicated 
that in part Tnp efficiency is a result of greater protein flexibility for forming DNA 
contacts, and stabilization of the DNA Tnp complex, once formed (275, 280, 293, 294). 
Factors affecting in vitro transposition of the Himar1-type mariner transposon have 
been well characterized. Himar1 can execute transposition in vitro using only its 
purified Tnp, in the presence of Mg2+ or Mn2+ (138). The Tnp encoded by these mariner 
elements belong to an extended superfamily of transposases (including Tn5) and 
retroviral integrases characterized by conserved positively charged residues, D,D35E or 
D,D34D in the catalytic domain of the protein (Fig. 29). As discussed for Tn5, the 
mariner Tnps have evolved to be less deleterious in their host via decreased activity. 
For in vitro application Lampe et al. identified hyperactive forms of Himar1 Tnp by 
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error-prone PCR of the transposase gene (137). A derivative of Himar1, termed MarC9 
with ~50 fold greater transposase activity was identified with two mutations governing 
enhanced catalysis (reproduction from reference 137, shown in Fig. 29). The mutations, 
Q131R and E137K in MarC9 were mapped to the domain of Tnp supposed to mediate 
nonspecific DNA binding, prompting the authors to speculate that enhanced MarC9 
activity may be attributed to a general increase in affinity for DNA(137).  
The mariner transposon elements are of the short-inverted terminal repeat 
(ITR)-type. These elements make up a large family of related transposons widely 
distributed among metazoans (218). More than 13 subfamilies of mariner elements have 
been described; within subfamilies elements have highly conserved sequences with 25-
100 % protein sequence identity (217). Despite this sequence similarity, Tnp of the 
different mariner elements almost exclusively act on the ITR of their transposon, in a 
mechanism that is thought to be entirely sequence specific. For example, the two known 
active mariner elements, Mos1 and Himar1 ITRs share 33 % identity, yet their 
respective Tnps can not transpose the other (140). Himar1 Tnp has been shown to 
preferentially transpose shorter transposons bearing the consensus ITR, with 
transposition frequency decreasing by ~38 % for every 1kb increase in size. The 
Himar1 Tnp specifically targets TA dinucleotides for transposon insertion in a manner 
almost entirely independent of nucleotides flanking the target site. However, in vitro 
studies have revealed that Himar1 does preferentially transpose into certain sites within 
a DNA target, suggesting that there is a preference for flanking sequences that are more 
malleable to the Tnp (139). It is thought that greater malleability of the nucleotide
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Figure 29. Schematic of the Himar1 Tnp derivative MarC9 
 
Functional domains of Himar1 including the putative DNA binding domains, and 
catalytic domain, and amino acids separating these regions are shown. D* denotes the 
putative catalytic residues of the D,D34D catalytic domain. Amino acids changes 
Q131R and E137K conferring hyperactivity to MarC9 are indicated. NLS indicates 
nuclear localization signals pertinent to transposition in vivo in eukaryotic hosts. 
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Figure 29. 
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sequence adjacent to the target site enhances recognition of TA nucleotides by Tnp. The 
TA preference exhibited by Himar1 Tnp is cation dependent. In the presence of Mg2+ 
the Tnp targets TA sites; however when Mn2+ is supplied, insertion site specificity is 
more lenient and includes G and C nucleotides as well (138).  
The Himar1 element has been advanced as a genetic tool for several reasons 
alluded to above. The Tnp of Himar1 displays minimal target site requirements for 
ensured mutagenesis of the target DNA template. This reaction is made all the more 
efficient by the application of a hyperactive form of the Himar1 Tnp resulting in a high 
frequency of transposition. Also, seminal studies by Robertson and colleagues 
analyzing Himar1 transposition in vitro confirm the reaction can be entirely researcher 
controlled with the use of purified Tnp and a mariner derived mini-transposable 
element (not encoding its own Tnp) (138, 139). 
 
Signature-tagged mutagenesis (STM) 
The technique of STM was conceived and developed by David Holden for 
analysis of Salmonella typhimurium (95). STM is a transposon mutagenesis system that 
employs a library of transposons containing unique DNA sequences i.e. “tags”. 
Traditionally the transposon library has been used for random insertion mutagenesis of 
bacterial species. The resulting pool of insertion mutants can then be tested in a species-
relevant model with recovery/persistence of a specific mutant detected via the unique 
DNA tag. When applied to in vivo studies of bacterial pathogenesis STM permits the 
high throughput screening of a mixed population of mutants. This type of negative 
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selection screening identifies factors required for virulence and has the advantage of 
identifying of previously uncharacterized virulence determinants.  
 The signature-tags are synthetic oligonucleotides designed with a 40 bp variable 
central region bordered by invariant ends. The tags were designed to exclude 
recognition sites of restriction endonucleases used for subsequent cloning of tags into 
the transposon element, while maintaining enough sequence variability that an identical 
sequence would occur once in 2 x1017 molecules (95). 
 The initial STM screening studies employed the gram-negative species S. 
typhimurium and a mini-Tn5 tagged transposon library (95). This mini-Tn5 
transposition system has been subsequently applied to various γ-proteobacteria 
pathogens, as the transposon is most active in this genetic background (93). STM has 
additionally been applied to gram-positive pathogens, albeit with alternative transposon 
delivery systems (Tn917, Tn1545, IS1096) originating from these bacteria (8, 36, 112). 
The indiscriminate mariner-Himar1 mini-transposon magellan2 has also been 
successfully employed for STM in gram-positive streptococcal species (92, 198).  
In the traditional application of STM a suicide plasmid encoded mini-Tn5 
transposon library with unique signature-tags was electroporated into E. coli and then 
transferred into the strain under scrutiny via conjugation. The resulting transconjugants 
were selected by acquired resistance markers conferred by genomic insertion of the 
transposon (73, 94, 209, 296). As some organisms are refractory to transposon 
mutagenesis, and in particular to the Tn5 system, the versatility of this method was 
expanded with the application of in vitro mutagenesis of target DNA, followed by 
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homologous recombination of transposition products for compilation of a mutant library 
(242). Regardless of the mechanism of transposition, after mutagenesis mutants bearing 
unique signature-tags are assigned to pools in which each tag is represented only once. 
During assembly of the mutant libraries bacteria are cultured in liquid media and/or 
agar plates. In this way, mutants with transposon insertion in genes essential for growth 
in vitro are automatically excluded as they are rendered uncultivable. Following 
creation of mutant library pools each pool is screened in vivo, where high selective 
pressures are encountered. The model of disease used is dictated by the pathogen under 
study; however infection must be monitored to find a relevant disease interval 
permitting colonization, and onset of disease prior to death. After a predetermined time, 
animals are sacrificed and bacteria recovered. The unique tags of the transposon are 
then used for detection of distinct strains received by the animal (the “input”), and 
strains recovered from the animal (the “output”).  
 The tag DNA hybridization detection method depicted in Figure 30 is that 
originally detailed by David Holden and colleagues (95). For this detection method the 
mutant library is first used to create hybridization membranes. Colonies may be blotted 
onto the membrane (colony blots), or dot blots created with PCR amplicons of 
signature-tag sequences used, or plasmid DNA containing signature-tags used spotted 
onto the membrane. Differently tagged mutants are pooled into groups prior to 
inoculation into the animal; a portion of the inoculum is later used to create the input 
pool probe. After in vivo selection viable mutants are recovered and used for 
preparation of the output pool probe. Probes are developed by PCR amplification and 
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labeling of signature-tags present in the input and output strain populations. These 
labeled probes are then hybridized on the dot blot membranes for comparison of the 
presence and absence of strains in the input and output pool. Mutants not recovered by 
negative selection yield a signal on the input pool dot blot, lacking in the output pool 
dot blot.  
 A few considerations are necessary to derive reliable results from negative 
selection analysis by STM. To ensure accurate identification of clones, signature-tags 
are often prescreened for consistent and reproducible detection and lack of cross-
hybridization (95). The pool size and complexity of the pools administered should also 
be considered, as these factors are inversely related to the accuracy of results obtained. 
As the complexity of the pool tested increases the likelihood that virulent mutants will 
not de detected also increases (in the instance that they are not present in sufficient 
numbers), resulting in virulent strains categorized as avirulent. Detection by DNA 
hybridization is particularly sensitive to the complexity of the pool tested, as pool 
complexity is inversely related to the quantity of labeled tag for each transposon. 
Therefore, for accurate detection pool sizes should not exceed the detectable threshold. 
Another phenomenon to consider is the possibility of a bottleneck occurring during 
colonization (92). In principle signature-tagged mutagenesis depends on all strains 
having equal access to colonization for onset of infection. The population of bacteria 
that survive during colonization must overcome selective pressures encountered in vivo. 
Initial design and optimization of signature-tagged mutagenesis screens typically 
include experiments evaluating whether a bottleneck is occurring.
 
177 
Figure 30. STM screening schematic 
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Achieving consistently reproducible results from the recovery pool confirms that this is 
not the case. A general requirement for meaningful screening is a large output pool, 
exceeding 104 bacteria to recover the maximal number of tags (73, 95). The parameters 
described here directly affect the outcome of STM screening.  
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Rationale 
 
 
 
 
 An in vivo screening for S. sanguinis SK36 IE virulence determinants by 
random signature-tagged mutagenesis identified 5 avirulent mutants with transposon 
insertions in ORFs encoding housekeeping genes or genes necessary for survival under 
anaerobic conditions (198). The lack of identification of classical virulence factors, e.g., 
those facilitating adhesion in colonization, was surprising given the abundance of 
putative virulence factors predicted from the complete SK36 genome sequence (285). In 
the described experiments the signature-tagged mutagenesis technique was modified for 
a directed application to genes predicted to encode cell wall-associated proteins and 
sortases. Through this comprehensive analysis we hoped to determine the role of S. 
sanguinis cell wall-associated proteins in early IE. 
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Results 
 
 
 
 
Identification of putative S. sanguinis SK36 Cwa protein ORFs 
The genome sequence of S. sanguinis SK36 is the largest (2.4 Mb) published for 
a streptococcal species, and includes the most open reading frames (2,272) (285). 
Search algorithms incorporating features characteristic of Cwa proteins were used to 
identify ORFs encoding putative Cwa proteins. The patterns applied include the sorting 
site LPXTG pattern, followed by a region rich in hydrophobic residues, and capped by 
positively charged C-terminal residues. Two prediction patterns (in Materials and 
Methods) were used to screen for putative Cwa proteins among the SK36 ORFs. Thirty-
seven positive hits resulted from searching with the more stringent Fuzzpro pattern (B), 
whereas 14 additional positive hits occurred when searching with pattern (A). N-
terminal signal peptide prediction by SignalP differentiated between erroneously 
identified cytoplasmic proteins, and proteins putatively undergoing Sec-mediated extra-
cytoplasmic export. Protein sequences of SK36 ORFs positive by Fuzzpro prediction 
and predicted to encode an N-terminal signal peptide were then visually inspected for 
an LPXTG pattern. Three of the 33 remaining ORFs lacking a C-terminal LPXTG 
pattern were likely multiple-pass integral cytoplasmic membrane proteins, as 
determined by TMHMM analysis. Using these subtractive prediction methods, 30 
putative cell wall-associated proteins were identified for SK36 (Table 4).
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Table 4. Predicted S. sanguinis Cwa proteins 
 
Putative Cwa proteins were identified by two algorithms (described in Materials and 
Methods). Proteins positive for algorithm (B) had four or less mismatches, whereas 
proteins identified by algorithm (A) had five mismatches. Several proteins believed for 
other reasons to be Cwa proteins were missed by the prediction method used (not 
identified= NID), due to mismatches exceeding the threshold (¤), or lack of a predicted 
N-terminal signal peptide (‡). The sorting signal for each ORF is shown, with the 
LPXTG in bold. The SignalP server was used for prediction of N-terminal signal 
peptides. For this purpose two algorithm were applied, the neural network (NN) for 
detection of secreted (cell surface-targeted proteins), and the hidden Markov model 
(HMM) that assigns a signal-peptide probability value to a given sequence. Numerical 
values in the NN column are the ‘D score’; referred to as the average of the signal 
peptide algorithm and the predictive cleavage site algorithm score. Proteins with NN 
cutoff values greater than 0.45 were considered positive for a signal peptide (Y=Yes). 
The (HMM) probability value is also given, with 1 meaning a sequence is extremely 
probable for containing a signal peptide (Y=Yes). The TMHMM server was used for 
prediction of the number of helices (potential transmembrane domains). The number of 
predicted helices for each protein is given in the THMMM column. Proteins lacking an 
LPXTG pattern were discarded from the list of putative Cwa proteins. Discarded 
proteins with greater than two predicted transmembrane domains, and a predicted N-
terminal signal peptide are listed are putative integral membrane proteins. 
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Table 4. 
 
                  SignalP
Ss Gene NN                        HMM TMHMM Fuzzpro Mismatches
Putative Cwa proteins
SSA_0146 0.616 Y 1.000 Y  1 LPHTGQASNALLTVAGVISALGTAGLSLRSRKKED 2
SSA_0167 0.893 Y 1.000 Y  2 LPATGTNQSFLALIGTVMLSVLAFVGFKRKKN 0
SSA_0243 0.811 Y 1.000 Y  0 LPVTGEKTSSLGLLGLVMTGLAGIFTFKKRERQ 1
SSA_0227 0.857 Y 1.000 Y  2 LPKAGENASWIMIAAGVALVGLVGFIVFRAKKK 1
SSA_0273 0.617 Y 1.000 Y  1 LPKTGSQSSLLTNLLGLGLLGLGAGFLGLKKKS 0
SSA_0303 0.691 Y 1.000 Y  0 LPETGAKDAVYLPYLGLAAIIGALGLGKLKGKED 3
SSA_0453 0.416 N 0.999 Y  1 LPKTGTSTSLLALLGGFLAFLAGLLTFRKSNN 1
SSA_0565 0.795 Y 1.000 Y  0 LPKTGENSSWLLLAGQMLLLMAMKLFYKKRSLD 3
SSA_0684 0.561 Y 0.996 Y  2 LPKTGQDTSVWMLILGFLTFGGAVGLTKRQRD 2
SSA_0805 0.771 Y 1.000 Y  2 LPKTGQETTLWLSVAGLAILVGFGSYVFLQKKTR 3
SSA_0829‡ 0.318 N 0.000 N  0 LPQTGETESKASILALGLGALGLAFKRRKKKSDSEE 5
SSA_0904¤ 0.681 Y 1.000 Y 1 LPKTGTEETSYLAASLLAGVSGLGLIGLEKRKKSLKTKR NID
SSA_0905 0.703 Y 1.000 Y  0 LPKTGTEETSYLAASLLAGLSGLGLIGLEKRKKKSED 2
SSA_0906 0.678 Y 1.000 Y  0 LPKTGTEETSYLAASLLAGVSGLGLIGLEKRKKKSED 2
SSA_0956 0.708 Y 1.000 Y  0 LPKTGSNASSLLIYLGFAALLASAGFRLSKKES 3
SSA_1019 0.787 Y 1.000 Y  1 LPKTGSETSIFAIAAGFALILLSALAYRFKKAN 2
SSA_1023 0.696 Y 1.000 Y  0 LPNTGNTNSSFLGVAIISLLASIGLLHSKKERKK 3
SSA_1063 0.670 Y 0.999 Y  1 LPKTGSSEKAVYSVVGLGLLLAGLGLGISVRKSKEQ 1
SSA_1065 0.910 Y 1.000 Y  2 LPKTGDSSSLFLVLLGALFLFGAVYLYDLSSRRL 4
SSA_1112 0.785 Y 1.000 Y  2 LPKTGEAQTSTATIGFFGLALAGILGFLGLKEKQKD 1
SSA_1234   0.825 Y 1.000 Y  0 LPQTGSESAVALSLVGMVLGFFGLAGIKKSHKED 1
SSA_1301 0.341 N 0.997 Y  0 LPNTGSEAERLAIFGMALGAAAFLGTNKRRRRDEDYN 5
SSA_1591       0.804 Y 0.927 Y  1 LPSTGEQVTIMGLAGLIILAGVFILLKKTNKN 1
SSA_1632       0.796 Y 1.000 Y  2 LPNTGGIGTTILYLIGTSLVLGAGVLFIIKKRADSR 1
SSA_1633     0.833 Y 1.000 Y  2 LPNTGGIGTTILYLVSTSLVLGAGVLFVVKKRVSTK 1
SSA_1634        0.879 Y 1.000 Y  2 LPNTGGIGTTILYLSGTGLVLGAGILWMLKKRVNKK 2
SSA_1635¤ 0.569 Y 0.997 Y  2 LPETGGNGTLLYLWGGSVITLGSAIWLIVRNKLYRKFQ NID
SSA_1663        0.772 Y 1.000 Y  2 LPFTGTEISFTLLAFGLILIVGCGVYFGIRFKK 4
SSA_1666      0.254 N 0.999 Y  2 LPATGSAESLGLVLAGLVVLALLGLYRKTRLSK 2
SSA_1750  0.814 Y 1.000 Y  2 LPKTGQNTSGWAVLGLTLLMFAFTLKKRSRN 2
SSA_2020 0.664 Y 1.000 Y  1 LPETGSQETRASFVLAGLLVAGAAGLFLLKKKED 0
SSA_2023 0.472 Y 0.999 Y  1 LPKTGNQEDKFLPLAGLAFLGMGLLAGRKKQED 2
SSA_2121 0.884 Y 1.000 Y  2 LPRTGQEENLLVTILGFLAALLAGGMLVAKAKCS 3
Putative Integral Membrane Proteins
SSA_0614 0.619 Y 0.955 Y  10 LWNMNASWLIFIIIGVIALLLSIEKKKDIKER 5
SSA_0871 0.472 Y 1.000 Y  4 DPKLFSPIMIAALFVLGILIGSLGSIISMRRFLKI 4
SSA_1049 0.625 Y 0.111 N  6 LTTQNWGMGSTIGVVLIVAMLFTMWATKERRGR 5  
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Two proteins not identified by the Fuzzpro pattern searches due to mismatches 
exceeding the permitted threshold, SSA_0904 and SSA_1635, appeared to be cell wall-
associated based on homology and gene location (NID, Table 4). SSA_0904 encodes 
CrpA (Csh-related protein A) and exists in an operon with additional Csh-like proteins 
CrpB (SSA_0905), and CrpC (SSA_0906), both of which were identified as Cwa 
proteins. A gram-positive N-terminal signal peptide was predicted for this ORF, and 
SSA_0904 was included in the comprehensive analysis of S. sanguinis Cwa proteins in 
vivo. 
SSA_1635 is putatively the first gene in a cluster of predicted Cwa protein 
encoding genes including SSA_1634, SSA_1633, and SSA_1632. ORFs SSA_1632, 
1633, and 1634 exhibit amino acid sequence identity ranging from 48 % to 62 % over 
the entirety of the protein sequences. Identity with SSA_1635 is restricted to the C-
terminus of the protein and a unifying LPXTGGXG sorting pattern. The genomic 
clustering of SSA_1635-1632 and the proximity of these genes to a gene encoding a 
putative sortase, SSA_1631 (sortase C class) (Fig. 33C), suggests these genes encode 
cell wall-anchored protein substrates recognized by SSA_1631. From this locus 
SSA_1631, 1632, 1633, and 1634 were included in the comprehensive in vivo analysis.  
 One protein positive by Fuzzpro analysis, SSA_0829, was not predicted by 
SignalP to include a gram-positive N-terminal signal sequence (Table 4). In the case of 
SSA_0829, this may be attributed to transport via an alternative accessory Sec-mediated 
pathway, as described for an SSA_0829 homolog in S. gordonii, GspB. This 
SecA2/SecY2 dependent mode of extracytoplasmic export is reliant upon conserved 
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Gly residues within a hydrophobic region proximal to the amino terminus of the 
cytoplasmic, precursor Cwa protein (16, 17). SSA_0829 is a member of the serine-rich 
glycoprotein family, which includes Fap1 of S. parasanguinis, SrpA of Streptococcus 
cristatus, SraP of S. aureus, Srr proteins of S. agalactiae, and Hsa of S. gordonii 
Challis, in addition to GspB, discussed above (89, 230, 234, 247, 284). In keeping with 
the repeating serine residues of this protein, SSA_0829 was designated serine-rich 
protein A, SrpA, by Plummer et al (204).  
 
Identification of unique Cwa proteins of S. sanguinis  
The Cwa protein repertoire predicted for S. sanguinis exceeds predictions for 
related streptococcal species. Application of identical bioinformatics to S. gordonii CH1 
subsp. Challis, S. mutans UA159, and S. mitis NCTC 12261 predicted 23, 6, and 15 cell 
wall-associated protein encoding ORFs, respectively (Tables 5, 6, and 7). The degree of 
relatedness between these species is reflected in the number of shared Cwa protein 
homologs. Eighteen of 33 predicted S. sanguinis Cwa proteins have significant 
homology to putative S. gordonii Cwa proteins. These include the previously 
characterized S. gordonii antigen I/II homologs SspA and SspB, cell surface 
hydrophobicity associated proteins A (CshA) and CshB, and serine-rich protein, Hsa. In 
addition four S. sanguinis uncharacterized proteins with putative enzymatic functions 
have homologs in S. gordonii, and four proteins containing CnaB-like collagen domains 
are conserved between the two species (Table 5). 
 
 Table 5. Predicted Cwa Proteins of S. gordonii CH1 (Sg) 
             SignalP
Sg  Gene ID Description Ss NN HMM Fuzzpro
gi_157151510 Serine protease 0.267 N 0.000 N  LPNTGQAGDGMSLLGLFLSLCTFGLIRQRGKEEQD
gi_157151208 Nuclease/phosphatase domain SSA_1750 0.245 N 0.000 N  LPATGEQRGHWVAFGFLVLIFAYPLSRKSKKSSNL
gi_157151122 Collagen binding domain SSA_1019 0.259 N 0.003 N  LPKTGTAESSAFSVLVGFLLLVASVFLYRTKKVN
gi_157150004 Glycosyl hydrolase family 0.253 N 0.000 N  LPNTASQETAFVAEAVLLAALGGLLLAGKKKED
gi_157151439 SspA SSA_0303 0.561 Y 1.000 Y  LPKTGTNDSSYMPYLGLAALVGVLGLGQLKRKEDE
SSA_0956
gi_157150597 SspB SSA_0303 0.548 Y 1.000 Y  LPKTGTNDATYMPYLGLAALVGFLGLGLAKRKED
SSA_0956
gi_157150159 Serine protease 0.223 N 0.000 N  LPKTGQEDQTSLALSLFGITSLALAGMVIHKKREE
gi_157151265 Exo-beta-D-fructosidase SSA_2023 0.448 N 1.000 Y  LPKTATQEDKFLPLAGLAFLGMGLLAGRKKQED
gi_157151173 Zinc carboxypeptidase family SSA_2020 0.266 N 0.000 N  LPKTGTQEMTEGFKLASILIACSAGLFLLKKKED
gi_157150906 Beta-N-acetylhexosaminidase SSA_2023 0.445 N 1.000 Y  LPQTGTTSAWPITLLGTALALIGLGGRKKRKG
gi_157151454 Cell wall surface protein SSA_0565 0.865 Y 1.000 Y  LPNTGSRLSVWAMMSGILALVSGFALLIWKHKKES
gi_157150739 Cell wall surface protein SSA_0684 0.610 Y 1.000 Y  LPNTGETSTVLLSMIGFAFAGLVGYVVRKKGKA
gi_157149904 CshA SSA_0904 0.522 Y 1.000 Y  LPRTGSQTSDQTASGLLAAIASLTFFGLANRKKKS
SSA_0905
SSA_0906
gi_157151344 Collagen binding domain SSA_0805 0.276 N 0.000 N  LPKTGEQAAIWLSVAGVSILVILGGVFVVLRKKNK
gi_157150914 Streptococcal hemagglutinin SSA_0829 0.240 N 0.000 N  LPRTGESESKASILALGIGALGLAFKKRKKNESED
gi_157150842 CshB SSA_0904 0.528 Y 1.000 Y  LPRTGSQTSDQTASGLLAAIASLTFFGLANRKKKS
SSA_0905
SSA_0906
gi_157150937 Cell wall surface protein SSA_1112 0.538 Y 1.000 Y  LPNTGEAQTATATIGFFGLALAGLLGLLGLKEKQK
gi_157150885 5'-nucleotidase SSA_1234 0.590 Y 1.000 Y  LPETGTKESPALLIVTLFTAFLGIFGFKKSQED
gi_157150970 X-prolyl dipeptidylaminopeptidase 0.167 N 0.000 N  LPETGQKENSWSIYGMLSLLLAGLWKVISGRKEEK
gi_157150569 Beta-galactosidase SSA_2023 0.546 Y 1.000 Y  LPNTGSQSDQAAITTGLALLGLGASLVAGKRRKED
gi_157151048 Cna protein B-type domain SSA_1663 0.211 N 0.000 N  LPLTGTELSFTLLALGLTMIVGWGVYYGTRFKN
gi_157150237 Collagen binding domain SSA_1666 0.222 N 0.003 N  LPNTGSSDSKFIFVVGLATLMLLGLVWKKKHS
gi_157150742 Cell wall surface protein 0.459 Y 0.756 Y  LPNTGEHANGFAALLGLVLASVTAFFNFRRKKH
gi_157150875 Cell wall surface protein SSA_0565 0.619 Y 1.000 Y  LPKTGTSATMVNEVIIGMILVLMGLLLRRKPKH  
 
The sorting signal for each predicted Sg ORF is shown, with the LPXTG in bold. The SignalP server was used for prediction 
of N-terminal signal peptides by both NN and HMM algorithms (descriptions of values are given in Table 4). The S. gordonii 
protein annotation is listed (270). S. sanguinis (Ss) SK36 protein homologs were identified by BLASTP analysis.  
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 Table 6. Predicted Cwa Proteins of S. mutans UA159 (Smu) 
 
               SignalP
Smu Gene ID Description Ss NN HMM Fuzzpro
gi_24378602 FruA SSA_2023 0.529 Y 0.989 Y  LPDTGDHKTDLSQLGVLAMIGSFLVEIAGYFKKRKD
gi_24379087 SpaP SSA_0303 0.789 Y 1.000 Y  LPNTGVTNNAYMPLLGIIGLVTSFSLLGLKAKKD
gi_24379427 WapA 0.931 Y 1.000 Y  LPSTGEQAGLLLTTVGLVIVAVAGVYFYRTRR
gi_24379528 WapE 0.594 Y 1.000 Y  LPDTGVQKNNQLALIALGTGLILLSGLLLSKRKSLK
gi_24379801 GbpC 0.823 Y 1.000 Y  LPHAGAAKQNGLATLGAISTAFAAATLIAARKKEN
gi_24380381 Dextranase 0.175 N 0.000 N  LPQTGDNNETRSNLLKVIGAGALLIGAAGLLSLIKGRKKD  
 
The sorting signal for each predicted Smu ORF is shown, with the LPXTG in bold. The SignalP server was used for 
prediction of N-terminal signal peptides by both NN and HMM algorithms (descriptions of values are given in Table 4). The 
S. mutans protein annotation is listed (3). S. sanguinis (Ss) SK36 protein homologs were identified by BLASTP analysis.  
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Table 7. Predicted Cwa proteins of S. mitis NCTC 12261 (Smi) 
 
            SignalP
Smi Gene ID Description Ss NN HMM Fuzzpro
SMT0163 Amylopullulanase SSA_0453  0.791 Y 1.000 Y  LPNTGTKNDHKLLFAGISILALLGLGFLLKNKKEN
SMT0272 Glycosyl hydrolase family 85 family  0.113 N 0.000 N  LPNTGTVDANEALIAGLASLGLASLALTLKQKKEDED
SMT0737 Cell wall surface protein  0.466 Y 1.000 Y  LPNTGTEDHANLVVLGLLGVLSGFGFLAHKKKEVEK
SMT0779 Muramidase-released protein  0.601 Y 1.000 Y  LPNTGTEANASLAALGLLGALGGFGLLARKKKED
SMT0780 Muramidase-released protein  0.638 Y 1.000 Y  LPNTGTEANASLAAFGLLGALGGFGLLARKKKED
SMT0787 Mucus binding protein precursor (Mub)  0.496 Y 1.000 Y  LPKTAGHSSGMAHVLGVFGLIAGFSLVGKAKRDE
SMT0793 Surface protein C (PspC)  0.781 Y 1.000 Y  LPETASHDSILLVVGFLSALSGVLLFKVKKD
SMT0819 CshA SSA_904  0.456 Y 1.000 Y  LPNTGTEDNASLAALGLLGVLSGFGLVARKKKED
SSA_905
SSA_906
SMT0925 ABC transporter efflux protein  0.440 N 0.543 Y  LPNIGVLLVFLVALTVLNIVGLRRYRKV
SMT1139 R5 protein  0.532 Y 1.000 Y  LPNTGTADNASLAALGLLGVLSGFGLVARKKKED
SMT1189 PspA  0.917 Y 1.000 Y  LPNTGGKDNVAIASLGFLGLLLGALPFVKRKN
SMT1291 Cell wall surface protein  0.398 N 0.999 Y  LPNTGTESNAALAAFGFVGILSGLSIVLRKKDNE
SMT1537 Bovine homologue of human Hr44  0.294 N 0.000 N  LPNTGTEDHASLAALGLLGALSGFGLIARKKREDEE
SMT1642 Cell wall surface protein SSA_1112  0.123 N 0.000 N  LPYTGEAQTSMATLGFFGLALAGLLGGLGLKAKKEEND
SMT0785 Cell wall surface protein SSA_0829  0.491 Y 1.000 Y  LPNTGIQEDRTTGTVGVLSLLGAFGLLFAKKKKDDEEEA  
 
The sorting signal for each predicted Smi ORF is shown, with the LPXTG in bold. The SignalP server was used for 
prediction of N-terminal signal peptides by both NN and HMM algorithms (descriptions of values are given in Table 4). The 
S. mitis protein annotation is listed online (http://www.tigr.org/). S. sanguinis (Ss) SK36 protein homologs were identified by 
BLASTP analysis.  
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Four predicted S. sanguinis Cwa proteins are conserved in S. mitis, and two conserved 
between S. sanguinis and S. mutans (Tables 6 and 7, respectively). A putative alkaline 
amylopullulanase (SSA_0453) is unique to S. sanguinis and S. mitis of the four species 
compared. Comparative analysis suggests the majority of predicted Cwa proteins of S. 
sanguinis (18 of 33) are homologous to predicted proteins of similar spp., suggesting 
conservation of specific fitness factors during species divergence. 
We then sought to determine whether the remaining 15 proteins with no 
homologs in S. gordonii, S. mutans, and S. mitis were actually unique to S. sanguinis. A 
comparison of the S. sanguinis genome to complete genome sequences of 55 other 
gram-positive spp., related and unrelated oral microbes, and unrelated causative spp. of 
infective endocarditis indicated that 8 predicted Cwa proteins are unique to S. sanguinis. 
These include the ORFs SSA_1632, SSA_1633 and SSA_1634, described above, in 
addition to SSA_0146, SSA_0167, and SSA_0273, SSA_1063, and SSA_1023. 
SSA_1063 has been previously described as the platelet aggregating surface protein, 
CbpA. SSA_1023 was unique to S. sanguinis among the 55 species compared, yet has 
some sequence similarity to the muramidase released protein (Mrp) of S. suis, and von 
Willebrand factor binding protein (vWf1) of S. lugdunensis. Although these analyses 
are predictive in nature they do suggest multiple mechanisms of acquisition of S. 
sanguinis cell wall associated protein ORFs. While many were likely inherited from a 
common ancestral species, some—in particular, unique, uncharacterized, hypothetical 
proteins—were likely acquired by horizontal gene transfer and therefore may be unique 
to S. sanguinis within the viridians group of streptococci.  
 
189 
Identification of putative S. sanguinis SK36 sortases  
Gram-positive sortases may be divided into sub-families based on conserved 
residues surrounding the LXTC active site, distinctive transmembrane topology, as well 
as genomic clustering with putative substrates (49, 59). Three sortase-like proteins of S. 
sanguinis SK36 were identified by homology searches with 45 publicly available 
sortase sequences. The S. sanguinis sortase-like proteins were annotated based on 
similarity to one of three subfamilies, SrtA, SrtB or SrtC (Table 8). SSA_1219 was 
homologous to the majority of published SrtA sequences queried, with the exception of 
the prototypical SrtA of S. aureus. As previously documented for this subfamily, within 
the active site residues (LXTC) X is a Val residue (Fig. 31A). (Iso or Thr are also 
common.) This protein subfamily is also characterized by an N-terminal signal 
peptide/transmembrane domain directing type I membrane topology (59). Hydropathy 
analysis of the S. sanguinis SrtA sequence identified a single transmembrane domain, 
restricted to the N-terminus of the protein (Fig. 31B). Finally, the SSA_1219 gene 
encoding SrtA is not clustered with any putative substrate, suggesting that activity of 
this sortase is not limited to a subset of Cwa proteins (Fig. 31C). 
Of the three sortase-like proteins identified, SSA_0022 had the greatest 
sequence identity to previously published SrtB sequences. These characterized and 
uncharacterized SrtB-related proteins were grouped based on a conserved Ser residue 
proximal to the catalytic TLSTC Cys residue (Fig. 32A) (199). A Ser residue also 
occurs in the LXTC of SSA_0022, suggesting that this protein may be similar in 
function to other SrtB homologs. Yet the SSA_0022 genomic locus presents a paradox. 
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Table 8. Identification of S. sanguinis sortase-like ORFs 
 
Sortase A class: SSA_1219 SSA_0022 SSA_1631
GI:3238307_S. aureus subsp. aureus COL   ● 
GI:1201902_E. faecalis V583 ●   
GI:1028429_S. mutans UA159 ●   
GI:2650068_C. diphtheriae NCTC 13129 ○ ○ ○ 
GI:1088124_B. anthracis str. Ames ●   
GI:111657852_S. pneumoniae TIGR4 ●   
GI:901269_S. pyogenes M1 GAS ●   
GI:1201386_E. faecalis V58 ●   
Sortase B class:    
GI:2859503_S. aureus subsp. aureus 
MRSA252  ●  
GI:891152_B. halodurans C-125  ●  
GI:1083901_B. anthracis str. Ames  ●  
GI:900461_S. pyogenes M1 GAS  ●  
GI:4962816_S. pyogenes str. Manfredo  ●  
GI:4916727 C. difficile 630  ●  
Sortase C class:    
GI:3036999_A. naeslundii T14V   ● 
GI:1199996_E. faecalis V583   ● 
GI:2650116_C. diphtheriae NCTC 13129   ● 
GI:2650498 C. diphtheriae NCTC 13129   ● 
GI:2650495_C. diphtheriae NCTC 13129   ● 
GI:2650024_C. diphtheriae NCTC 13129   ● 
GI:2650023_C. diphtheriae NCTC 13129   ● 
GI:930405_S. pneumoniae TIGR4   ● 
GI:930404_S. pneumoniae TIGR4   ● 
GI:930406_S. pneumoniae TIGR4   ● 
GI:1116387_C. acetobutylicum ATCC 824   ● 
GI:939748_B. subtilis subsp. subtilis str. 168   ● 
 
The sortase GIs used to identify S. sanguinis sortase-like proteins are shown. The S. 
sanguinis SK36 protein best matching a given query sequence is indicated (●). Queries 
lacking a homolog in S. sanguinis are also indicated (○).  
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Figure 31. Characteristics of a SrtA-like protein 
A) A ClustalW alignment of SrtA sequences from S. mutans UA159 (SMU_1113), S. 
pyogenes M1 GAS (SPY_1154), S. pneumoniae TIGR4, S. sanguinis SK36, E. faecalis 
(EF_3056), and B. anthracis str. Ames highlights conserved residues at the LXTC 
active site (indicated by asterisks), as well as similar neighboring residues (indicated by 
periods and colons)  
B) A tmap hydropathy prediction of the SrtA sequence highlights a single hydrophobic 
region at the N-terminus of the protein, suggesting a type I topology of this 
transmembrane protein.  
C) The S. sanguinis SK36 srtA locus is shown. In dark grey are neighboring genes, ldh 
and gyrA conserved in S. gordonii Challis CH1, S. mutans UA159, S. pyogenes M1 
GAS, and S. agalactiae NEM16. SSA_1218, putatively encoding radC is conserved 
between S. sanguinis and S. gordonii. SSA_1217, encoding a putative glutamine 
amidotransferase, is not conserved at this locus. Putative promoter and terminator 
elements are depicted. 
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Figure 31. 
A. 
GI:1028429_S.mutans       TDKN-KVYTYVISEVKTVTPEHVEVIDNRPGQNEVTLVTCTDAGAT-ART 214 
GI:901269_S.pyogenes      TDKE-KIYEYIIKDVFTVAPERVDVIDDTAGLKEVTLVTCTDIEAT-ERI 217 
GI:111657852_S.pneumoniae TDKN-KVYTYEIREVKRVTPDRVDEVDDRDGVNEITLVTCEDLAAT-ERI 216 
GI:125718040_S.sanguinis  TDKE-QVYTYVITSVETVTPDRTDLIEDTEGVTEITLVTCEDAAAT-NRT 219 
GI:1201902_E.faecalis     TDLS-TVYTYKITSVEKIEPTRVELIDDVPGQNMITLITCGDLQAT-TRI 209 
GI:1088124_B.anthracis    YDNE-NEYEYAVTGVSEVTPDKWEVVED-HGKDEITLITCVSVKDNSKRY 220 
GI:1201386_E.faecalis     NDREGHSFIYKVKEQKHVDMTDTTMLNLTRKPT-LTLITCDQATKTTGRI 235 
                                   * .   : * :     :       ::       :**:** .   .  *  
 
B. 
 
 Query sequence  
loose cutoff  ---- 
strict cutoff ____  
C. 
SSA
1217 radC srtA gyrA ldh
 
 
193 
In Staphylococcus aureus, Bacillus spp., and Listeria monocytogenes SrtB is encoded in 
an iron regulated operon and recognizes a unique sorting signal (NPxyTN) on its 
cognate substrate, the heme-iron binding protein IsdC (157, 165, 187) (Fig. 32B). The 
genomic clustering of SrtB with IsdC in S. aureus, B. anthracis, and L. monocytogenes 
suggests a highly specific activity for this protein. In S. pyogenes strains Manfredo and 
M1 GAS, and S. sanguinis SK36 the srtB gene is not in an operon with putative Cwa 
proteins with the NxyTN sorting signal. In the case of S. pyogenes Manfredo srtB is 
flanked by genes encoding putative Cwa proteins bearing an LPXTG sorting signal 
(SPYM50104), the sorting signal LPLAG (SPYM50106a), and a putative novel sorting 
signal of QVXTG (SPYM50106). A similar genomic arrangement exists in S. pyogenes 
M1 GAS (Fig. 32C). In S. pyogenes strain AM3 this sortase transpeptidase, containing 
catalytic site residues characteristic of SrtB (TLSTC) is annotated as SrtC1. Is has been 
demonstrated that SrtC1 is required for cell surface anchoring of a proximal ORF with 
the QVPTGV sorting signal (11). Further investigation of the homologous ORF in S. 
pyogenes M1 GAS, Spy0128, revealed this SrtC1 substrate to be the backbone 
component of a gram-positive surface pilus, decorated by Spy0130 subunits (175). It 
appears that in streptococcal species SrtB homologs are required for surface assembly 
of Cwa proteins with functions unrelated to substrates of analogous sortases in S. aureus 
and B. anthracis. 
In S. sanguinis the srtB ORF is not proximal to any genes encoding Cwa 
proteins with the conventional recognition sequence NxyTN. If streptococcal 
SrtB homologs recognize a deviant signal sequence, then PcsB (SSA_0019) may be the 
 
194 
Figure 32. Characteristics of a SrtB-like protein 
 
A) SSA_0022 was annotated SrtB due to the conservation of a Ser residue in the LXTC 
catalytic site. A ClustalW alignment with characteristic SrtB sequences of S. aureus 
subsp. aureus MRSA252, B. anthracis Ames, as well as SrtB-related proteins of S. 
pyogenes M1 GAS (GI: 900461) and S. pyogenes Manfredo (GI: 4962816) reveals 
similarity in these catalytic site residues.  
 
B) In S. aureus, B. anthracis and L. monocytogenes srtB is within a Fur regulated 
operon. The candidate SrtB substrate, IsdC is indicated in green. In L. monocytogenes 
SvpA anchoring to PG is dependent on SrtB; a putative additional L. monocytogenes 
SrtB substrate, encoded by lmo2186 has 33 % identity to IsdC and contains a potential 
SrtB sorting motif, NKVTN (22, 187). Additional conserved genes at this locus in S. 
aureus, B. anthracis and L. monocytogenes are indicated by like color-coding, genes not 
conserved are in black.  
 
C) In streptococcal species the srtB locus is arranged differently. In green are genes 
putatively coding for cell wall-associated proteins with the LPXTG motif (spyM50104, 
Spy0130), or an LPLAG sorting signal (spyM50106a). In blue are genes putatively 
encoding candidate SrtB substrates which contain a sorting signal QXXXG. The 
anchoring of a SrtB substrate with this sorting pattern has only been demonstrated for S. 
pyogenes AM3 (11).
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Figure 32. 
 
A. 
 
GI:2859503_S. aureus      YIRT--DFENDQDYQQFLDETKRKS-VINSDVNVTVKDKIMTLSTCEDAY 227 
GI:1083901_B. anthracis  YIET--DFSSDTEYTSFLEKIQEKS-LYKTDTTVTAGDQIVTLSTCDYAL 237 
GI:900461_S. pyogenes   LLFNPIDVDISSK-NEFLNHIKQKS-VQYREILTTNESRFVALSTCEDMT 225 
GI:4962816_S. pyogenes  LVFNPNAITNQDQQKQLVDYISKRS-KQFKPVKLKHHTKFVAFSTCENFS 233 
GI:125716908_S. sanguinis     FYRT--EFKDDEDFTTQLRNIYEAARTKDPEMKIKASDRYLVLSTCREED 246 
                                 .   .  . .    :    . :         .   : :.:***     
 
B. 
S. aureus Newman
isdB isdA isdC isdD isdE isdF srtB isdG
isdC isdX1 isdX2 isdE isdFisdXE2 srtB isdG
lmo
2186
lmo
2184
lmo
2183
lmo
2182 srtB
lmo
2180svpA
B. anthracis Sterne
L. monocytogenes EGD-e
100 aa  
 
C.  
S. pyogenes Manfredo
S. pyogenes M1 GAS
S. sanguinis SK36
100 aa
spyM
50104
spyM
50105
spyM
50106 srtB
spyM
50106a
SPy
0127
SPy
0128 srtB
SPy
0130
sagA SSA0020
SSA
0021 srtB
``
SSA
0023
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candidate substrate for the transpeptidase. This protein includes the residues QPEVG 
near the C-terminus, and has 44 % sequence identity to the S. agalactiae PcsB protein. 
Altered morphology of S. agalactiae and S. mutans PcsB-related protein mutants 
suggests the protein acts as a murein hydrolase to split the division septum between 
adjacent daughter cells. Streptococci are globular cells that typically divide in 
approximately the same plane at each cell cycle, producing elongating chains. In 
contrast S. mutans sagA and S. agalactiae pcsB mutants exhibit division in multiple 
planes (44, 212). The loss of PcsB expression has also been linked to enhanced 
susceptibility to cell wall-targeting antibiotics, as well as antibiotics with intracellular 
targets, suggesting that additional defects in the cell wall exist beyond proper cell 
division (212). Likewise an S. mutans sagA mutant exhibited greater sensitivity to 
osmotic stress, increased temperatures, and low pH (44). These observations have 
resulted in the suggestion that PcsB is a general stress-related protein. Interestingly 
PcsB is essential in S. pneumoniae, but related proteins are not essential for growth of 
either S. agalactiae or S. mutans (44, 172, 212). Therefore additional species-specific 
activities may be attributable to PcsB. S. pneumoniae PcsB cell localization analysis by 
cell fractionation and Western blotting indicated the protein was predominately 
localized to the plasma membrane or secreted from the cell (172). The exposure of PcsB 
to extracellular milieu has also been inferred by the protective effect garnered by this 
protein in pneumococcal vaccine studies (82). Though it remains unconfirmed, it is 
possible that PcsB may additionally be anchored to the PG of the cell wall during 
trafficking from the plasma membrane to secretion from the cell. Cell localization, 
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general function, and the relationship between pcsB and the neighboring srtB ORF 
remain uncharacterized in S. sanguinis.  
SSA_1631 was annotated as SrtC based on translated sequence conservation 
with the Sortase C-group/subfamily 3 transpeptidases proposed by Dramsi and 
colleagues (59). Sortase C transpeptidases are characterized by a C-terminal 
hydrophobic domain that may act as a membrane anchor to drive type-II membrane 
topology of this protein. Hydropathy analysis of the S. sanguinis SrtC amino acid 
sequence predicted both N- and C-terminal hydrophobic regions (Fig. 33B). As sortases 
act on proteins at the cell surface it is likely that the N-terminal hydrophobic region 
drives Sec-dependent export of the enzyme, whereas the C-terminal region determines 
membrane topology. In addition a conserved proline residue following the LXTC 
catalytic site links the S. sanguinis SrtC to previously described SrtC enzymes (Fig. 
33A). As previously mentioned, SSA_1631 is clustered with the putative Cwa protein 
encoding genes: SSA_1635, SSA_1634, SSA_1633, and SSA_1632 (Fig. 33C). In S. 
pneumoniae, C. diphtheriae, and E. faecalis the Cwa genes flanking SrtC encode gram-
positive pilin subunits. The polymerization of pilus subunits is dependent on the 
adjacent sortase in these species (13, 183, 256).  
Patterns predictive of the pilin motif (“WxxxVxVYPK”) and the E box 
(“YxLxETxAPxGY”) were screened against the putative S. sanguinis Cwa proteins 
neighboring SrtC. Similar to E. faecalis pilus associated proteins EbpA, EbpB, and 
EbpC, E box determinants were identified in SSA_1635, SSA_1634, SSA_1633, and 
SSA_1632 with almost perfect fidelity to the E box motif (183). 
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Figure 33. Characteristics of a SrtC-like protein 
 
A) The S. sanguinis SrtC homolog SSA_1631 catalytic site includes conserved residues, 
indicated by red coloring. The active site encompasses LXTC with a conserved Pro 
distal to the essential Cys residue. In the case of sortase C group the charge and polarity 
of X is conserved and is represented by green text.  
 
B) A tmap hydropathy analysis revealed two discrete regions of hydrophobic residues, 
one at the extreme N-terminus (a signal sequence for extra-cytoplasmic export), and a 
C-terminal region that may define the membrane topology of the transpeptidase.  
 
C) In the chromosome of S. sanguinis SK36 srtC is grouped with potential substrates, 
SSA_1635, SSA_1634, SSA_1633, and SSA_1632. 
 
199 
Figure 33. 
 
A. 
 
GI:125718436 S. sanguinis  VEPEDISSLAIDPDQDYCTLVTCTPYGINSHRLLVRGHRVPNEKNISKSS 236 
GI:930404 S. pneumoniae  IEPTNFDDLLIVPGHDYVTLLTCTPYMINTHRLLVRGHRIPYVAEVEEE- 244 
GI:930405 S. pneumoniae       VEPNDFEPVLIQHGEDYATLLTCTPYMINSHRLLVRGKRIPYTAPIAER- 212 
GI:1199996 E. faecalis  VEPTDTKDLHIESGQDLVTLLTCTPYMINSHRLLVRGHRIPYQPEKAAAG 242 
GI:2650498 C. diphtheriae     VLPTETEDLRPEQGKDYITLITCTPYGINTHRLMVRGHQVPLAPEDHEVF 257 
GI:2650495 C. diphtheriae     VTPDKTSLLRRTSNKDQVTLITCTPYGINTHRLIITAERVPMDPQGESAF 276 
GI:2650116 C. diphtheriae     VLPEDTKLLAPDPNKDQITLITCTPYAVNSHRLLVRAHRVDLDPNDPNLT 249 
GI:2650023 C. diphtheriae     IRPAEIDRIQPIPDRDLITLVTCTPYGINTHRLLVTAERVPMEPGEADRA 278 
                              : * . . :    ..*  **:***** :*:***:: ..::         
 
B. 
 
 
Query sequence  
loose cutoff ---- 
strict cutoff ___ 
 
C.  
100 aa
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SSA_1634 contained a putative pilin motif with the least deviations from the consensus 
pattern (259) (Table 9). These results suggest these putative Cwa proteins may undergo 
SrtC dependent polymerization in S. sanguinis to form a gram-positive surface pilus, as 
has been previously described for other gram-positive species. 
Genes encoding sortases have been identified in almost all gram-positive 
bacteria (49, 185). Pallen et. al observed that genomes including a sortase enzyme 
invariably were predicted to encode at least two, and sometimes many more (199). The 
abundance of sortases and multitude of Cwa precursors suggests that sortases act non-
redundantly to the benefit these organisms.  
 
Annotation of identified Cwa protein ORFs 
 BLASTP and CDD searches enabled annotation of predicted S. sanguinis Cwa 
proteins. Of the 33 proteins identified, 4 did not have adequate similarity to suggest 
homology, nor conserved domains suggestive of protein function, and are described as 
hypothetical in Table 10. Proteins described as conserved uncharacterized in Table 10 
were detected by MudPIT (described below). The majority of remaining proteins could 
be grouped functionally into two groups that are not entirely exclusive; putative 
adhesins, or putative enzymes. Putative enzymatic Cwa proteins include SSA_0243, 
SSA_1065, SSA_1234, SSA_1591, SSA_1750, and SSA_2023. Proteins with 
homology to SSA_0453, and SSA_1591 suggest these proteins may confer both 
enzymatic and adhesion properties. 
  
Table 9. Conserved motifs exist in the pilin-like proteins of SK36 
 
  Features of the major pilin protein   
      
Strain  Name  CWSSa Pilin motif  E box  References 
C. diphtheriae NCTC13129 SpaA LPLTGG WLQDVHVYPK FCLVETATASGY (256) 
C. diphtheriae NCTC13129 SpaD LPMTGG WNYNVVAYPK FCLKETKAPAGY (256) 
C. diphtheriae NCTC13129 SpaH LPLTGG WLYDVNVFPK YVLVETEAPTGF (256) 
S. pneumoniae TIGR4 RgrB IPKTGE DVVDAHVYPK YYLEETKQPAGY (13) 
E. faecalis V583 EbpA LPETGG KYGEIHYAGK 
YTLTEVKAPAGH 
YVLTETFTPEGY (183) 
 EbpB LPKTNE SLTHIHLYPK YFLEEISAPKGY (183) 
 EbpC LPSTGG ELAVVHIYPK 
YILEEVKAPNNA 
YYLEETVAPDDY (183) 
S. sanguinis SK36 SSA_1634 LPNTGG YNNDVQVYLK YKLVETITPKGY This study  
 SSA_1633 LPNTGG AGAGFTLYKK YKLVESTTPAGY This study  
 SSA_1632 LPNTGG YVQDVKVSSK YKLVESTVPSGY This study 
 SSA_1635 LPETGG WNFQEYEKPK YALNETLVDNKT This study 
Consensus sequenceb  LPXTG WxxxVxVYPK YxLxETxAPxGY  
201 
 
a. CWSS, cell wall sorting signal  
b. Consensus sequences of the sorting signal (226), gram-positive pilin motif (259), and E box motif (256). Residues 
that are highly conserved are indicated by bold lettering (229). 
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Cwa proteins with putative enzymatic functions 
 Putative nucleotide phosphoesterase and 5’ nucleotidase activities were predicted 
for two identified Cwa protein ORFs, SSA_0243 and SSA_1234. The B. subtilis YfkN 
homolog of SSA_0243 (62 % sequence similarity) has tri-functional nucleotide 
phosphoesterase activity (41). The purified YfkN enzyme can release inorganic phosphate 
from 2’, 3’ cyclic nucleotide phosphates (cyclic 2’, 3’ NMP), which requires both 2’, 3’ 
phosphodiesterase activity and 2’ or 3’ nucleotidase activity. YfkN has an additional lesser 
activity as a 5’ nucleotidase (41). Both domains conferring these functions to YfkN were 
identified in S. sanguinis SSA_0243 (pfam00149: phosphoesterase family including 2’, 3’ 
CAMP phosphodiesterase, and pfam02872: 5’ nucleotidase C-terminal domain) (156). The 
multifunctional enzyme YfkN is supposed to have resulted from fusion of two genes 
conferring the separate functions (41). 
 SSA_1234 is similar (41 %) to the UshA, 5’ nucleotidase of B. cereus (228). This 
nucleotidase was previously demonstrated to have 5’, and 3’ nucleotidase and 
phosphotransferase activities. However UshA lacks sugar hydrolase and cyclic 
phosphodiesterase activities (228). Similar 5’ nucleotidases have been reported for many 
gram-negative species including the NucA protein of H. influenzae. One putative 
biological role of these proteins is hydrolysis of extracellular nucleotides, and subsequent 
intracellular transport of hydrolytic products for use as substrates of cell wall synthesis 
(291). 
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Table 10. S. sanguinis Cwa protein annotation  
S. sanguinis       
Gene ID Gene  Ortholog  Bacterium Description 
SSA_0227¤       Collagen binding domain; 
pfam05737 (156) 
SSA_0303¤ sspC sspA, B S. gordonii Antigen I/II, Promotes binding to 
collagen, dentinal tubule 
        
invasion(152); coaggregation with 
P. gingivalis (153); binding to 
        sAG (110) 
    spaP/pac S. mutans Adherence to sAG; cariogenicity 
(52, 152); adherence to fibronectin, 
collagen and fibrinogen (14); 
bacteremic virulence  
SSA_0453¤¥   pula S. pyogenes Amylopullulanase, hydrolysis of 
pullulan and starch at neutral 
        
pH, independent glycoprotein 
binding capacity (108) 
    spuA S. pneumoniae Immunogenic; pullulan degradation 
SSA_0805¤       
Collagen binding domain; 
pfam05737 (156) 
SSA_0829¤ srpA     
Platelet binding and aggregation 
(122, 204); HUVEC invasion (241); 
    Has S. gordonii endocarditis virulence (248); 
        binding to sAG (110) 
SSA_0904¤ crpA cshA S. gordonii Adherence to A. naeslundii, S. 
oralis and immobilized 
SSA_0905¤ crpB cshB S. gordonii  fibronectin (169); invasion of 
SSA_0906¤ crpC     HUVEC cells (241); platelet 
adhesion (cshA) (98) 
SSA_0956¤ sspD sspA, B S. gordonii Antigen I/II, Promotes binding to 
collagen, dentinal tubule invasion; 
        coaggregation with P. gingivalis; 
        binding to sAG 
SSA_1019¤       Collagen binding domain; 
pfam05737 (156) 
SSA_1023¤   vwb1 S. lugdunensis Von Willebrand factor (vWf) 
binding protein (188) 
    mrp S. suis 
Immunodominant protein expressed 
during S. suis swine infection (252, 
283) 
SSA_1063¤       Von Willebrand factor type A 
domain; cd00198 (156) 
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S. sanguinis     
Gene ID Gene  Ortholog  Bacterium Description 
SSA_1632¤   rrgA, rrgB S. pneumoniae Surface pilus locus; in vitro 
adherence to A549 epithelial 
SSA_1633¤       cells; colonization and virulence in 
vivo; proinflammatory response 
SSA_1634¤       mediator (13) 
SSA_1635¤         
SSA_1663¤ cbpA     Platelet aggregation; endocarditis 
virulence; collagen binding domain; 
        pfam05737 (156) 
SSA_1666¤       Collagen binding domain; 
pfam05737 (156) 
SSA_0243¥   yfkN B. subtilis 5' nucleotidase, 2', 3' 
phosphodiesterase and 2' (or 3') 
        
nucleotidase for reprocessing 
extracellular nucleotide phosphates 
        under restrictive growth; binding to 
        HA (41) 
SSA_1065¥ 
      
Beta-hexosaminidase A; glycosyl 
hydrolase 3 family NTD 
        
(pfam00933); glycosyl hydrolase 3 
family CTD (pfam01915); 
        
extracellular hydrolysis of (1,3 and 
1,4) β-D-glucans (156), (267) 
SSA_1234¥   ushA B. cereus Nucleotidase; hydrolysis of 5' and 3' 
nucleotides (228) 
SSA_1591¤¥   abpB S. gordonii Dipeptidase (156) 
SSA_1750¥   ssnA S. suis Immunogenic, extracellular 
nuclease (74) 
SSA_2023¥   fruA S. mutans Fructan hydrolase; synthesis of 
inulin-type β2,1- linked fructose 
        
polymers for extracellular storage 
(23); Cariogenicity (32) 
SSA_0565   prgA E. faecalis Surface exclusion protein (61) 
SSA_0684   fibA P. micros Fibril-like structure subunit, self-
aggregation (131) 
SSA_1301       Conserved uncharacterized 
SSA_1112       Hypothetical 
SSA_0273       Hypothetical 
SSA_2020       Hypothetical 
SSA_0167       Hypothetical 
SSA_0146       Hypothetical 
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S. sanguinis     
Gene ID Gene  Ortholog  Bacterium Description 
SSA_2121       Conserved uncharacterized 
 
Cwa proteins are grouped by general functions, as putative enzymes (¥), or adhesins (¤). 
Proteins lacking sufficient sequence identity by BLASTP analysis are listed as 
hypothetical. Previously hypothetical proteins detected by MudPIT are listed as conserved 
uncharacterized. Portions of this table were adapted from (285). 
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SSA_1750 shares 60 % amino acid sequence similarity with the previously 
described extracellular nuclease of S. suis, SsnA, which targets single-stranded, double-
stranded and linear DNA for degradation. In S. suis SsnA is cell wall anchored and 
prevalent among porcine isolates from internal sites including joints, brain and organs (74). 
SsnA is expressed during infection, as has been previously documented for DNA nucleases 
produced by GAS, and staphylococci (9, 43, 74). The function of SsnA was determined to 
be Ca2+ and Mg2+ dependent (74); similarly the pfam03372 Mg2+ dependent catalytic 
domain was identified for SSA_1750 (156). Extracellular nuclease production is elaborated 
during lethal murine staphylococcal infection, suggesting nuclease production may be a 
virulence mechanism (43). However nuclease production may be more indirect, possibly 
for nutrient acquisition at the site of infection or for competition with resident flora, by 
degradation of extracellular DNA to impact the transformation capacity of other bacteria. 
The SSA_1065 amino acid sequence contains both pfam00933 and pfam01915 
(156), which comprise the N-terminal and C-terminal domain, respectively of the family 3 
glycosyl hydrolases. The function of family 3 glycosyl hydrolases was previously 
described for germination and elongation of barley (Hordem vulgare) in formation of 
coleoptiles (267). The exohydrolase enzyme, ExoI of barley is a 2-domain globular protein 
that contains a catalytic site for hydrolysis between the two domains, in addition to a 
secondary binding site for β1,3 and β1,4 β-D glucans (267). The surface production of 
bacterial glycosyl hydrolases is thought to aid the organism in degradation of 
environmental oligosaccharides for liberation of a valuable cellular carbon source (46).  
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SSA_2023, the FruA (S. mutans) homolog likely serves a similar valuable function 
in nutrient acquisition. In S. sanguinis and S. mutans fructan hydrolases generate 
extracellular inulin-type polymers composed mainly of β2,1-linked fructose (23). This 
function is putatively for storage of extracellular polysaccharide in biofilms that may be 
catabolized during nutrient deprivation (83, 100). FruA of S. mutans has the capacity to 
release fructose from levan, inulin, and raffinose, and can cleave sucrose to form fructose 
and glucose. The expression of FruA is tightly controlled and repressed when S. mutans is 
cultured in the presence of hexose sugars (33). Finally, FruA production contributes to 
dental caries development in the rat model of this disease (32).  
SSA_0453 encodes a putative pullulanase, based on conservation of four highly 
conserved regions that form the catalytic domain of pullulanase enzymes. The pullulanase 
PulA enzyme of S. pyogenes is also referred to as a “strepadhesin”, since this protein is 
associated with binding of S. pyogenes to thyroglobulin, submaxillary mucin, fetuin and 
asialofetuin in vitro (108). PulA additionally hydrolyses pullulan and starch at a neutral 
pH. The dual properties of this protein led Hytonen and colleagues to suggest that PulA 
may not be as important for nutrient acquisition, as for colonization by degrading host 
glycoconjugates to reveal specific binding sites. Additional purported functions of PulA 
include modification of self cell surface carbohydrates, or cell surfaces of other bacteria 
(108).  
SSA_1591 encodes a putative dipeptidase (pfam03577) (156), with 60 % protein 
sequence similarity to the amylase binding protein B (AbpB) of S. gordonii. (Another S. 
sanguinis AbpB homolog, SSA_1593, shares 62 % sequence similarity.) The amylase 
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binding capacity of streptococci is critical for colonization of the oral cavity, as only 
animals secreting sufficient amounts of salivary α-amylase are colonized by bacteria 
capable of binding this protein (224, 253). AbpB has been demonstrated as an important 
mediator of rat oral cavity colonization in rats consuming a diet void of sucrose. However, 
AbpB was not required for oral colonization in rats consuming a sucrose diet, and the 
contribution of AbpB to colonization may be secondary to glucosyltransferase activity 
(253). AbpB is also predicted to act as a dipeptidase, though this function has not been 
characterized. In general cell surface exposed dipeptidases may mediate the local 
extracellular free amino acid concentration and assist in scavenging of proteins around the 
cell. Additional contributions may include proteolysis of imported peptides, and general 
cell maintenance by assisting in surface protein turnover (84).   
 
Putative S. sanguinis Cwa protein adhesins 
Five predicted S. sanguinis Cwa proteins contain the domain mediating collagen 
binding of the S. aureus adhesin Cna. Cna of S. aureus is an important virulence factor for 
multiple infections attributed to this organism, including infective endocarditis (99, 214). 
Cna is an MSCRAMM that contains two major domains, A and B, in addition to features 
directing extra-cytoplasmic export and cell wall anchoring. The collagen binding function 
has been localized within the A domain (245), and a trench that occurs within this domain 
accommodates the collagen triple helix. The A region can be subdivided into three 
sequential domains (N1, N2, then N3) that differentially contribute to collagen binding. 
Zong and colleagues deduced the “collagen hug” model of Cna binding to collagen (295). 
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The authors described progressive associations with collagen leading to secure 
sequestration of the collagen ligand. To summarize, binding is initiated by hydrophobic 
interactions between the N1-N2 subdomains and the collagen ligand. The N1 and N2 
subdomains then wrap around the collagen triple helix and progressively hug the ligand 
until an extension of the N2 subdomain, referred to as “the latch” inserts into a trench on 
the N1 subdomain surface, resulting in secure ligand binding (295). Cwa proteins: 
SSA_0227, SSA_0805, SSA_1019, SSA_1663, and SSA_1666 are all predicted to contain 
an A domain-like region permitting collagen adhesion (pfam05737) (156). Additional 
members of the collagen binding MSCRAMM family have been identified in gram-
positive pathogens including E. faecalis, S. equi, S. mutans, and E. faecium, which contain 
a region resembling the N1N2 domain (141, 184, 215, 223). Thus the proposed “collagen 
hug” model may be a conserved mode of collagen association in this protein family.  
The B domain contains multiple repeats that are not required for collagen adhesion. 
Instead the B region is thought to provide flexibility and stability to Cna for projection of 
the A region away from the cell surface (53). Only S. sanguinis Cwa proteins containing 
pfam05737 were annotated as putative collagen binding proteins; of these SSA_0227, 
SSA_1663, and SSA_1666 also include a Cna B domain-like region (pfam05738) (156). 
Only the Cna B-like region was identified in Cwa protein SSA_2121; as this region alone 
is insufficient for collagen binding, SSA_2121 was not annotated as a collagen binding 
protein. The multitude of collagen adhesins predicted for S. sanguinis suggests that this 
phenotype is important for colonization and persistence in the oral cavity, and may 
contribute to development of IE. 
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SSA_1663, annotated as CpbA has also been shown to induce platelet aggregation 
(98). Expression of SSA_1663, and putatively the platelet aggregation phenotype attributed 
to this protein was demonstrated as a virulence determinant for IE in a past study (96). 
The Antigen I/II proteins of oral streptococci are a family of multifunctional 
adhesins that promote fitness in the oral cavity. The antigen I/II proteins of S. sanguinis, 
SspC and SspD are encoded by SSA_0303, and SSA_0956, respectively. The well 
characterized antigen I/II proteins of S. gordonii, SspA and SspB have greater sequence 
identity to SspC of S. sanguinis, than SspD. However it remains likely that S. sanguinis 
antigen I/II homologs serve distinct functions, as has been described in S. gordonii. 
Heterologous expression of SspA and SspB in L. lactis identified exclusive adhesive 
characteristics of these proteins. In this heterologous system expression of SspA resulted in 
enhanced binding to salivary agglutinin glycoprotein over SspB, whereas expression of 
SspB resulted in enhanced adhesion to collagen I and C. albicans (102). Ssp polypeptides 
of S. gordonii additionally mediate attachment to A. naeslundii, an organism important in 
plaque development, and attachment to the periodontal pathogen, P. gingivalis (55, 136). 
In S. gordonii sspA and sspB are clustered at the same genomic locus, with sspA preceding 
the sspB gene. Despite this arrangement the genes are differentially expressed in response 
to environmental stimuli including pH, temperature and osmolarity (69). In S. sanguinis 
sspC and sspD genes are not clustered.  
Antigen I/II was first described for S. mutans, in which the SpaP/Pac surface 
protein was first considered to be two distinct antigens; however antigen II was later 
determined to be a breakdown product of antigen I. This predominant surface protein of S. 
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mutans is required for dentinal tubule invasion (as are SspA and SspB of S. gordonii), and 
enhanced cariogenicity of this species (52, 152). The SpaP/Pac adhesin additionally 
mediates binding of S. mutans to collagen type I, fibronectin and fibrinogen, potentially for 
promotion of endodontic infection or adherence to fibrin clots (like those occurring in IE) 
(14). The sequence similarity to these previously characterized proteins suggests that SspC 
and SspD of S. sanguinis also mediate adhesion phenotypes.  
SSA_0829 encodes the previously described serine rich protein, SrpA. SrpA of S. 
sanguinis is a glycoprotein that has been shown to associate with the platelet von 
Willebrand Factor receptor, glycoprotein Ib, in a sialic acid dependent manner, resulting in 
acceleration of platelet aggregation (122, 204). The S. parasanguinis SrpA homolog, Fap1 
was required for adhesion to PS and biofilm formation in the presence of glucose (76). An 
additional SrpA homolog in S. gordonii, Hsa, was demonstrated to mediate invasion of 
HUVEC cells, suggesting a role for this protein in pathogenesis and IE (241). Hsa was 
shown to contribute to infectivity in the rat model of IE under competitive conditions 
(248). The particular adhesive property attributed to Hsa and related serine rich proteins is 
the recognition of sialoglycoconjugates. Binding of this ligand may mediate the multiple 
functions described for this protein family to date. The contribution of SrpA of S. 
sanguinis to IE was first investigated in the studies described here.  
 SSA_0904, SSA_0905 and SSA_0906 are homologous to the cell surface 
hydrophobicity (Csh) proteins A and B of S. gordonii. CshA and CshB of S. gordonii are 
antigenically related high molecular weight polypeptides that comprise fibrillar cell surface 
extensions (168). Both CshA and CshB, as their name implies have been shown to infer 
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hydrophobicity to S. gordonii, and expression of both proteins was shown to be necessary 
for colonization of the murine oral cavity (170). It has also been demonstrated that CshA 
and CshB of S. gordonii mediate invasion of HUVEC cells, as well as binding to 
fibronectin, and inter-bacterial adhesion with A. naeslundii, and S. oralis (169, 241). A 
CshA-related protein of S. sanguinis has also been implicated in aggregation of platelets, a 
phenotype correlated with virulence in development of IE (98). The S. sanguinis Csh-
related proteins, SSA_0904, SSA_0905, and SSA_0906 were annotated as Csh-related 
protein A (CrpA), B (CrpB), and C (CrpC), respectively. In S. gordonii the cshA and cshB 
genes exist at distinct loci. In contrast the Crp encoding genes in S. sanguinis are clustered 
at the same locus, with crpA most 5’ and crpC most 3’. Promoter and terminator elements 
were predicted for the intergenic regions separating crpA, crpB, and crpC, indicating these 
genes may not be co-transcribed. This possibility, in addition to adhesive properties 
ascribed to S. sanguinis Crp proteins require further investigation.  
 The predicted homolog for SSA_1023 is the von Willebrand factor (vWf) binding 
protein vWf1 of S. lugdunensis (188). vWf is a large glycoprotein occurring in plasma and 
the storage granules of platelets. vWf mediates hemostasis by binding to exposed matrix 
molecules, like collagen at sites of vascular endothelium damage to promote subsequent 
platelet adhesion and aggregation (221). A repetitive region at the C-terminus of the S. 
lugdunensis vWf1 mediates association with vWf. Recurring residues similar to the pattern 
identified for vWf1 are in the C-terminus of SSA_1023. vWf1 of S. lugdunensis is 
conserved among clinical isolates, suggesting a role for this protein in pathogenesis (188). 
Specifically vWf1 interaction with vWf at sites of vascular injury may facilitate 
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colonization of vascular lesions in the development of infection. For S. sanguinis and S. 
lugdunensis this may be particularly relevant for progression of IE. A similar repetitive 
region was identified in the immunodominant, muramidase released protein (Mrp) of S. 
suis (188). SSA_1023 homology with Mrp is restricted to the repeats occurring at the C-
terminus of the protein. Mrp is expressed during infection; however it is not required for 
pathogenesis in porcine infection (236, 252). 
 A vWf type A domain (cd00198) was identified in SSA_1063 (156). The 
implications of having a vWf like structure on the surface of S. sanguinis are numerous, 
including enhanced platelet aggregation for colonization of vegetation components or 
enlargement of the vegetation, as well as colonization of subendothelial extracellular 
matrix proteins. Also, interaction between SSA_1023 and SSA_1063 might promote 
aggregation of this species though specific ligand binding. These intriguing possible 
attributes of a vWf-like streptococcal surface protein require further investigation.  
 SSA_1632, SSA_1633, SSA_1634, and SSA_1635 were described above in 
reference to their putative cognitive sortase, SrtC (SSA_1631). The S. pneumoniae gram-
positive surface pilus was previously characterized (13). As in S. sanguinis, the 
pneumococcal pilin subunit genes, rrgA, rrgB, and rrgC are clustered with sortase 
enzymes mediating assembly of the pilus structure. Expression of this locus was associated 
with colonization of A549 lung epithelial cells, as well as competitive colonization of the 
murine respiratory tract. Expression of the surface pilus was shown to elicit a robust 
inflammatory response in challenged mice, suggesting that this surface structure has a 
profound impact on the severity of disease and the host response to infection (13). 
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Similarly, gram-positive pilus structures described for GBS elicit a protective response 
against re-infection (144). The E. faecalis endocarditis- and biofilm-related pilus locus 
encodes a surface pilus and pilus related sortase (Bps), and is a determinant of E. faecalis 
biofilm formation and virulence in vivo (121, 183). The contribution of a putative S. 
sanguinis surface pilus in IE had not been investigated prior to this study. 
 SSA_0565 is annotated as a conserved hypothetical protein in GenBank; however 
the protein sequence has 26 % identity and 42 % similarity to Sec10 of E. faecalis. In E. 
faecalis Sec10 (also referred to as PrgA) is encoded by pCF10-borne prgA. The 
components of pCF10 mediate gene transfer via pheromone inducible conjugative 
plasmids (119). This event requires aggregation of donor (pCF10 encoding) and recipient 
cells in liquid culture. The aggregation substance mediating mating aggregate formation 
for genetic transfer, Asc10 (also referred to as PrgB) is also encoded on pCF10 (195). 
Sec10 acts to promote genetic transfer to naïve cells by preventing conjugation between 
donor cells (61). E. faecalis cell surface exposure of both Sec10 and Asc10 has been 
demonstrated by SEM (194). Conjugative plasmids are not part of the genome of S. 
sanguinis SK36; however the genetically competent Streptococcus may be capable of 
DNA acquisition by this mechanism. If SSA_0565 has a similar function to Sec10, this 
ORF may be a remnant of a past conjugative event. In the case of E. faecalis conjugative 
plasmids are of clinical significance due to their role in dissemination of antibiotic 
resistance cassettes; pCF10 confers tetracycline resistance to recipient cells (60). 
 A BLASTP search for homologs of SSA_0684 resulted in positive hits for an S. 
pneumoniae FibA subunit-like protein (GI:147930705) (33 % ID, 49 % similarity in 
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residues 766 – 1082 of SSA_0684), and the FibA-subunit of the fibril-like surface structure 
of Peptostreptococcus micros (GI:4106521) (29 % ID, 39 % similarity in residues 500 – 
800 of SSA_0684). P. micros is one of the causative agents of periodontal disease (87). 
Two morphology types have been described for P. micros, a smooth and a rough type 
(265). The rough type morphology is determined by production of FibA-containing 
fimbriae (131). Interestingly, the rough type variants switch to the smooth morphology 
when cultured in vitro (130). However, both variants produce abscess formation in a 
murine skin model, and both have been isolated from periodontal patients (129, 264).  
 Differences between SSA_0684 and FibA occur at the extreme C-terminus of the 
protein, in the region determining cell surface association. Specifically, the Cp1 family 
sequence repeats reported for the extreme C-terminus of the 393 aa FibA protein are not 
conserved in SSA_0684 (273). These repeats are thought to confer carbohydrate binding 
capabilities to the protein, and in the case of S. pneumoniae PspA, this region is involved 
in anchoring of the proteins to lipoteichoic acid in a choline-mediated interaction (273, 
290). The lack of conservation of this region is unsurprising given the identification of an 
LPXTG pattern at the C-terminus of SSA_0684. Similarity to the remainder of FibA 
suggests the proteins may share other functional properties that remain to be determined.  
 
Detection of S. sanguinis Cwa proteins by MudPIT 
 Multidimensional protein identification technology (MudPIT) was used for 
detection of S. sanguinis proteins in two cellular fractions, a mutanolysin released cell wall 
associated protein fraction, and the remaining protoplast fraction. The MudPIT technique 
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requires proteolytic digestion of the protein pool into fragments that are separated by 
strong cation exchange chromatography followed by reverse phase chromatography. The 
peptides are then subjected to tandem mass spectrometry MS, for determination of the 
mass-to-charge ratio of each fragment. Peptide information derived is searched against an 
in silico proteolytic digestion database of predicted ORFs to identify actual ORFs detected. 
The MudPIT analysis was performed with the assistance of Dr. Patricio Manque of the 
Center for the Study of Biological Complexity at Virginia Commonwealth University. 
 Fourteen of the predicted S. sanguinis Cwa proteins ORFs were detected by 
MudPIT technology (Table 11). Detection of the hypothetical protein SSA_1301 in both 
protoplast and cell wall (mutanolysin released) fractions, and the hypothetical protein 
SSA_2121 in the cell wall associated fraction resulted in reclassification of these ORFs as 
conserved uncharacterized (reflected in Table 10). Antigen I/II homologs SspC and SspD 
(SSA_0303, and SSA_0956, respectively) were both detected in the cell wall and 
protoplast fraction suggesting that these proteins were abundant in the cell at the time of 
sampling for MudPIT analysis. Proteins containing the collagen binding domain 
pfam05737 (156) were also detected as being simultaneously present. CbpA (SSA_1663) 
and SSA_0805 were detected in the cell wall associated fraction, whereas SSA_1019 was 
detected in the protoplast fraction. SSA_1023, which shares homology with the S. 
lugdunensis vWf1, and S. suis Mrp was detected in the cell wall fraction. The CshA related 
proteins, CrpC (SSA_0906) and CrpA (SSA_0904) were both detected as being abundant 
in the experiment. As for cell wall associated enzymes of S. sanguinis SK36, both 
SSA_0243 (the putative cyclo-nucleotide phosphodiesterase), and SSA_1065 (putative 
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Table 11. Detection of S. sanguinis Cwa proteins by MudPIT 
 
S. sanguinis (Ss) Cwa proteins detected as abundant by MudPIT analysis of cell wall-
associated proteins and protoplast proteins are described. The E-value given for each 
protein reflects the probability that the protein was identified incorrectly. A smaller E-
value reflects a decreased probability that the protein was identified erroneously (cutoff 
1.00E+00). Proteins not listed may have been expressed under the condition tested, but the 
protein abundance may be under the limit of detection. 
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Table 11. 
 
 
 
Ss ORF Description  Protoplast Cell wall 
SSA_1666 Collagen binding domain; pfam05737  7.56E-05 
SSA_0805 Collagen binding domain; pfam05737  6.50E-06 
SSA_1019 Collagen binding domain; pfam05737 1.00E+00   
SSA_1632 Putative pilin subunit  2.69E-08 
SSA_0956 SspD 1.00E+00 4.52E-03 
SSA_0303 SspC  6.89E-09 
SSA_1023 Von-Willebrand factor binding protein  1.38E-03 
SSA_0904 CrpA 1.00E+00   
SSA_0906 CrpC 5.24E-03 1.60E-06 
SSA_0684 FibA fibril subunit-like protein 7.41E-03 1.07E-04 
SSA_1234 5' Nucleotidase  8.56E-06 
SSA_1065 Beta hexosaminidase-like protein 2.03E-03   
SSA_0243 Cyclo-nucleotide phosphodiesterase 6.37E-04 1.00E-02 
SSA_2121 Conserved uncharacterized   1.52E-04 
SSA_1301 Conserved uncharacterized 1.26E-05 1.95E-09 
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beta-hexosaminidase) were detected in the protoplast fraction. SSA_0243 was also 
detected in the cell wall fraction. That additional predicted Cwa proteins were not detected 
does not exclude the possibility of their expression or presence at the time of protein 
fractionation. This method is particularly sensitive to the concentration of the protein 
mixture analyzed, proper denaturation of proteins prior to digestion, and detection of 
proteins that are abundant in the sample.  
 
In vitro transposition to create an STM mutant pool 
 The 31 predicted cell wall-associated protein encoding ORFs, and 3 sortase-like 
ORFs described above were subjected to in vitro transposition. Each ORF was PCR 
amplified to create a 2.5 kb product, which was subsequently used as a target for in vitro 
transposition with the pJFP1 encoded magellan2 mini-transposon containing a unique 
signature tag. The target amplicon size of 2.5 kb was of conscious design based on 
previous experiments in the lab indicating that regions of homology ≥ 1kb flanking non-
consensus sequence yield greater transformation efficiency (Dr. Todd Kitten, personal 
communication). With this in mind, primers used for target gene amplification were 
designed with the preferred insertion site roughly equidistant from either end of the 
amplicon. Following end-filling and ligation reactions, transposition products were 
transformed into S. sanguinis SK36. A diagnostic PCR reaction coupling ORF-specific 
flanking primers (up or dn) with a transposon inverted repeat primer (Mout) was used to 
estimate the site of transposon insertion site in Cmr transformants. Among the clones 
screened those with predicted insertion within the ORF, close to the 5’ end of the ORF 
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were selected for further studies. The estimated insertion site for each ORF targeted, as 
well as the signature tag used is indicated in Table 12. The accuracy of diagnostic PCR for 
prediction of the transposon insertion location was tested for 7 STM mutants. In all strains 
analyzed DNA sequencing confirmed that transposon insertion occurred very close to, if 
not within the predicted interval obtained from diagnostic PCR (Table 12).  
The signature tags used in mutant generation were prescreened by Todd Kitten for 
consistent and specific DNA hybridization. For simplicity each of the 40 tags approved for 
mutagenic application were assigned a number between 1 and 40. STM mutant strain 
designations reflect the signature tag number employed, as well as whether the target ORF 
coded for a Cwa protein (CWA), or a sortase enzyme (SRT).  
Successfully mutagenesis of all 34 predicted proteins by the directed STM 
technique resulted in the creation of a 34-strain mutant library.  
 
In vivo screening of the STM pool  
In previously described pilot studies the rabbit model of IE was optimized for 
evaluation of S. sanguinis virulence factors (198). This model of infection was superior to 
the rat model of IE (179, 180) due to apparent bottlenecking during STM trials in the rat 
model, not observed in the rabbit model (198). The S. sanguinis inoculum size was also 
previously optimized for the rabbit model. In three inocula tested, 2 x 108, 2 x 109, and 2 x 
1010 CFUs, the highest inoculum proved lethal within 24 hours of injection, whereas the 
other two inoculum sizes had no effect on the observed results. All doses of bacteria 
administered resulted in infection, and reproducible recovery as detected by dot blot 
 
221 
Table 12. Estimation of mini-transposon insertion location 
 
For each predicted Cwa protein or sortase ORF in vitro transposition was performed with a 
different magellan2 mini-transposon incorporated signature tag (signature tag #). 
Following transformation of transposition products, PCR amplification of cells from Cmr 
transformants was used for estimation of the transposon insertion site. Mutants were 
chosen for in vivo testing based on the presence of the transposon insertion within the gene 
of interest and its proximity to the start of the ORF, with preference given to mutants with 
interruption closer to the beginning of the gene. The estimated distance between the 
transposon insertion site and the start site of the gene is indicated for each selected mutant. 
For several mutants, the actual insertion site was determined by DNA sequencing. PCR 
estimation was quite accurate, with the actual site of insertion very close to, if not within 
the predicted interval. 
 
222 
Table 12.  
 
 
 
SSA  gene # Signature Tag # ORF size (bp) Estimated site Actual site
SSA_1112 1 1575 413 - 445
SSA_2023 2 4215 879 - 916
SSA_1663 3 4533 924 - 935 923
SSA_1591 4 2046 549 - 600
SSA_0805 5 1674 183 - 369 190
SSA_1634 6 1458 187 - 234
SSA_1633 7 1437 376 - 477
SSA_1632 8 1437 380 - 425
SSA_0956 9 4113 327 - 333
SSA_0227 10 2081 1065 - 1081 1085
SSA_0565 11 2583 452 - 490 478
SSA_1301 12 2559 87 - 181 113
SSA_0303 13 4518 445 - 480
SSA_0273 14 1413 196 - 204
SSA_1023 15 2673 883 - 894
SSA_1019 16 2382 394 - 535 485
SSA_1631 18 885 512 - 567
SSA_0905 19 5898 1114 - 1157
SSA_0906 20 8007 1223 - 1254
SSA_1219 21 753 175 - 279
SSA_0684 22 3819 366 - 412
SSA_1234 23 2424 401 - 414
SSA_0022 24 840 416 - 489
SSA_1063 25 1350 318 - 372
SSA_2020 26 3105 808 - 853
SSA_0167 27 999 311 - 397
SSA_0146 28 2391 196 - 237
SSA_0453 29 3699 365 - 435 
SSA_1666 30 1935 560 - 579 569
SSA_1065 31 2790 835 - 885
SSA_0904 33 8970 824 - 869
SSA_1750 34 2247 417 - 510
SSA_2121 38 4683 322 - 362
SSA_0243 40 2409 364 - 400  
 
223 
hybridization (198). In the STM screens described below the inoculum administered 
ranged from 1 x 107 CFUs to 2 x 108 CFUs. 
 Three independent in vivo screens were conducted for analysis of the STM mutant 
pool. Each strain was tested in at least two independent experiments, in at least three 
rabbits in each experiment. The dot blot DNA hybridization technique used for detection 
of strains inoculated into the rabbits (the input pool), and strains recovered from the rabbits 
(the output pool) is depicted in Figure 30. Figure 34 presents a summary of strains tested in 
each experiment, and the results obtained. The first STM experiment was conducted with a 
portion of the strains composing the final, complete pool. The pool tested included 
previously unevaluated strains CWA4, CWA9, CWA10, CWA12, CWA13, CWA14 and 
CWA15. Dot blot hybridization confirmed the recovery of STM mutants CWA4, CWA10, 
CWA13 and CWA9, suggesting that ORFs mutagenized in these strains are not essential in 
the rabbit model of IE. The competitiveness of CWA15 was difficult to determine, as 
detection of this strain among recovery pools was inconsistent (data not shown). CWA12 
displayed a strong signal in the input pool, yet weak signal in the recovery pools, 
suggesting that this strain did not survive negative selection in vivo.  
The next STM in vivo analysis was conducted using the entire 34 strain mutant 
pool. Of the five rabbits tested in this experiment two had shorter infection duration than 
others, as a result of apparent animal duress. The study was carried to 20 hours post-
inoculation for the remaining rabbits. Despite shorter duration of infection in two of the 
rabbits, the hybridization patterns of these rabbits were consistent with those experiencing 
20 hours of infection. Unfortunately the interpretation of results was confounded by 
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variability in signature-tag hybridization observed for the input pool dot blot. Because 
conclusiveness is dependent on presence of the strain in the inoculum, definitive results 
were obtained only for strains exhibiting a strong signal on the input blot (data not shown). 
Strains retaining virulence are indicated in Figure 34.  
Results representative of the final independent experiment, in which the entire 
mutant pool was screened, are shown in Figure 35. Bacterial recovery from one of the 
three rabbits tested was below the range yielding reproducible results; therefore only 
results from rabbits with higher recoveries are included. The input blot of this experiment 
showed minimal variability with high signature-tag chemiluminescent signal intensity of 
signature tags for the majority of strains analyzed. Likewise, the majority of strains tested 
were recovered, indicated by the strong chemiluminescence observed in the output blots. 
Of 34 mutants screened, 29 retained virulence as detected by signature-tag hybridization 
(Figure 34).  
Relative comparison to the negative control pJFP1 signature tags (‘N’, Fig. 35) 
highlights differences among strains. For example, signature tag 12, representing strain 
CWA12 exhibited stronger signal intensity in the input blot, but negative control signal 
intensity in the recovery blots. That this tag was not detected in the recovery pool 
suggested that this strain did not survive negative selection in vivo. Results for four strains, 
SRT21, SRT24, CWA15 and CWA30 were inconclusive due to low signal intensity of 
signature-tag hybridization on the input pool membrane.  
An in vitro growth study performed in conjunction with the animal study suggests 
that poor detection is not entirely reflective of reduced growth in vitro (Fig. 36). 
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Figure 34. Summary of STM screen results 
 
STM Experiment
S. sanguinis ORF Tag 1 2 3 Key:
SSA_1112 1 ND ● ● ND Not determined
SSA_2023 2 ND ● ● ● Competitive
SSA_1663 3 ND ● ● ◘ Inconclusive
SSA_1591 4 ● ● ● ○ Not competitive
SSA_0805 5 ND ◘ ●
SSA_1634 6 ND ● ●
SSA_1633 7 ND ● ●
SSA_1632 8 ND ● ●
SSA_0956 9 ● ◘ ●
SSA_0227 10 ● ● ●
SSA_0565 11 ND ● ●
SSA_1301 12 ○ ◘ ○
SSA_0303 13 ● ● ●
SSA_0273 14 ● ● ●
SSA_1023 15 ◘ ◘ ◘
SSA_1019 16 ND ● ●
SSA_1631 18 ND ● ●
SSA_0905 19 ND ◘ ●
SSA_0906 20 ND ● ●
SSA_1219 21 ND ◘ ◘
SSA_0684 22 ND ● ●
SSA_1234 23 ND ● ●
SSA_0022 24 ND ◘ ◘
SSA_1063 25 ND ◘ ●
SSA_2020 26 ND ● ●
SSA_0167 27 ND ● ●
SSA_0146 28 ND ● ●
SSA_0453 29 ND ● ●
SSA_1666 30 ND ◘ ◘
SSA_1065 31 ND ● ●
SSA_0904 33 ND ◘ ●
SSA_1750 34 ND ● ●
SSA_2121 38 ND ● ●
SSA_0243 40 ND ● ●  
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Figure 35. Representative dot blot hybridization results 
 
A) The layout of STM-plasmid containing membranes is shown. Each number represents a 
Cwa protein mutant bearing that unique signature tag. Tags not used for mutation are 
negative controls (N), and are indicated by purple boxes. 
 
B) Actual hybridization results are shown for the input pool (at the left), and output pools 
of bacteria recovered from rabbits. The presence of a strain is indicated by strong 
chemiluminescent signal intensity. Low signal intensity indicates diminished presence of a 
strain or poor hybridization for other reasons. Purple boxes indicate background signal 
intensity of negative control plasmid DNA.  
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Figure 35. 
 
 
 
 
 
Input Output 1 Output 2
1 9 N 25 33
2 10 18 26 34
3 11 19 27 N
4 12 20 28 N
5 13 21 29 N
6 14 22 30 38
7 15 23 31 N
8 16 24 N 40
STM dot blot layout:
B. Hybridization results:
A.
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Figure 36. In vitro growth of STM strains 
 
STM strains were grown in vitro overnight concurrent with the third rabbit experiment. 
Strains retaining competitiveness in vivo are in gray symbols. Strains requiring further 
analysis, due to apparent avirulence, CWA12, or poor signal intensity in the inoculum, 
CWA15, SRT21, SRT24, and CWA30 are indicated by colored symbols. Each strain is 
indicated by its signature-tag number. 
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Figure 36. 
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Strains CWA15, CWA24 and CWA30 grew comparably to the parental strain SK36, 
whereas SRT21 grew more slowly than wild-type. An alternate explanation for low signal 
intensity in the input blot is degradation of signature tag DNA impeded DNA:DNA 
hybridization required for detection. To eliminate this complication strains yielding 
inconclusive results were further analyzed by competitive index assays. 
 
Re-evaluation of STM strain stability without antibiotic selection 
 Before further testing of STM mutants we wanted to establish stability of the 
mutation without antibiotic selection of the transposon. Cells harvested from overnight 
cultures of each STM strain in BHI (no antibiotic) were used as template in PCR. The 
region of transposon insertion in each strain was PCR amplified by specific primers 5’ and 
3’ to the ORF interrupted (Appendix B). The presence of the transposon was suggested by 
the size of the PCR product obtained. Maintenance of the transposon results in an amplicon 
of 3.5 to 4 kb, whereas absence of the transposon is indicated by a smaller band of 2 to 2.5 
kb. For all strains evaluated, a larger band of ~3.5 to 4.0 kb was detected which represents 
the ORF containing the transposon. For CWA11, CWA12, CWA14 and SRT21 an 
additional smaller band of was observed (data not shown). The double band pattern 
observed in these strains may be attributed to non-specificity of primers used, or the 
presence of more than one genotype. To confirm these results four colonies of strains 
CWA11, CWA12, CWA14 and SRT21 grown in the presence of Cm were subsequently 
cultured in liquid BHI with Cm overnight. The stationary phase cells were then 
subcultured in BHI without Cm for a second overnight period. Cells were harvested from 
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the plus and minus Cm conditions and used as template for PCR, as described above. The 
two conditions tested would indicate the dominant allele in the presence and absence of 
antibiotic selective pressure. PCR products observed for CWA11, CWA12, and CWA14 
were identical in the presence and absence of antibiotic (Fig. 37A and 37B), thus 
confirming the stability of the mutant allele without Cm selection. However the mutant 
allele was not detected for strain SRT21 in the absence of Cm (Fig. 37B). To correlate 
these findings with animal experiment data the strains CWA11 and CWA14, with 
signature-tags 11 and 14, respectively, exhibited strong DNA hybridization signal intensity 
in both input and output blots (Fig. 35B). CWA12, with signature-tag 12 showed strong 
signal intensity in the input blot, but not in output blots (Fig. 35B). Transposon 
maintenance in strain CWA12 independent of Cm selection suggests that low signal 
intensity of this strain following in vivo competition is cannot be attributed to genotypic 
changes in this strain. In contrast the apparent loss of the mutant allele in SRT21 could 
explain the poor dot blot hybridization observed for this strain during in vivo screening 
(Fig. 35B, tag 21). For STM screening strains were cultured in vitro without antibiotic for 
3 hours prior to inoculation, which could provide adequate time for out-growth of the 
strain lacking the selective marker.  
To address this issue a new srtA mutant was developed in the SK36 genetic 
background. A gene SOEing construct was designed for insertion of aad9 of pR412 
between the first 29, and last 23 codons of srtA, to couple the deletion of srtA with the 
insertion of a selective marker. The inconclusive in vivo results obtained for another 
sortase STM mutant, SRT24 led to the decision to generate a novel srtB mutant as well.
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Figure 37. Detection of the transposon in the absence of Cm selection 
 
Four colonies (1 to 4) of S. sanguinis strains CWA11, CWA12, CWA14 and SRT21 were 
analyzed by PCR product size determination for the presence of the transposon in strains 
cultured in the presence of Cm (selective for the transposon) (A). Stationary phase cells in 
BHI containing Cm were subcultured in the absence of Cm (B). Sizes of PCR products for 
CWA11, CWA12, and CWA14 were similar (~ 4 kb in size) in the presence and absence 
of selective antibiotic (A and B), indicating the presence of the transposon in these strains 
under both growth conditions. In contrast, a smaller dominant band (~ 2 kb) is observed for 
SRT21 after growth in Cm overnight (A), which becomes the only observable band 
following subculture in BHI without Cm (B). The amplicon size expected for 
srtA::magellan2 was 3.459 kb, the anticipated amplicon for WT srtA was 2.077 kb.  
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Figure 37. 
 
 
 
A. PCR amplification of strains from BHI with Cm 
 
 
 
 
B. PCR amplification of strains from BHI  
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Gene SOEing was used to create a mutant construct by insertion of the kanamycin 
resistance cassette kan between the fist 27 and last 16 codons of srtB, thus combining 
deletion of srtB with the insertion of a selective marker for kanamycin resistance. S. 
sanguinis SK36 was transformed with the gene SOEing mutagenic constructs, and 
transformants selected by spectinomycin or kanamycin resistance conferred by mutation of 
srtA or srtB, respectively. The resulting srtA mutant was designated JFP42, and the srtB 
mutant designated JFP44. 
 
Competitive index studies 
 Dot blot hybridization qualitatively differentiated between STM mutants that 
retained competitiveness in the rabbit model of IE, a single putatively uncompetitive strain 
(CWA12), and strains of inconclusive competitiveness (CWA15, CWA30, SRT21 and 
SRT24). These results are merely suggestive of exploitive vs. underrepresented strains, and 
relative attenuation for particular strains is difficult to determine. A competitive index (CI) 
assay was used to assign a quantitative value to the competitiveness of CWA strains 
requiring further testing. The previously described Emr derivative of SK36, JFP36 
(Chapter IV) was used as the competitive control strain in these experiments. In the CI 
algorithm the ratio of mutant/control strain CFUs recovered from rabbits is divided by the 
ratio of mutant/control strain CFUs administered to rabbits. A CI value of 1 indicated equal 
competitiveness between the mutant and WT control. A CI value less than one indicated 
reduced competitiveness of the mutant vs. the WT control. A CI value greater than one 
 
235 
suggests that mutant competitiveness exceeds that of the WT control. Statistical analyses 
were then applied to determine whether the difference in competitiveness was significant 
CI analysis of CWA12 
 To determine the competitiveness of CWA12 relative to the virulent control, 
JFP36, the two strains were co-inoculated into three catheterized rabbits in two 
independent studies. Contrary to preliminary evidence from dot blot hybridization 
implicating CWA12 as a noncompetitive strain, the mean competitive index value obtained 
for this strain relative to JFP36 was 0.959 (Fig. 38). Therefore CWA12 was equally 
competitive to the control strain. The conflicting results from these assays may be 
attributed to reduced plating efficiency of this strain as a function of increased chain 
length. In dot blot hybridization, signature tag probes are developed from strains in liquid 
culture for the input pool, vs. in vivo recovered colonies subsequently sub-cultured in 
liquid media for the output pool. If a strain exhibits a poor plating efficiency (forms fewer 
colonies) at the same optical density as other strains, then it may be construed that the 
strain is not present, or is diminished in the pool. The design of the CI study would account 
for differences in plating efficiency of strains, as the ratios of CFUs of strains both 
inoculated into and recovered from rabbits are compared. When viewed by phase contrast 
microscopy early stationary phase cultured CWA12 formed much longer chains that the 
competitive control, JFP36. In addition CWA12 formed roughly 0.5 colonies for every 1 
colony of JFP36 at an equal optical density of 0.8. That dot blot hybridization is 
sufficiently sensitive to detect and translate this difference is very encouraging. Our 
findings from the CI assay, coupled to observations regarding chain length and plating 
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efficiency of CWA12 confirm that expression of the ORF mutated in CWA12 is not 
required for full competitiveness in vivo. 
CI analysis of CWA15 
 The competitiveness of CWA15 relative to JFP36 was tested in three rabbits 
between two CI experiments. The two strains were co-inoculated into catheterized rabbits, 
with competitiveness assessed 20 hours later. In contrast to the inconclusiveness of dot blot 
hybridization results, the CI assay definitively showed CWA15 to be significantly more 
competitive than JFP36 in vivo, with a mean CI value of 1.547 (Fig. 38). This result 
suggests the ORF interrupted in CWA15, SSA_1023, is not required for full 
competitiveness, and in fact expression of SSA_1023 may impede competitiveness in 
experimental early infective endocarditis.  
CI Analysis of CWA30 
 Inconclusiveness of CWA30 in the initial STM screen prompted further 
investigation of this strain in a CI assay. A CWA30 and JFP36 co-inoculum was tested in 
two rabbits in a single animal trial. The mean CI value obtained for CWA30, 1.120 
suggests that expression of SSA_1666, the putative Cwa protein ORF mutated in this strain, 
does not contribute to competitiveness in vivo (Fig. 38). SSA_1666 was annotated as a 
putative collagen binding protein, based on identification of conserved domains of the Cna 
collagen binding protein of S. aureus, pfam 05737 and 05738 (156). At least four 
additional putative collagen adhesins and homologs of two characterized collagen adhesins 
have been identified in S. sanguinis SK36. The abundance of Cna-like proteins of S. 
sanguinis suggests that collagen adhesion is important for fitness in the oral niche.
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Figure 38. CI analysis of S. sanguinis SK36 derivatives 
 
CI comparisons were performed for S. sanguinis STM mutants, CWA12, CWA15, and 
CWA30 relative to the Emr competitive control JFP36. Isogenic derivatives of SK36, 
JFP44 and JFP42 were also compared to JFP36. Competitiveness of the srpA mutant 
VT1614 was determined relative to SK36. The scatterplot includes the CI calculated for 
each animal (symbol), and the mean CI value for the mutant (bar). The dotted line at a CI 
of one represents the CI value for equal competitiveness. The STM strain CWA15 was 
significantly more competitive than JFP36 (*= P = 0.0421). The srtA mutant JFP42 was 
significantly less competitive than JFP36 (**= P < 0.0001). The table includes the CI 
phenotype for each strain, a description of the mutagenized ORF, the mean CI value for 
each strain, and the range of CI values obtained. 
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Figure 38. 
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Mutant  Phenotype Description ORF Mean CI (Range) 
CWA12 Competitive Conserved Uncharacterized 0.959 (0.63 - 2.03) 
CWA15 Hyper-competitive FibA/MRP-like 1.547 (1.28 - 1.69) 
CWA30  Competitive Collagen binding domain 
(pfam05737) 
1.120 (1.04 - 1.20) 
VT1614 Competitive SrpA 1.588 (1.15 - 2.12) 
JFP44 Competitive SrtB 1.011 (0.91 - 1.21) 
JFP42 Noncompetitive SrtA 0.167 (0.05 - 0.27) 
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Whether this phenotype correlates with development of infective endocarditis has yet to be 
tested. One complication of such a study would be the abundance of proteins mediating 
such an interaction, and likelihood of functional redundancy among these proteins.  
CI analysis of VT1614 
 To determine the contribution of SrpA in competitiveness in vivo a previously 
described isogenic srpA mutant of SK36, VT1614 (204) was compared to the parental 
strain in three rabbits in a single CI experiment. At twenty hours of infection bacteria were 
recovered and plated to determine the CI value of VT1614. The mean CI value for 
VT1614, 1.58 demonstrates that mutation of srpA does not negatively affect 
competitiveness in vivo (Fig. 38). This is particularly interesting given evidence that the S. 
gordonii SrpA homolog, Hsa contributes to competitiveness in the rat model of IE (248). 
However, the previous evaluation did not account for the number of CFUs administered by 
computation of a CI value; instead only recovery was expressed as CFUs/mg vegetation.  
CI analysis of JFP44 
 The SSA_0022, srtB homolog mutant, JFP44 was compared to JFP36 in three 
rabbits in a single CI experiment. The mean CI derived for JFP44, 1.02, confirms that 
expression of srtB is not required for early infective endocarditis (Fig. 38). The wild-type 
competitiveness exhibited by JFP44 suggests that proper cell localization of the unknown 
SrtB transpeptidase substrate(s) is not required for the onset of disease.  
CI analysis of JFP42 
 Initial competitive index analysis of the srtA mutant JFP42 in three rabbits revealed 
the strain to be significantly less competitive that the competitive control strain, JFP36 
 
240 
with a mean CI value of 0.07 (P= 0.0061). This experiment was repeated in two additional 
independent experiments with three rabbits each. The subsequent studies confirmed that 
JFP42 showed a significant reduction in competitiveness, with an overall mean CI value of 
0.167 (P < 0.0001) (Fig. 38). The competitive phenotype of this mutant suggests the 
expression of srtA is required for full competitiveness in vivo. SrtA is likely the major, 
housekeeping sortase in S. sanguinis, responsible for anchoring the majority of Cwa 
proteins. The observed decrease in competitiveness for JFP42 in conjunction with results 
from the comprehensive analysis of S. sanguinis Cwa proteins suggests that development 
of S. sanguinis IE is a multi-factorial process mediated by more than one Cwa protein 
dependent on SrtA. 
 
In vitro CI comparison of JFP42 and JFP36  
 An in vitro CI assay was used to determine whether JFP42 exhibited a general 
growth defect in vitro owing to mutation of srtA. A mutant with a general growth defect 
would be expected to perform less well in a CI assay, and this experiment would indicate 
whether the described in vivo findings were attributed to attenuated growth rather than 
reduced colonization efficiency or virulence. For this experiment strains were adjusted to 
an equal optical density and then co-cultured for the typical infection duration (~20 hours). 
The in vitro CI value was derived by comparing CFUs of strains prior to co-culture to 
CFUs following co-culture. The mean in vitro CI value obtained for JFP42 vs. JFP36 from 
five independent experiments was 0.58. If co-culture had no effect on growth as 
determined by CFUs, a mean CI value of 1.0 would be expected. As 0.58 (range: 0. 2 – 
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1.302) is less than 1.0, it appears that JFP42 exhibits a slight growth defect in vitro during 
co-culture with JFP36. However the CI value is not significantly different from a value of 
equal competitiveness (P= 0.2185), and it is unlikely this in vitro effect accounts for the 
reduced CI value for JFP42 in vivo. While this type of assay indicates strain-specific 
growth deficiencies, it does not replicate the selective pressures encountered by strains 
during infection.  
 
Individual inoculum comparison of JFP42 and SK36 
 One possible complication of co-inoculation of strain in the CI assay is phenotypic 
complementation of the mutant by the presence of the WT strain. For example, if a mutant 
is capable of adhering to the WT strain (i.e. piggybacking), then it would benefit from 
adhesins required for colonization of the vegetation expressed by the wild-type. Also, 
secreted proteins from the WT strain might also prove advantageous to the mutant during 
co-infection. The possibility of complementation was examined by single-strain infections. 
 Four catheterized rabbits each were inoculated with JFP42 or SK36, and recovery 
of bacteria was assessed 20 hours later. In our hands vegetation size is often an indicator of 
bacterial recovery, with larger recoveries yielding more reliable results obtained from 
larger vegetations. To control for differences in the size of vegetations recovered, CFUs 
were normalized by vegetation weight.  
 In this study four rabbits received 1.84 x 108 CFUs of JFP42, and four rabbits 
received 6.55 x 107 CFUs of SK36. The mean recovery for rabbits receiving JFP42 was 
8.69 log CFU/g vegetation. The mean recovery for rabbits receiving SK36 was 9.03 log 
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CFU/g vegetation (Fig. 39). The difference in recovery between the two rabbits was not 
significant (P= 0.1036), and therefore virulence of JFP42 is similar to SK36 when 
monitored 20 hours after infection. This is in contrast to CI studies in which JFP42 was 
significantly less competitive. The actual defect for JFP42 may be in competitive 
colonization of the vegetation, as it is apparent that in the absence of competition JFP42 
can develop an infection similar to wild-type. An alternative possibility is that JFP42 is 
attenuated for vegetation colonization, yet grows to levels similar to wild-type in the 
intervening period between colonization and termination of the experiment.  
 In an in vivo experiment of shortened infection duration (2 hours) we examined 
whether JFP42 exhibited attenuated colonization of the vegetation in the absence of a 
competitor. Four catheterized rabbits received 1.35 x 107 CFUs JFP42, and four 
catheterized rabbits received 2 x 107 CFUs SK36. Two hours later the infection was 
terminated, and recovered bacteria were normalized to the vegetation weight collected. At 
two hours of infection the mean recovery for JFP42 was 3.03 log CFU/g vegetation (range: 
2.7 – 3.68 log CFU/g). The mean recovery was greater for SK36, 4.314 log CFU/g 
vegetation (range: 3.47 – 5.3 log CFU/g) (Fig. 39). This difference is statistically 
significant (P= 0.0422), and suggests that JFP42 is attenuated for colonization of the 
vegetation relative to the parental strain, SK36. This deficiency is likely exacerbated when 
JFP42 is competed against a control in an experiment requiring co-inoculation of bacteria. 
In this scenario the control with an arsenal of Cwa proteins lacking in the srtA mutant 
would be better suited for adherence to or association with vegetation components in the 
colonization process and would readily out-compete a strain lacking these determinants.
 
243 
Figure 39. Individual inoculum comparison of JFP42 and SK36 
 
Catheterized rabbits received a single strain inoculum of JFP42 or SK36 and infection 
proceeded for 20 or 2 hours prior to recovery of bacteria. CFUs obtained were adjusted by 
the gram vegetation weight recovered. At 20 hours the difference in the mean log CFU/g 
vegetation recovered from rabbits receiving JFP42 vs. SK36 was not quite significant (P = 
0.1036). In contrast, at two hours post-infection significantly more CFUs were recovered 
from rabbits receiving SK36 than rabbits receiving JFP42 (*= P= 0.0422).  
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Figure 39. 
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Evaluation of S. sanguinis sortase mutant biofilm formation  
A semi-quantitative static biofilm formation assay was used to determine the 
contribution of S. sanguinis Cwa proteins to biofilm formation. Sortase mutant derivatives 
of S. sanguinis SK36; JFP42, JFP44, and SRT18, were compared to the parental strain and 
wild-type competitive control, JFP36. The srpA isogenic mutant of SK36, VT1614 was 
used as a negative control in this experiment (204). The S. parasanguinis SrpA homolog, 
Fap1 was previously shown to be required for wild-type biofilm formation in the presence 
of 1 % glucose (76). Biofilm formation was measured in the wells of PS plates following 
20 hours of static culture in BM supplemented with 1 % sucrose or 1 % glucose.   
 When cultured in the presence of glucose, biofilm formation as quantified by CV 
staining was similar for SK36 and its Emr competitive derivative, JFP36. VT1614 was 
most attenuated for biofilm formation (P < 0.001) relative to wild-type (Fig. 40A). The 
srtA mutant JFP42 also exhibited a significant reduction in biofilm formation, though the 
amount of biofilm detected for JFP42 exceeded that for VT1614. Biofilm formation of the 
srtC STM mutant, SRT18 was also significantly decreased relative to SK36. In contrast, 
the srtB mutant JFP44 exhibited significantly greater biofilm formation than wild-type, and 
far exceeded biofilm mass detected for other sortase mutants tested (Fig. 40A). From this 
experiment it is apparent that Cwa proteins of S. sanguinis are required for biofilm 
formation in glucose supplemented media in vitro. This phenotype is most attributable to 
Cwa proteins dependent on SrtA for surface localization, of which SrpA is critical. 
However Cwa protein substrates of SRT18 also appear to mediate biofilm formation. In 
other gram-positive spp. expression of a class A sortase enhances cell surface exposure of 
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Cwa proteins polymerized by a class C sortase (244). If this is also the case for S. 
sanguinis the phenotype exhibited by SRT18 could be attributed to the lack of pilus 
assembly, whereas JFP42 would reflect the loss of the pilus from the cell surface. This is 
the first instance of assessment of SrtB in biofilm formation. The enhanced biofilm 
formation in this strain suggests that SrtB or SrtB substrates are required for maintenance 
of WT biofilm development.  
 Biofilm formation in sucrose-supplemented BM revealed carbon source-dependent 
intricacies of this process. In the presence of sucrose biofilm formation of VT1614, SK36, 
and JFP36 was similar; suggesting that under this growth condition SrpA is dispensable 
(Fig. 40B). Akin to this, SRT18 biofilm formation was similar to wild-type, and therefore 
pilus assembly may not be required for development of biofilms in sucrose. However, 
biofilm formation was significantly greater for JFP42 over wild-type, so SrtA-dependent 
Cwa proteins may impede development of the sucrose biofilm. This phenomenon was also 
observed for JFP44, with a significant increase in biofilm formation resulting from the loss 
of srtB expression (Fig. 40B). 
In the presence of sucrose the glucosyltransferase of S. sanguinis generates water 
soluble glucans (WSG) that are thought to contribute to the synthetic exopolysaccharide 
glucan matrix in the complex dental plaque biofilm (7, 251). With glucose as a carbon 
source WSG is not produced, and instead it appears that Cwa proteins are essential. These 
proteins may enhance primary adhesion of streptococci to the PS surface, and stabilization 
of the biofilm mass. Results for glucose biofilms indicate that sortases of S. sanguinis have 
drastically different roles in this process. Additional interplay between extracellular 
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Figure 40. Sortase mutation affects static biofilm formation 
 
A) Biofilm formation of S. sanguinis SK36 derivatives was determined in a semi-
quantitative static assay. S. sanguinis strains were subcultured in BM with 1 % glucose for 
20 hours before decanting and washing to remove planktonic cells. The remaining sessile 
cells were quantified by CV staining. Cell associated CV was suspended in 30 % acetic 
acid and the optical density recorded at 600 nm. Biofilm formation of JFP42 was 
diminished and similar to the previously described biofilm deficient mutant, VT1614. 
SRT18 also formed significantly less biofilm than wild-type. ***= P < 0.001, **= P < 
0.01 
 
B) S. sanguinis strains were subcultured in BM with 1 % sucrose for determination of 
biofilm formation n as described above. In BM with sucrose JFP42 and JFP44 formed 
significantly more biofilm than the WT strain, SK36. ***= P < 0.001, **= P < 0.01
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Figure 40. 
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determinants of exopolysaccharide production and Cwa proteins is suggested by JFP42 
biofilms grown in sucrose, when the loss of Cwa proteins caused greater biofilm formation 
over WT.  
 
S. sanguinis adhesion to PS is decreased for JFP42 
 A short time-course study was used to determine whether reduced adherence to PS 
accounted for decreased biofilm formation for JFP42. Late stationary phase S. sanguinis 
strains were sub-cultured in BM with 1 % glucose for 4 hours, and adherent bacteria 
determined by CV staining. Adhesion to PS was unaffected in JFP36 and JFP44 relative to 
SK36 (Fig. 41B). Adherence to PS was slightly higher for the SrtC mutant, SRT18, which 
is surprising given lower biofilm formation detected for this strain at 20 hours. While 
adhesion to PS is unaffected in this strain, the evolving biofilm post adhesion may not be 
as stable due to mutation of srtC. Attenuated biofilm formation has been previously 
described for a class C sortase mutant of E. faecalis (121). JFP42 was significantly 
attenuated for adhesion to PS relative to other strains tested (Fig. 41B). This phenotype is 
likely responsible for the decreased biofilm formation phenotype for JFP42 cultured in 
glucose supplemented BM (Fig. 40A). Total growth of strains (planktonic and sessile cells) 
in BM with 1 % glucose was measured at 450 nm prior to removal of non-adherent cells. 
Growth of JFP42 was significantly less than SK36; however the difference observed 
suggests that decreased growth does not account for the adhesion phenotype (Fig. 41A). 
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Figure 41. PS adhesion of S. sanguinis sortase mutants 
 
A) S. sanguinis strains were compared for adhesion to PS by subculture in PS plates for 
four hours in BM with 1 % glucose. The total growth (both planktonic and sessile cells) in 
biofilm medium was measured by an optical density reading at 450 nm. Growth of JFP42 
was significantly less than SK36; however JFP42 was capable of growth in BM with 1 % 
glucose. ***= P < 0.001 
 
B) Following removal of non-adherent cells, remaining streptococci were determined by 
CV staining. CV extracted from each well was measured by recording the optical density 
at 600 nm. The srtA mutant, JFP42 exhibited a significant decrease in adherence to PS vs. 
the other strains tested. ***= P < 0.001 
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Figure 41. 
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Complementation of JFP42  
 Complementation of the srtA mutation was required to confirm that in vivo and in 
vitro phenotypes of JFP42 were attributed to loss of srtA expression. In S. sanguinis and 
related streptococci, the srtA locus is 17 bp downstream of gyrA, which encodes DNA 
gyrase. The proximity of srtA and gyrA, suggests these genes are co-transcribed. Co-
transcription through the intergenic region of gyrA and srtA was confirmed by RT-PCR 
(Fig. 42A). gyrA is the first gene in this operon, as the proximal gene 5’ to gyrA is encoded 
on the opposite strand from gyrA and srtA. A putative promoter of gyrA expression was 
predicted in the online S. sanguinis genome annotation (http://watson.vcu.edu:81/cgi-
bin/gbrowse/sanguinis). This promoter element is separated from gyrA by a predicted 
ribosome binding site (RBS). In the first complementation strategy employed (depicted in 
Fig. 7) the predicted RBS of srtA, and the srtA coding region were fused to the predicted 
promoter for the gyrA operon by PCR amplification with a long primer including at the 5’ 
end the promoter for gyrA and the sequence just upstream from srtA at the 3’ end. This 
amplicon was then fused to the kan cassette for antibiotic selection, and 5’ and 3’ flanking 
regions of SSA_0169 by multiple step gene splicing by overlap extension (Gene SOEing) 
PCR amplification. Flanking SSA_1069 sequences permitted homologous recombination of 
the PCR product into the gene into which antibiotic resistance cassettes were inserted in 
the creation of strains JFP36, JFP56, and JFP76 (Chapter IV). Studies of JFP36, JFP56 and 
JFP76 show that mutagenesis of SSA_0169 does not affect relevant phenotypes like growth 
in vitro, and competitiveness in vivo. Therefore phenotypes observed following 
recombination of the PCR amplicon into this locus would only reflect restoration of 
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chromosomally encoded srtA. By restoration of srtA in single copy we intended to avoid 
potential effects of complementation by a plasmid encoded srtA, including multiple copies 
of srtA, and slower growth due to plasmid replication. In the resulting strain, S. sanguinis 
JFP47, the srtA mutation was maintained and selected for through Scr, and the wild-type 
srtA was maintained by selection for Knr.  
A CI assay was used for comparison of competitiveness of JFP47 relative to the 
competitive control JFP36. Three catheterized rabbits received an inoculum comprising 
both strains at equal optical densities. JFP47 was significantly less competitive than JFP36, 
with a mean CI value of 0.12 (range: 0.04 – 0.23). The similarity of the CI value for JFP47 
to that obtained for JFP42 (CI of 0.16) demonstrates that competitiveness in vivo was not 
restored by insertion of srtA at the SSA_0169 locus. qRT-PCR was used to determine 
whether the lack of complementation was attributed to lack of srtA expression in JFP47. 
The primer set used for detection of srtA transcript anneals to sequence deleted in creation 
of JFP42; therefore only transcript of the complete srtA gene was measured in JFP47 (Fig. 
42B). The srtA transcript abundance was compared between SK36, JFP36, JFP42 and the 
complementation strain JFP47. In JFP36 srtA transcript abundance was roughly half of that 
detected for SK36 (mean= 0.55) (Fig. 42C). The srtA transcript in JFP47 was roughly two-
thirds less abundant than in SK36 (mean= 0.3) (Fig. 42C). The decreased amount of 
transcript detected for JFP47 suggests that expression of srtA is impaired. This may be 
attributed to duplication of the gyrA promoter and titration of regulatory proteins and 
transcription factors between the two identical promoter sequences. In addition, SrtA 
production cannot be assumed from detection of srtA transcript. 
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Figure 42. Analysis of srtA transcription 
 
A) RT-PCR was used to determine whether srtA and gyrA are co-transcribed. Primers 
within the 3’ end of gyrA and 5’ end of srtA were used for PCR amplification of the 
intergenic region between the two genes, with cDNA synthesized from RNA of SK36 and 
JFP36 as template. As a control for DNA contamination RNA not treated with reverse 
transcriptase (RT) was also used as template. A transcript was detected for both SK36 
and JFP36 cDNA templates, confirming that gyrA and srtA are cotranscribed.  
 
B) Primers specific for srtA were used to detect srtA transcript in cDNA prepared from S. 
sanguinis SK36, JFP36, JFP42, JFP47. The srtA transcript was missing from JFP42 (as 
expected), but present in cDNA synthesized from SK36, JFP36 and JFP47 RNA.  
 
C) The level of transcription of srtA was determined in SK36, JFP36, JFP42 and JFP47 by 
qRT-PCR. Samples were normalized by the total amount of cDNA synthesized to control 
for differences in reverse transcription efficiency. Transcript level relative to SK36 is 
shown. The transcript level of srtA was one half or one third as abundant in JFP36, or 
JFP47, respectively. 
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Figure 42. 
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Additional phenotypes observed for JFP42 were not restored in JFP47, providing further 
evidence that functional SrtA is not produced (data not shown). One alternative, albeit less 
attractive possibility is that mutation of srtA in JFP42 resulted in polar effects unrelated to 
the loss of srtA expression.  
 To negate potential effects of duplicating the gyrA promoter, an alternative strategy 
was used for complementation of JFP42. In S. mutans a putative srtA promoter occurring 
within gyrA was reported. In this genetic background plasmid-borne srtA preceded by the 
putative promoter sequence caused partial restoration of the srtA mutant phenotype of 
decreased biofilm formation (146). A region corresponding to the predicted promoter for S. 
mutans UA159 was identified in S. sanguinis, 187 bp upstream of srtA, within the 3’ end 
of gyrA. A PCR amplicon of the putative promoter and the srtA coding region was cloned 
into the shuttle vector pVA838, resulting in pJFP50. Clones of JFP42 containing pJFP50 
were screened for restoration of the in vitro srtA mutant phenotype, adhesion to PS. 
Adhesion to PS of JFP42 was not restored by pJFP50 in any clone screened, and presence 
of pJFP50 did not affect the capacity of SK36 to adhere to PS (data not shown). The 
phenotypes of JFP42 (pJFP50) and JFP47 suggested that complementation of srtA was 
impeded by unsuccessful expression of the ORF. As promoter elements in these constructs 
were speculative, we sought to design a different complementation construct in which srtA 
would be expressed from a previously characterized promoter. The pCM18 vector was 
used for this purpose. Strong expression of the green fluorescent protein encoding reporter 
gene, gfpmut3 has been described for the pCM18-encoded L. lactis synthetic promoter, 
CP25. Green fluorescence of S. gordonii containing pCM18 confirmed that transcriptional 
 
257 
and translational signals are also recognized in streptococci (90). The promoter was 
manipulated for expression of srtA of S. sanguinis SK36 by cloning of srtA between the 
ribosomal binding site (RBSII), and gfpmut3 (Fig. 9). The resulting plasmid, pJFP52 was 
transformed into JFP42. Five clones of S. sanguinis JFP42 harboring pJFP52 were 
screened for restoration of PS adhesion, a phenotype attributed to loss of srtA expression. 
Compared to JFP42, all five clones exhibited restoration of binding equivalent to the WT 
vector control strain, SK36 (pCM18) (data not shown).  
The pCM18 vector was designed for stability in both gram-positive and gram-
negative species. Plasmid stability is critical during in vivo analysis as antibiotic selection 
cannot be used to ensure plasmid maintenance. Stability of this complementation plasmid, 
pFP52 in JFP42 was determined by growth of JFP52 in the absence of antibiotic selection 
(BHI alone), followed by plating of cells in the presence and absence of the plasmid 
selective antibiotic Em. A ~8 fold decrease in plating efficiency was observed for JFP52 
when plated in the presence of Em vs. on Sc plates alone. This difference in CFUs reflects 
the instability and loss of pJFP52 in the absence of antibiotic selection. Since this 
phenotype would negatively affect in vivo analysis, a final complementation strategy was 
employed. 
 In the final scheme for JFP42 complementation, the CP25 promoter and srtA 
coding region were cloned from pCM18 into the stable shuttle vector, pVA838. This 
strategy addressed both concerns regarding the stability of the vector used, and the capacity 
for srtA expression. The resulting plasmid, pJFP62 was transformed into JFP42, and clones 
screened for adherence to PS. The complementation strain JFP62 showed adherence to PS 
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comparable to WT and the WT vector control vs. the srtA mutant, JFP42 (Fig. 43). With 
adherence to PS restored, the possibility of co-integration of the plasmid was determined. 
Genomic DNA preparations of SK36, JFP42, both strains with the vector alone (pCM18), 
and the complementation strain JFP62 were compared by gel electrophoresis. When 
compared to the plasmid alone (pJFP62) and the vector control (pCM18) it was clear that 
the plasmid in JFP62 was maintained as an episomal element, and contained the srtA insert 
(data not shown). 
CI analysis was used to compare the competitiveness of JFP62 or JFP42 to the Tetr 
competitive control, JFP76. The mean CI value for JFP62 vs. JFP76 (0.53) was 
significantly greater than the mean CI for JFP42 vs. JFP76 (0.29) (Fig. 44A). Therefore 
competitiveness attributable to srtA was confirmed via complementation in the JFP42 
background. However, JFP42 and JFP62 were both significantly less competitive than the 
control, JFP76 (P < 0.001).  
That competitiveness of JFP62 was not completely restored may be attributed to 
slower growth of this strain as a result of maintenance of the episomal plasmid. In vitro 
growth studies comparing SK36, SK36 (pVA838), JFP42, JFP42 (pVA838), and JFP62 
demonstrated that strains harboring pVA838 grew slower (Fig. 44B). In summary, the 
partial complementation of JFP42 competitiveness by pJFP62-borne srtA suggests this 
phenotype is likely attributed to srtA, and not a polar effect of the srtA mutation in JFP42.
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Figure 43. Expression of srtA from pJFP62 restores adherence to PS 
 
The PS adherence assay was used to select a strain complementing the srtA mutant 
phenotype. Adherence was restored to levels similar to WT by expression of srtA from 
pJFP62. The presence of the vector, pVA838 alone did not affect adherence to PS in the 
SK36 and JFP42 genetic backgrounds. 
 
260 
Figure 43. 
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Figure 44. Competitiveness is partially restored in JFP62 
 
A) Competitiveness of JFP42 and JFP62 was determined relative to the virulent control 
JFP76 (Tetr SK36) with bacterial recovered at 20 hours post-infection. JFP62 was 
significantly more competitive than JFP42 (*= P= 0.0046), suggesting that reduced 
competitiveness of JFP42 is attributed to loss of srtA expression. However JFP62 was 
significantly less competitive than the control, JFP76 (**= P= 0.001).  
 
B) The lesser competitiveness of JFP62 is likely attributed to slower growth as a result of 
maintenance of pJFP62. JFP62 was compared to JFP42 and SK36 harboring pVA838 in an 
in vitro growth study. Strains adjusted to an equal OD were diluted 200-fold and growth 
monitored overnight. The growth curves of strains harboring pVA838 or its derivative, 
pJFP62 are prolonged, suggesting that maintenance of the plasmid results in slower 
growth.  
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Figure 44. 
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In vitro phenotypes related to SrtA 
 The assumption that in vivo and in vitro phenotypes of JFP42 were attributed to 
aberrant cell surface characteristics resulting from the loss of Cwa protein anchoring 
required further investigation. In past studies the approaches used to study gram-positive 
cell surface characteristics owing to sortases have included immunogold labeling for 
visualization of specific proteins by electron microscopy, catalysis of substrates by sortase-
anchored enzymes, Western blotting of cell wall protein fractions obtained by digestion 
with enzymes including lysostaphin, and mutanolysin, as well as flow cytometry of 
bacterial cells (61, 121, 123, 189). These methods require knowledge of Cwa protein 
substrates as well as tools for detection. 
 To demonstrate altered cell surface localization as a result of srtA mutation we 
focused on the most well characterized S. sanguinis Cwa protein, SrpA. In vitro 
phenotypes attributed to this protein have been previously described, and the mechanisms 
of export and glycosylation of the S. parasanguinis homolog, Fap1 revealed. A SrpA mAb 
(generously provided by Dr. Hui Wu, University of Alabama, in Birmingham, AL) was 
used to detect cell surface exposure of this protein by whole cell ELISA, and by Western 
immunoblotting of S. sanguinis cellular fractions.  
 
CwFrac for general detection of whole cells by ELISA 
 Polyclonal CwFrac antisera generated against Cwa proteins was used to detect 
differences in the amount of S. sanguinis whole cells present during the whole-cell ELISA. 
S. sanguinis JFP42 exhibits diminished adhesion to PS due to srtA mutation; therefore cells 
 
264 
of each strain were fixed to wells by 0.25 % glutaraldehyde by a previously described 
method to ensure a similar cellular density for each strain (103, 189). In the first 
experiment reactivity to serially diluted antibody was used to determine the non-saturating 
dilution of antibody for use. For this purpose CwFrac antisera was serially diluted 5,000 
fold, 10,000 fold, 50,000, fold 100,000 fold and 200,000 fold, and reactivity to the 
different dilutions of antisera determined for S. sanguinis strains SK36, JFP36, JFP76, 
JFP44, SRT18, JFP42 and VT1614. The range of reactivity for each strain over the 
dilutions used is shown in Figure 45. Near saturation was observed at a 5,000 fold dilution 
of antisera, whereas reactivity was undetectable at the 100,000 fold dilution of antisera. 
The linear trend between a 10,000 and 50,000 fold dilution of antisera represents the range 
of antibody dilution permitting specific and non-saturating detection of S. sanguinis. Based 
on these results the CwFrac antisera dilution of 1:25,000 was chosen for detection of S. 
sanguinis cells. 
 We then wanted to determine whether ELISA with CwFrac antisera could 
differentiate between differences in the number of whole cells present. Starting at the cell 
density used for SrpA ELISA (OD660 of ~0.9), cells of each strain were serially diluted 
two-fold across the plate, and then fixed to the wells by 0.25 % glutaraldehyde. Results 
showing reactivity to CwFrac (1:25,000) of serially diluted strains are shown in Figure 
46A. The stepwise decrease in reactivity with increasing serial dilution proves that CwFrac 
can be used to detect differences in the amounts of cells present. At the cell density 
examined by SrpA ELISA similar reactivity to CwFrac was demonstrated for each strain 
tested (Fig. 46B).
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Figure 45. General detection of whole cells by CwFrac 
 
Serial dilutions of CwFrac were tested against glutaraldehyde fixed whole cells of S. 
sanguinis strains shown in a whole cell ELISA. The diminishing reactivity observed as a 
function of antisera concentration reflects specific association with the S. sanguinis cell 
surface.  
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Figure 45. 
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Whole cell ELISA for detection of SrpA 
 To demonstrate difference in cell surface SrpA localization, S. sanguinis strains 
SK36, JFP36 (Emr SK36), JFP76 (Tetr SK36), JFP44 (ΔsrtB), and SRT18 (ΔsrtC) were 
compared to the srtA mutant JFP42, and the srpA mutant VT1614. The presence of SrpA 
on whole cells was determined by an ELISA with a SrpA monoclonal antibody. Wild-type 
levels of cell surface SrpA are demonstrated by SK36 and the competitive controls JFP36 
and JFP76 (Fig. 46C). The srtB and srtC mutants, JFP44 and SRT18 showed similar levels 
of SrpA to wild-type, confirming that SrpA cell surface localization is not dependent on 
these sortases. As expected the srtA mutant, JFP42 exhibited a significant reduction in cell 
surface exposed SrpA, that was restored in the complementation strain JFP62. Thus 
mutation of the putative major housekeeping sortase in S. sanguinis, SrtA, resulted in loss 
of cell surface localization of a Cwa protein substrate, SrpA.  
 Reactivity of JFP42 was slightly higher than the negative control strain, VT1614, 
deficient for SrpA production as a result of srpA genetic mutation (Fig. 46C). The defect in 
JFP42 is likely in SrtA-dependent covalent linkage of Cwa protein substrates, and not 
synthesis or extra-cytoplasmic export of precursor Cwa proteins. The limited amount of 
SrpA detected on the cell surface of JFP42 is likely residual extra-cytoplasmic, membrane 
associated protein and not protein covalently linked to PG. In the absence of the anchoring 
process, this protein is probably shed into the supernatant as previously described for other 
streptococcal SrtA mutants (189). This fate of SrpA in JFP42 was further investigated by 
immunoblotting of S. sanguinis cell fractions.  
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Figure 46. Mutation of srtA affects cell surface exposure of SrpA 
 
A) To demonstrate that CwFrac could be used for detection of different amounts of fixed 
cells in an ELISA, serially diluted S. sanguinis strains were detected with CwFrac antisera 
(1:25,000). Undiluted cells at an optical density (OD) at 600 nm of ~ 0.9 (indicated by 1), 
were diluted 2-fold, 4-fold, 8-fold, and 16-fold to establish the reactivity as the number of 
cells present decreased. A stepwise decrease in reactivity was observed with each dilution 
for all strains tested.  
 
B) The CwFrac reactivity for the dilution of cells used for detection of SrpA (undiluted 
cells at an OD at 660 nm of ~0.9) is shown.  
 
C) The reactivity of S. sanguinis whole, fixed cells to the α-SrpA mAb is shown. Mutation 
of srtA resulted in a significant decrease in surface exposed SrpA, comparable to the srpA 
mutant, VT1614. Expression of srtA from pJFP62 in the JFP42 background resulted in a 
restoration of wild-type levels of surface exposed SrpA. The amount of SrpA detected for 
in JFP44 and SRT18 suggests that cell surface exposure of SrpA is entirely dependent on 
SrtA. ***= P < 0.001 
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Figure 46. 
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SrpA immunoblot of S. sanguinis cellular fractions 
 To demonstrate the localization of SrpA in JFP42, S. sanguinis stationary phase 
cultures were used for preparation of supernatant containing secreted proteins, mutanolysin 
extracted cell wall-associated proteins, or proteins interior to the cell wall (protoplast 
proteins). Immunoblotting of the resulting protein fractions confirmed the presence of 
SrpA in the protoplast fraction, cell wall fraction and supernatant fraction of SK36 (Fig. 
47A). The immunoreactive bands in Figure 47 are typical of this glycosylated protein, and 
similar to those observed in characterization of orthologous proteins in S. parasanguinis 
and S. gordonii (240, 247, 284). The srpA gene is predicted to encode a protein of ~150 
kDa; however the carbohydrate moieties associated with this protein result in diffuse 
mobility by SDS-PAGE. SrpA was exclusively detected in the supernatant fraction of 
JFP42, suggesting that mutation of srtA results in the shedding of SrpA from the cell 
surface (Fig. 47A). This phenotype was partially complemented in JFP62, which exhibited 
enhanced cell wall association of SrpA.  
 
n-Hexadecane phase partitioning of S. sanguinis 
 In addition to the specific detection of a SrtA substrate described above, we also 
wanted to investigate a general cell surface phenotypes associated with expression of SrtA. 
One general property previously ascribed to Cwa proteins is hydrophobicity of the cell 
surface. In S. gordonii the property is partially conferred by CshA and CshB. This property 
is thought to be important for colonization of the tooth surface and maintenance as a 
member of the oral flora (278). Cell surface hydrophobicity of S. sanguinis strains was 
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Figure 47. Mutation of srtA causes extracellular accumulation of SrpA 
 
Stationary phase S. sanguinis cells were fractionated for detection of SrpA by 
immunoblotting. Supernatant associated proteins were precipitated with TCA (S), cell 
wall-associated proteins were extracted by mutanolysin treatment (M), and protoplast 
associated proteins were prepared by lytic methods (CL). In panel A the SrpA 
immunoblotting of the three protein fractions for S. sanguinis SK36, VT1614, JFP42, and 
JFP62 is shown. Mutation of srtA in JFP42 resulted in accumulation of SrpA in the 
supernatant fraction. In panel B the general protein stain SYPRO Ruby was used for 
observance of dominant protein bands in each fraction. SrpA was not readily detected by 
SYPRO Ruby, putatively attributed to the extensive glycosylation of this protein.  
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Figure 47. 
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determined by n-Hexadecane phase portioning. The percent affinity for hexadecane of each 
strain tested is shown in Figure 48. S. sanguinis SK36, competitive controls JFP36 and 
JFP76, sortase mutants JFP44 and SRT18, and the SrtA complemented strain JFP62 all 
exhibited similar, high affinities for hexadecane indicative of a strongly hydrophobic cell 
surface. Mutation of srtA resulted in significantly decreased affinity for hexadecane for 
JFP42. The shift in this cell surface property suggests deletion of srtA results in the loss of 
cell wall incorporated Cwa proteins conferring cell surface hydrophobicity. In a previous 
study the repeated in vitro passage of S. sanguinis oral isolates resulted in decreased cell 
surface hydrophobicity, and reduced adherence to hydroxyapatite (278). Therefore the loss 
of surface anchored Cwa proteins and the general shift of the cell surface of JFP42 to more 
hydrophilic state may account in part for reduced in vitro adherence phenotypes described 
above.
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Figure 48. n-Hexadecane phase partitioning of S. sanguinis strains 
 
Early stationary phase cells were vortexed with n-hexadecane (A0) for 1 minute, or left 
untreated (A), and then incubated at room temperature for 25 minutes. The optical density 
of the aqueous phase was then used to determine the percent affinity for hexadecane by the 
equation: 100 x [1 – (A0/A)]. The percent affinity for hexadecane of JFP42 was 
significantly reduced (*= P < 0.05 ), relative to JFP36, JFP76, JFP62, JFP44 and SRT18.  
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Figure 48. 
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Discussion 
 
 
 
 
From the first identification of the cell wall-associated protein class of surface 
proteins it was recognized these proteins act as mediators of gram-positive disease 
phenotypes (227). The wealth of information currently available points to diverse functions 
attributed to Cwa proteins, including cell envelope maintenance, essential cofactor 
acquisition, and adhesion (157, 184, 222). We sought to determine the role of S. sanguinis 
Cwa proteins in IE through a comprehensive analysis of predicted Cwa proteins and 
sortases of S. sanguinis SK36. The studies described here were the first to test the 
biological relevance of in vitro phenotypes previously attributed to S. sanguinis Cwa 
proteins that were thought to be important in development of IE.  
In total 33 Cwa proteins were predicted for S. sanguinis SK36. The repertoire of 
predicted Cwa proteins exceeds that of other gram-positive oral streptococci with the same 
predictive patterns applied. S. sanguinis is first and foremost a colonizer of the oral cavity, 
and member of the oral flora. The genome of S. sanguinis SK36, an oral isolate, was surely 
shaped by selective pressures encountered in this niche. Many Cwa proteins identified in S. 
sanguinis share homology with proteins described for closely related oral streptococci. 
However the identification of a small number of unique Cwa proteins for S. sanguinis 
suggests that horizontal gene transfer and genetic transformability of this strain further 
shaped the Cwa proteins encoded. S. sanguinis is a prominent streptococcus in dental 
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plaque (1), and a frequent agent of streptococcal IE (57, 67, 181). The abundance of Cwa 
proteins predicted for this species may confer a selective advantage to S. sanguinis for 
these phenotypes. Factors mediating S. sanguinis colonization of the oral cavity may serve 
dual functions to promote IE as well. For example, multiple previously described Cwa 
proteins have been shown to adhere to salivary agglutinin, as well as extracellular matrix 
proteins (110, 152, 241). In the case of SrpA, and its homolog in S. gordonii, Hsa, the 
mode of interaction for seemingly distinct phenotypes is actually quite similar. The 
recognition of sialylated glycoconjugates by Hsa has been shown to mediate association 
with salivary proteins MG2 and SAG, binding to the sialylated GP1bα platelet receptor, 
and adherence to the α2, 3 linked sialic acid of glycophorin A, an erythrocyte membrane 
protein (249, 250, 286). Recognition of sialylated glycoproteins by Hsa provides the basis 
for explanation of how this oral microbe is well suited for development of a cardiac 
disease. 
To elucidate the role of S. sanguinis Cwa proteins and sortases in early IE STM 
was applied to 31 Cwa protein and 3 sortase ORFs predicted by bioinformatics. The 
resulting pool was screened in the rabbit model of IE. Replicate, independent experiments 
confirmed that of the 31 identified Cwa protein ORFs, 28 were not required for the 
development of IE. CI assay of the remaining 3 mutants, CWA12, CWA15 and CWA30 
revealed that no single Cwa protein was required for the onset of disease. Rather than 
refuting in vitro phenotypes of S. sanguinis Cwa protein mutants considered relevant for 
disease, reduced competitiveness of the srtA mutant indicates S. sanguinis Cwa proteins 
contribute to IE, yet these proteins may perform redundant functions. Previous studies of S. 
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sanguinis platelet interaction identified 3 different Cwa protein mutants attenuated for this 
phenotype (97, 98). Simultaneous expression of these proteins during IE might negate the 
mutation of a single ORF, as additional proteins provide the same function. Perhaps the 
most striking evidence of functional redundancy comes from real-time PCR analysis of 
Cwa protein transcript levels in an isogenic mutant of S. gordonii DL1 lacking expression 
of antigen I/II homologs. Herzberg and colleagues found that with the loss of SspA and 
SspB expression, transcript abundance of other cell surface adhesins increased (292). 
Therefore an additional, unaccounted cellular response may be induced in mutants under 
selective conditions encountered in vivo and in vitro for compensation of the introduced 
mutation. 
MudPIT analysis of S. sanguinis cell wall and protoplast fractions identified several 
Cwa proteins with similar putative functions as being simultaneously abundant. Among the 
proteins detected were three Cwa proteins containing the A domain of Cna (pfam05737). 
In total 5 putative Cwa proteins of S. sanguinis were predicted to include this collagen 
adhesion domain. Two additional Cwa proteins, SspC and SspD may share this capacity as 
collagen adhesion has been described for S. gordonii antigen I/II homologs (152). 
Therefore it is possible that S. sanguinis encodes 7 proteins promoting collagen binding. 
This arsenal of putative collagen adhesins suggests that these determinants are very 
strongly selected in the oral niche. A more detailed analysis of the expression pattern and 
collagen adhesion potential of predicted adhesins is required to determine whether these 
proteins are functionally redundant or act cumulatively. The functional redundancy 
hypothesis does provide further explanation of previous findings in a random STM 
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analysis of S. sanguinis SK36, in which no Cwa protein was identified as a virulence factor 
(198). 
The analysis of an S. sanguinis srtB mutant, JFP44, and srtC mutant, SRT18 
provided additional insight to the unique role of S. sanguinis sortases during early IE. In E. 
faecalis, an unrelated common causative agent of IE, expression of SrtC was determined to 
be required for competitiveness in development of IE (183). Analysis of the S. pneumoniae 
pilus locus has also indicated that pilus polymerization is required for virulence in vivo 
(13). The arrangement and constituents of the srtC locus in S. sanguinis suggests this 
protein also acts in polymerization of Cwa protein subunits to create a pilus structure. 
However STM screening of the srtC mutant SRT18 revealed that expression of SrtC is not 
required for competitiveness in vivo. If SrtC of S. sanguinis does catalyze pilus assembly, 
then this function is not required for the onset of disease. Putative pilin subunit mutants 
CWA6, CWA7 and CWA8 also maintained competitiveness in vivo. However the effect of 
mutation on cell surface structures was not investigated. In C. diphtheriae, S. pyogenes and 
S. pneumoniae a dominant pilus subunit that composes the pilus shaft has been identified 
which contains conserved motifs directing pilus polymerization (pilin motif) and 
association with accessory pilus proteins (E box) (13, 175, 256). All putative pilus proteins 
identified for S. sanguinis were predicted to include the E box and some variation of the 
pilin motif. It is possible that these proteins are interchangeable in pilus assembly, or 
compose distinct pilus structures. The presence and composition of a pilus on the surface 
of S. sanguinis requires further investigation. 
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Expression of srtB was determined to be dispensable for development of IE by CI 
analysis of JFP44. SrtB is conserved in S. gordonii; however the Cwa protein substrate(s) 
for this sortase have yet to be identified. The work conducted in this chapter was restricted 
to putative Cwa proteins containing the LPXTG pattern. If SrtB of S. sanguinis is similar 
in function to characterized SrtB proteins of other gram-positive spp., it may anchor 
proteins with a sorting pattern deviating from LPXTG. The potential substrate PcsB, 
containing the C-terminal pattern, QPEVG and an N-terminal signal peptide (as assessed 
by SignalP), is encoded upstream of srtB. If this ORF is surface anchored by SrtB, the 
experiments described provide evidence that it is not required for establishment of disease. 
As the most pronounced in vivo phenotypes were observed for the srtA mutant, this 
strain as well as srtB and srtC mutants were used for further characterization of cell surface 
phenotypes. Cell surface hydrophobicity was significantly decreased following mutation of 
srtA. Bacterial cell surface hydrophobicity is commonly used as an indicator for the 
propensity of bacteria to interact with the surrounding environment. In fact, cell surface 
hydrophobicity is correlated with co-aggregation between bacterial cells, adherence to 
hydrophobic surfaces, and adherence to fibrin in vitro (101, 168). S. sanguinis binding to a 
highly hydrophobic polystyrene surface was also decreased by mutation of srtA. These 
findings suggest that expression of SrtA and potential Cwa protein substrates of SrtA 
confer this cell surface property. Cell surface expression of the Cwa protein SrpA was also 
tested in isogenic mutants of S. sanguinis SK36. SrpA was not cell surface exposed 
following mutation of srtA, the putative major sortase of S. sanguinis SK36. The defect in 
Cwa protein substrate surface anchoring coupled with a global shift to a more hydrophilic 
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cell surface following deletion of srtA suggests that reduced competitiveness observed for 
JFP42 may be attributed to the loss of more than one Cwa protein virulence determinant 
from the cell surface. 
The studies described here established that SrtA is required for full competitiveness 
in development of IE. This is in keeping with previously described analyses of SrtA 
homologs in other gram-positive pathogens. In fact, the clearest evidence of Cwa protein 
contribution to disease has been gleaned from in vivo characterization of sortase mutants 
(113, 135, 145, 200). The 10-fold reduction in competitiveness for JFP42 and persistence 
of this strain in individual inoculum assays indicates that S. sanguinis IE is a process 
mediated by multiple factors additional to Cwa protein and sortase expression. This is in 
contrast to a lipoprotein mutant identified for S. sanguinis which exhibits a 3,000-fold 
reduction in competitiveness in vivo (Dr. Sankar Das, personal communication).  
The observation that SrtA expression is required for normal colonization 
phenotypes does introduce a possible target for preventative therapies. A combination 
multi-gene DNA vaccine combining plasmid-encoded clumping factor A (ClfA), 
fibronectin binding protein A (FbpA), and SrtA was demonstrated to elicit a protective 
response against S. aureus and increased survival in a murine infection model (78). This 
presents a possibility for advancement of preventative measures against S. sanguinis IE.  
 
  
 
GENERAL DISCUSSION 
 
The incidence of infective endocarditis has remained unchanged over the past two 
decades, despite advances in diagnostics methods, antimicrobial and surgical therapies, and 
complication management (176). The undeterred rate of infection is in part due to changing 
risk factors for this disease. In the pre-antibiotic era the predominant risk factor for IE was 
chronic rheumatic heart disease, which is now rare in industrialized countries (171). This 
risk group has been replaced with persons vulnerable due to high-risk behaviors, or more 
aged populations prone to pre-disposing cardiac risk factors. The majority of IE cases (~70 
% of NVE episodes) are attributed to staphylococci and streptococci. As for the new risk 
groups, intravenous drug users are most commonly afflicted with S. aureus IE, with skin 
flora as the major source. The incidence of Streptococcus bovis as a causative agent of 
disease increases proportionally with age–an observation potentially attributed to a greater 
rate of digestive tumors in the elderly (176). These emerging trends are reflective of 
changing population dynamics in developed countries and imply that IE will remain a 
health-care concern in the future.  
Viridians streptococci are the most common causative agents of streptococcal IE (at 
least 50 % of community acquired NVE cases not associated with drug use; 282) and 
multiple reports implicate S. sanguinis as the most common causative agent of viridans 
streptococcal IE (57, 67, 216, 272). American Heart Association guidelines for patients at 
 282  
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risk for IE undergoing dental procedures have shifted drastically in the past 60 years in 
concert with the recognition that most cases of IE cases are not attributed to dental 
treatment, but are more likely caused by daily activities. The latest guidelines noted that 
both dental treatment and daily tasks induce similar densities of bacteria in the blood, yet 
routine activities are much more likely to cause bacteremic events resulting in IE. The 
authors suggested that the risk of bacteremia associated with IE would be better prevented 
by improved oral health care in at-risk patients with underlying heart conditions. In 
patients most at risk, antibiotic prophylaxis may still be recommended, with the 
acknowledgement that only a small number of cases are preventable by this strategy (281).  
Antimicrobial therapy for treatment of IE is equally complex, with extensive 
treatment regimens suggested. One complication of this therapy is penetration of 
antimicrobial compounds within the fibrin-platelet meshwork of the vegetation, which has 
been demonstrated as refractory to antimicrobials in the past (51). This observation, in 
addition to the risk of increased antimicrobial resistance among bacterial agents of IE 
highlights the critical importance of development of prophylactic measures against IE for 
at-risk groups. Thus far the most promising vaccine candidate for viridans group 
streptococci is the lipoprotein FimA of S. parasanguinis. Expression of FimA was required 
for development of S. parasanguinis IE (34).  Administration of a FimA immunogen was 
found to be protective against S. parasanguinis IE, as well as IE caused by additional 
viridans streptococcal species predicted to encode FimA homologs including S. mitis, S. 
mutans, and S. salivarius (127, 271). Further molecular characterization of S. sanguinis IE 
determinants is necessary for advancement of our understanding of this disease. The aims 
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of experiments described here included the characterization of a previously described IE 
virulence determinant, the development of genetic tools facilitating the screening and 
identification of virulence factors for IE, and identification of putative adhesins required 
for development of IE through a comprehensive analysis of S. sanguinis Cwa proteins in 
vivo.  
 In Chapter III the requirement of NrdD for anaerobic growth of S. sanguinis SK36 
was explored. As documented for L. lactis, S. aureus and E. coli, evaluation of NrdD in S. 
sanguinis was complicated by residual function of the Class Ib RNR under microaerophilic 
conditions. Instead of supplementing growth media with class I RNR inhibitors, fully 
reduced soft-agar was used for evaluation of nrdD mutant strains. Transposon insertion 
and in-frame deletion mutagenesis of nrdD both resulted in arrested anaerobic growth, 
confirming the requirement for NrdD expression in the absence of oxygen. In an STM 
analysis of genes required for Proteus mirabilis urinary tract infection an attenuated nrdD 
mutant was also identified. The authors suggested that oxygen-limiting conditions may 
develop during urinary tract infection as a result of high bacterial cell density (31). This 
may also be the case in IE, in which bacteria have been documented to grow within the 
vegetation to reach cell densities of 108 to 1011 CFU per gram of vegetation (64). The 
bacteria likely proliferate, protected from circulating host defense mechanisms by layered 
fibrin-platelet matrices. The aerobic metabolism of the streptococci may generate a 
progressively reduced condition that can not be relieved by oxygenated blood surrounding 
the vegetation. This study was not the first to propose anaerobiosis of the infective 
vegetation; a previous screen of S. aureus STM mutants in the rabbit model of IE 
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demonstrated that anaerobic/microaerophilic mutants were attenuated in vivo (50). 
However, staphylococcal and streptococcal pathologies in IE are quite different in that 
staphylococcal infection is typically more acute and invasive, whereas streptococcal IE 
infection often presents as sub-acute, with some features of chronic disease. In addition, 
the attenuated staphylococcal mutants were not characterized, and therefore the nature of 
mutations conferring anaerobic sensitivity is not known. In vitro characterization of the 
avirulent nrdD mutant (198) provided further insights to streptococcal factors required for 
persistence in vivo. The extreme measures required for demonstration of anaerobic 
sensitivity of S. sanguinis nrdD mutants suggest that anaerobiosis occurs within the 
infective vegetation–and the time course of in vivo infection confirms that this occurs 
within 20 hours of the onset of bacteremia. Although oxygen levels within the infective 
vegetation have not been measured, the findings described suggest a restriction of oxygen 
availability at the site of infection.   
The publication of the SK36 S. sanguinis genome sequence in 2007 realized the 
possibility for greater characterization of this species, with this strain serving as the model. 
Of particular interest to the medical community is identification of S. sanguinis virulence 
determinants that may serve as targets for prophylaxis of IE. In keeping with this goal, in 
Chapter IV a locus was identified that may be used for genetic manipulation without 
directly affecting important cellular phenotypes including in vitro growth, genetic 
competence, biofilm formation, and competitiveness in the rabbit model of IE. The 
plasmid repertoire developed for this purpose, with three different antibiotic resistance 
determinants, could be expanded to include additional selective markers, or for ectopic 
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expression of native genes to allow for complementation of mutations elsewhere on the 
chromosome. Two of the strains developed in Chapter IV, JFP36 and JFP76 were used as 
controls for competitive index analyses in Chapter V to establish the competitiveness of 
Cwa protein mutant or sortase mutant strains–with successful discrimination between 
differing levels of competitiveness in mutants tested. Therefore a genetic tool has been 
developed which will facilitate the future screening and identification of S. sanguinis 
virulence determinants.  
In Chapter V the contribution of S. sanguinis Cwa proteins to early experimental IE 
was investigated. Cwa proteins are attractive vaccine targets as they are surface exposed, 
and have been demonstrated to interact with host cell surface receptors and extracellular 
matrix proteins. S. sanguinis SK36 putatively encodes 33 Cwa proteins; mutants defective 
for production of 31 of these proteins were included in a comprehensive STM screen. A 
srpA mutant (204), which lacks the 32nd Cwa protein, was also tested in the rabbit model of 
IE by competitive index analysis. The in vivo experiments described demonstrated that no 
single Cwa protein was required for development of IE–a finding that is counterintuitive 
given past characterization of this protein family in animal infection models. Among the 
predicted Cwa proteins encoded by S. sanguinis it is likely that SrtA is responsible for cell 
surface localization of the majority. Competitive index analyses of a srtA mutant 
determined expression of srtA to be required for full competitiveness in vivo, with Cwa 
proteins dependent on SrtA for surface-anchoring putatively mediating initial contacts for 
colonization of the sterile thrombus. Homology searches of predicted S. sanguinis Cwa 
proteins indicate that several proteins may be grouped by functional similarity, and may be 
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redundant in vivo. This possibility is most clearly evidenced by the srtA mutant strain, 
which would likely be defective for surface localization of the majority of Cwa proteins 
(including groups of putatively functionally redundant proteins). The srtA mutant does 
provide an opportunity for further characterization of the general contribution of S. 
sanguinis SrtA-dependent Cwa protein substrates to IE. Of particular interest is 
characterization of streptococcal-host factor interactions, including the assessment of 
platelet-interaction, adherence to fibrin-platelet matrices, and resistance to phagocytosis.  
Expression of SrtA has also been linked to infectivity in S. aureus IE, with lesser 
srtA mutant bacterial recovery following 2 days of infection (276). In contrast to S. aureus, 
srtA expression in S. sanguinis may be important for colonization of the vegetation, but not 
in replication following colonization, in that bacterial numbers recovered from rabbits 
infected at 20 hours were not significantly different between the srtA mutant and a wild-
type strain. These findings imply that SrtA, in addition to unidentified SrtA-dependent 
Cwa proteins mediating vegetation colonization may serve as candidates for prevention of 
IE onset.  
Gram-positive Cwa proteins have been tested as vaccine candidates in the past, 
with some success (35, 78, 178, 225). However several complications arise in developing a 
Cwa protein based preventative strategy for S. sanguinis IE. S. sanguinis is benign in the 
oral cavity and may actually be beneficial in this niche through competitive inhibition of 
oral pathogens (132). An optimal vaccination strategy would balance the advantageous 
contribution of S. sanguinis in the oral flora while reducing the propensity for IE by 
targeting surface proteins specifically expressed in transient bacteremia. Thus far S. 
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sanguinis proteins uniquely expressed during bacteremia have not been described, and it is 
possible that few candidates will arise as S. sanguinis is an opportunistic agent of IE that 
evolved primarily for maintenance in the oral cavity. A future direction for prophylaxis 
research should include expression analysis of S. sanguinis genes during bacteremia for 
identification of proteins that are enhanced under these conditions relative to growth in an 
oral biofilm. Such a study would require the development of an adequate control condition 
for relative expression analysis; however it is feasible given the availability of a genomic 
microarray for S. sanguinis SK36.  
 Additional considerations for prophylactic strategies include identification of 
vaccine candidates shared among S. sanguinis endocarditis isolates to identify those most 
common in nature, and the use of proteins conserved among common causative agents of 
viridans IE. Acknowledgement of the natural complexity of resident flora is required for 
production of an efficacious preventative strategy. In addition, the protection afforded by 
the previously identified immunogen FimA warrants further investigation (127, 271). Of 
particular interest is the immunology governing the inhibition of IE by vaccination with 
FimA. Identification of specific immunological factors that potentiate this response may 
direct the conception and optimization of future preventative strategies.  
Experimental analyses of antibody penetration within the vegetation have shown 
the fibrin-platelet matrices to form a sheath that limits access of antibody to bacteria within 
the vegetation (166). Due to the complications with identification of an optimal IE-specific 
virulence candidate described above, an attractive alternative may include the development 
of vegetation diffusible small-molecule inhibitors against prokaryotic genes known to be 
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expressed during IE. One potential target includes NrdD, which has no eukaryotic 
counterpart. The time course of anaerobiosis in IE would require further monitoring to 
assess the feasibility of this. If anaerobiosis within the vegetation occurs within hours of 
colonization, then progressive vegetation enlargement owing to reseeding of bacteria at the 
site of infection, or outgrowth of bacteria within the vegetation may be avoided. However 
if anaerobiosis occurs later in infection, after the vegetation has achieved a mass resulting 
in frequent septic embolization, then efficacy would be diminished.  
 Conclusions derived from experiments performed here, in combination with the 
previous random STM screen for S. sanguinis virulence determinants present a model of 
streptococcal transition between initial colonization of the vegetation and growth following 
colonization. During transient bacteremia the streptococci express and utilize surface-
exposed proteins, including SrtA-dependent Cwa proteins, for colonization of the site of 
endothelial damage in a process that may be dependent on a sterile thrombus. Surface 
localization of these proteins does not appear to be important for growth following 
adherence, at 20 hours post colonization. Instead genes encoding for cytoplasmic proteins 
with housekeeping functions like bacterial cell wall synthesis, generation of nucleic acids 
and amino acids, and anaerobic condition-specific genes are required for persistence (198). 
Expression analyses of streptococcal genes at different times post-infection may aid in 
understanding of this complex and multi-factorial disease, as well as identification of 
future therapeutic targets. 
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APPENDIX A 
 
Oligonucleotides for PCR amplification 
 
ARTR-SalI-24495-up ...GCTTTTGGTCGACAATATCGCAGCCAAG 
ARTR-23327-dn ...........AGCCATTCATATGCTTGACTGGAGCAGTTTCAAACTTC 
ARTR-21212-up ...........GTCAAGCATATGAATGGCT 
ARTR-SalI-20031-dn ...TGGTGCGTCGACTGGCTTCGTTGTCTTC 
ARTR-EcoRI-up1.........AAAACAGTCAGCCGAATTCTATTT 
ARTR-EcoRI-up2.........AGGTTTAAAGAGAATTCATTTGTCCTAAGGG 
ARTR-EcoRI-dn...........TTCGAATTCTGGTCGTCTCAGCTCC 
spcUP............................CCGCTCTAGAACTAGTGGATCC 
spcDO ...........................CAATTTTTTTATAATTTTTTTAATCTG 
DAM303.......................AAGGGCCCGTTTGATTTTTAATG 
DAM347.......................CCGAATTCTAGGTACTAAAACAATTCATCCAGTAA 
0169-SalI-up .................CCGGTCGACTGTCTATGGTGGACAGCGTCC 
0169-SalI-dn .................CCGGTCGACTCGTGACGGAAGCAGACTTGG 
pSerm-NcoI-up .............CATGCCATGGCCGGGCCCAAAATTTGTTTGAT 
pSerm-NcoI-dn .............CATGCCATGGAGTCGGCAGCGACTCATAGAAT 
1069RE-up....................CATGGGTGACGCGGCCGCTGCAGGCGCGCCTGCGAACA 
1069RE-dn....................CATGTGTTCGCAGGCGCGCCTGCAGCGGCCGCGTCACC 
Sc-NotI-up ....................CCGGCGGCCGCCCGCTCTAGAACTAGTGGATCC 
Sc-NcoI-dn....................TCTCGACCATGGCAATTTTTTTATAATTTTTTTAATCTG 
Tet-NotI-Up ..................CAGTCGGCGGCCGCCTAGGTTGATTTTCGTTC 
Tet-NcoI-Dn .................TCTCGACCATGGCTAGGTCACTAAGTTATTTT 
TetMF1 .........................TGTGTGTGACGAACTTTACCGA 
TetMF2 .........................TCTGCAAAAGATGGCGTACAAGC 
6-26-BamHI-up.............AAGCGGATCCAGTACGCCTGGGCGAAGACC 
6-26-BamHI-dn.............TGGCGGATCCTTTCCCACGCGCAGAGGGAC 
srtA1 .............................GTAATAGCGAAACGGACGCAGAAGC 
srtA2 .............................GGATCCACTAGTTCTAGAGCGGAAAGATTAAGCCTAGGGCCAC 
srtA3 .............................CAGATTAAAAAAATTATAAAAAAATTGGTCGAGTATGACAAGGCT 
 CCT 
srtA4 .............................TGAGGGTGTCAAAGAAGTTGGCGGA 
srtB1..............................TCATCCAGTCTTATCTGGTCCTGCT 
srtB2..............................CATTAAAAATCAAACGGGCCCTTGCAAATGCCAACAACAAAGAGC 
 TGT 
srtB3..............................TTACTGGATGAATTGTTTTAGTACCTAGAATTCGGGATTTTCTGGA 
 CAAGCATGGCAAG 
srtB4..............................AATCGTCTCCATACTAGCCGCATAG 
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Oligonucleotides for PCR amplification 
 
0169-2...........................CTTCCCAGTTGTAATCCAAGA 
0169-3...........................TTACTGGATGAATTGTTTTAGTACCTAGAATTCGGATATTTCTTAT 
 CATCGGGTTT 
0169srtAP .....................TCTTGGATTACAACTGGGAAGGCGATGTAAACGTTTTTACAAACG 
 GTTCAAAATACTGAAAAATTAAAGAAAATGTCGAATCGTAAAAG 
 AGGACCTC 
kansrtA..........................CATTAAAAATCAAACGGGCCCTTCGGAAAAAGAGTCAAAATCAG 
 CAAG 
srtA-EcoRI-up...............AAGCGAATTCTAGCTAGTGAGTATC 
srtA-EcoRI-dn...............GTTAGAATTCTTTCTAACCTTTGGAGTG 
srtA-SphI-up .................GGACGCATGCATGGTACAAGGA 
srtA-SphIdn...................GAGTGCATGCTAACCTTTGGAGTG 
pJFP52srtA-up ..............CCGGCTCGTATGTTGTGTGG 
pJFP52EcoRI-dn...........GTCTGAATTCTTACGCATGCTAACCTTTGG 
 
Oligonucleotides for transcript detection 
 
0169-F...........................ATGAAGCAAAAACCCGATGA 
0169-R ..........................TTTTCTGGAAGCTGTTCTGGA 
1220-IG-1219 F ............TTTACAAGCGTCGAAGCAGA 
1220-IG-1219 R............AAGCCTAGGGCCACAAAAAT 
1219-F (srtA) ................GGCATCACAGGGGCTAGTAA 
1219-R (srtA) ................CGCAGCATCCTCACAAGTAA 
16S-F ............................TTCGGATCGTAAAGCTCTGTTG 
16S-R ............................GTAGTTAGCCGTCCCTTTCTGG 
 
Oligonucleotides for screening and sequencing  
 
Jxn-up ...........................GTCCTGCTTTATGCTCGACTG 
Jxn-dn ...........................CGCATCCAGTAAAGTGCTGG 
Mout .............................CCGGGGACTTATCAGCCAACC 
PB1 ...............................GATCTCTACAACCTCAAGC 
PB2 ...............................TCCATTCTAACCAAG 
PB11 .............................TCTACAACCTCAAGC 
PB12 .............................TCCATTCTAACCAAG 
spc246...........................TCAATGGTTCAGATACGACGACT 
spc638...........................GCCGTATGATTTTAACTATGGAC 
kan306R........................AGCCATCATGCCGTTCAAAGTGC 
kan637F ........................CACGGCGACCTGGGAGACAGCAA 
CP25 .............................CTTTGGCAGTTTATTCTTGA 
gfpmut...........................TTGTGCCCATTAACATCACC 
pVA838-2245 ...............AGGCGTTTAAGGGCACCAAT 
pVA838-2939 ...............GTAACACGCCACATCTTG 
pVA838-5331 ...............CCAATGGCATCGTAAAGAAC 
 
315 
 
 
APPENDIX B 
 
Oligonucleotides for directed signature-tagged mutagenesis 
  
SSA_1112-up................TGACGATGGCAGCAGTGACTC 
SSA_1112-dn................ACACTCCCCGATACGAGCCTC 
SSA_2023-up................AGTTTCAAATCACGGAGCCGCTGC 
SSA_2023-dn................ACGTAGTAAGTCATGGCCGCA 
SSA_1663-up................TTTGGGAGAAATTGAGGCCGCT 
SSA_1663-dn................ACAAACCCAGTAGGAGCAAGGCTC 
SSA_1591-up................GTGTCAACCGTTGCCAATCAC 
SSA_1591-dn................TCTTTGGATAGCTGGCGGAGC 
SSA_0805-up................GCTGTGACAGCAGTTGGTG 
SSA_0805-dn................TCAGGGTACGCAGGCCCTC 
SSA_1634-up................GACGGTTACACCGGATTCC 
SSA_1634-dn................CTTGTTCGCCCAGCAGCAG 
SSA_1633-up................CGGGACAACACCCCAAAGC 
SSA_1633-dn................AGCTTTGACCTCCGCAGAG 
SSA_1632-up................AGTGCTACCTTAGGAACGACC 
SSA_1632-dn................TCCCTTGACCGCCAACTGG 
SSA_0956-up................CCTTGGATGAACTGTTAGCGAC 
SSA_0956-dn................TGTCAAGACGGCCTGGGGCTC 
SSA_0227-up................CAAGAAGATGACGGAGGAAACG 
SSA_0227-dn................AAAGATGGTTACACACCGAGC 
SSA_0565-up................GCTCAACAGGTCGTCCAAACC 
SSA_0565-dn................TGTGCCTGAGCCAGTTGCTGG 
SSA_1301-up................TGGTCGGACTTTTGACCAAGC 
SSA_1301-dn................TGCTGCTAGAACTGCCTGAGC 
SSA_0303-up................TGATGAAGCCTTGACTGGTGC 
SSA_0303-dn................CCAAGCCTTATCATTGCGGAATTG 
SSA_0273-up................CCCATACTCCGATGCTGGACG 
SSA_0273-dn................AAAGTCCATCTCAAATGGCTCAG 
SSA_1023-up................TCTATGGAGACGGTCCTGACA 
SSA_1023-dn................CAAAGCGAGTCATTTCTAATACTGG 
SSA_1019-up................TCGCTCTTATGCAGACATGC 
SSA_1019-dn................TGAACGGCAGCACCGTCTG 
SSA_1631-up................CGATGATGCTGTTATGGGTGGTCT 
SSA_1631-dn................TCCTACTTTAGATGGCGGTGCT 
SSA_0905-up................CGATTCGGAAACTAAACGTCGGTG 
SSA_0905-dn................CTGCCTCATTAATTGGCACACG 
SSA_0906-up................AGGATTGGATTCACGAGGCGGACTC 
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Oligonucleotides for directed signature-tagged mutagenesis  
 
SSA_0906-dn................TGACCGTCACCGAGGCTGGGGTTC 
SSA_1219-up................TTAATGTCCAGCAAGACCGCAGTG 
SSA_1219-dn................CCAGTATGATAGATGTCGCCAG 
SSA_0684-up................ACTTTGAAGTTCGTGAGCGTGCAG 
SSA_0684-dn................TTTAGCCGGCTGTGTCGGGGTGGCT 
SSA_1234-up................TCGCTCAGGATGGTCCTGC 
SSA_1234-dn................TCAAGGCAACTGCTGATTCG 
SSA_0022-up................TTTCACTTTTCGCGGCTGCTG 
SSA_0022-dn................AGCCGACAAGGCCTCTGTTGCGCCA 
SSA_1063-up................AGGTTCCACATCTAACGGACGTG 
SSA_1063-dn................AGGGTAAATACTACAGGGCGGACC 
SSA_2020-up................TTAACGTTGAGCACTTGGCCGA 
SSA_2020-dn................ATCAACCTGACTGGTCCGAGCAGC 
SSA_0167-up................AGCCTCTACTTCTAGCCCCATGG 
SSA_0167-dn................GGCTGATAGAATAAGCAGCTGCAC 
SSA_0146-up................AGGTAAAACGCGACCTGTC 
SSA_0146-dn................AGAGCCGCCATTTGAGGAGCGCT 
SSA_0453-up................TGCTCAATCTGGTCTCCGGTGTGGT 
SSA_0453-dn................GCACCGACAGATCCAGCCAAGCGCA 
SSA_1666-up................TATTGACCAAGGCGGAACTCC 
SSA_1666-dn................ATAGTCCGGATTCAGCGCCAG 
SSA_1065-up................CCCAACCGGTAGCGTTGGTTG 
SSA_1065-dn................TGATACCATCCTTGATGAGCGGCAC 
SSA_0904-up................TCCTTTTAGGTACTGCGGCTACAG 
SSA_0904-dn................ACCTTGAATGCCCTCGCTGCTGGCA 
SSA_1750-up................AGAAGGTAGCTATCAGCCAGC 
SSA_1750-dn................TTGAGACGGTTGGGAGCTGTC 
SSA_2121-up................TTCCTTTATGGTTGCGGCCAG 
SSA_2121-dn................TCCAACCGTTAGCAGCCGTCA 
SSA_0243-up................AGACATAGTCATGGCGAACCTC 
SSA_0243-dn................TGGTTGCTCAATAGGAACCGGT 
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